TWI687161B - Ester compounds and use thereof - Google Patents

Ester compounds and use thereof Download PDF

Info

Publication number
TWI687161B
TWI687161B TW106111751A TW106111751A TWI687161B TW I687161 B TWI687161 B TW I687161B TW 106111751 A TW106111751 A TW 106111751A TW 106111751 A TW106111751 A TW 106111751A TW I687161 B TWI687161 B TW I687161B
Authority
TW
Taiwan
Prior art keywords
compound
trifluorobenzyl
methyl
present
trans
Prior art date
Application number
TW106111751A
Other languages
Chinese (zh)
Other versions
TW201739353A (en
Inventor
松尾憲忠
香谷康幸
中山幸治
Original Assignee
日商大日本除蟲菊股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商大日本除蟲菊股份有限公司 filed Critical 日商大日本除蟲菊股份有限公司
Publication of TW201739353A publication Critical patent/TW201739353A/en
Application granted granted Critical
Publication of TWI687161B publication Critical patent/TWI687161B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/743Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of acids with a three-membered ring and with unsaturation outside the ring
    • C07C69/747Chrysanthemumic acid esters

Abstract

提供一種具有優良的有害生物防除效力的化合物。 Provide a compound with excellent pest control effect.

一種酯化合物及使用該酯化合物之有害生物防除劑及有害生物防除方法,以下列的通式[化1](I)表示:

Figure 106111751-A0305-02-0001-90
An ester compound and a pest control agent and pest control method using the ester compound are represented by the following general formula [Chem 1] (I):
Figure 106111751-A0305-02-0001-90

[式中R1是表示氫原子或甲基,R1表示甲基時R2也表示甲基,而且R1表示氫原子時R2為以下列通式[化2](2)

Figure 106111751-A0305-02-0001-91
[Where R 1 represents a hydrogen atom or a methyl group, when R 1 represents a methyl group, R 2 also represents a methyl group, and when R 1 represents a hydrogen atom, R 2 represents the following general formula [Chem 2] (2)
Figure 106111751-A0305-02-0001-91

(此處X及Y為同一或不同,表示氫原子、鹵素原子、 氰基、碳數1~4的烷基、碳數2~5的烷氧基羰基或碳數1~4的鹵烷基)表示的基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基]。 (Here X and Y are the same or different, and represent a hydrogen atom, a halogen atom, a cyano group, a C 1-4 alkyl group, a C 2-5 alkoxycarbonyl group or a C 1-4 haloalkyl group ), R 3 represents a hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, ethynyl or propynyl].

Description

酯化合物及其用途 Ester compounds and their uses

本發明是關於酯化合物以及使用該酯化合物的害蟲防除劑及害蟲防除方法。 The present invention relates to an ester compound, a pest control agent using the ester compound, and a pest control method.

以往為了防除有害生物而合成種種的化合物(參照非專利文獻1、2)。而且,在專利文獻1、2及3揭示有某種酯化合物。但是,該等揭示的有害生物防除成分的防除效力未必令人滿意。 Conventionally, various compounds have been synthesized to prevent harmful organisms (see Non-Patent Documents 1 and 2). Furthermore, Patent Documents 1, 2 and 3 disclose certain ester compounds. However, the effectiveness of the disclosed pest control ingredients may not be satisfactory.

[專利文獻1]:日本國特開昭57-165343號公報 [Patent Document 1]: Japanese Patent Laid-Open No. 57-165343

[專利文獻2]:日本國特許第4289331號公報 [Patent Literature 2]: Japanese Patent No. 4289331

[專利文獻3]:日本國特許第2647411號公報 [Patent Document 3]: Japanese Patent No. 2647411

[非專利文獻1]:[續醫藥品的開發 第18卷 農藥的開發III]、廣川書店、1993年、p.493 [Non-Patent Document 1]: [Continued Development of Pharmaceuticals Volume 18 Development of Pesticides III], Guangchuan Bookstore, 1993, p.493

[非專利文獻2]:[擬除蟲菊酯(pyrethroid)]、Springe公司、2012年 [Non-Patent Document 2]: [Pyrethroid (pyrethroid)], Springe, 2012

本發明是以提供具有優良的有害生物防除效 力的新穎酯化合物及使用該酯化合物的害蟲的驅除方法為課題。 The present invention is to provide an excellent pest control effect A powerful novel ester compound and a method for eradicating pests using the ester compound are problems.

本發明人們考慮了可藉由將拜富寧(transfluthrin)、美特寧(metofluthrin)及丙氟菊酯(profluthrin)所代表的四氟苄基酯(tetrafluorobenzyl ester)化合物的芳香環上的F原子取代成Cl原子或Br原子而開創具有殘餘效應(residual effect)的提高等優良的特性之化合物。專心致志進行了檢討的結果發現,以下列通式(1)表示的酯化合物(以下有稱為含Cl酯化合物的情形),或以下列通式(I)表示的酯化合物(以下有稱為含Br酯化合物的情形)具有優良的有害生物防除效力,而達到完成本發明。 The inventors considered that the F atom on the aromatic ring of the tetrafluorobenzyl ester compound represented by transfluthrin, metofluthrin, and profluthrin Substitution of Cl atoms or Br atoms creates compounds with excellent characteristics such as improvement of residual effects. As a result of a dedicated review, it was found that the ester compound represented by the following general formula (1) (hereinafter referred to as a Cl-containing ester compound), or the ester compound represented by the following general formula (I) (hereinafter referred to as containing In the case of Br ester compound), it has an excellent pest control effect, and the present invention has been completed.

也就是說,本發明是關於以下的發明。 In other words, the present invention relates to the following inventions.

[1]、一種酯化合物,以下列的通式[化1](1)表示:

Figure 106111751-A0305-02-0004-3
[1] An ester compound, represented by the following general formula [Chem 1] (1):
Figure 106111751-A0305-02-0004-3

[式中R1是表示氫原子,R2為以下列通式[化2](2)[化2]

Figure 106111751-A0305-02-0005-4
[Where R 1 represents a hydrogen atom, and R 2 is represented by the following general formula [Chem 2] (2) [Chem 2]
Figure 106111751-A0305-02-0005-4

(此處X及Y為同一或不同,表示氫原子、鹵素原子、氰基、碳數1~4的烷基、碳數2~5的烷氧基羰基(alkoxy carbonyl group)或碳數2~4的鹵烷基(haloalkyl),X表示氫原子時Y表示氫原子、鹵素原子、碳數1~4的烷基、或碳數2~5的烷氧基羰基,X表示鹵素原子、氰基、碳數1~4的烷基、碳數2~5的烷氧基羰基或碳數2~4的鹵烷基時,Y表示鹵素原子、氰基、碳數1~4的烷基、碳數2~5的烷氧基羰基或碳數2~4的鹵烷基)表示的基,R3是表示氫原子、三氟甲基(trifluoromethyl)、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基]。 (Here X and Y are the same or different, and represent a hydrogen atom, a halogen atom, a cyano group, a C 1-4 alkyl group, a C 2-5 alkoxy carbonyl group (alkoxy carbonyl group) or a C 2~ Haloalkyl of 4, when X represents a hydrogen atom, Y represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 4 carbon atoms, or an alkoxycarbonyl group having 2 to 5 carbon atoms, and X represents a halogen atom, a cyano group , Alkyl having 1 to 4 carbons, alkoxycarbonyl having 2 to 5 carbons or haloalkyl having 2 to 4 carbons, Y represents a halogen atom, cyano, alkyl having 1 to 4 carbons, or carbon Alkoxycarbonyl group having 2 to 5 or haloalkyl group having 2 to 4 carbons), R 3 represents a hydrogen atom, trifluoromethyl (trifluoromethyl), methyl, methoxy, methoxymethyl Radical, allyl, ethynyl or propynyl].

[2]、一種酯化合物,以下列的通式[化3](I)表示:

Figure 106111751-A0305-02-0005-5
[2]. An ester compound represented by the following general formula [Chem. 3] (I):
Figure 106111751-A0305-02-0005-5

[式中R1是表示氫原子R2為以下列通式[化4](II)[化4]

Figure 106111751-A0305-02-0006-6
[Where R 1 represents a hydrogen atom R 2 is represented by the following general formula [Chem 4] (II) [Chem 4]
Figure 106111751-A0305-02-0006-6

(此處X及Y為同一或不同,表示氫原子、鹵素原子、氰基、碳數1~4的烷基、碳數2~5的烷氧基羰基或碳數2~5的鹵烷基,X表示氫原子時Y表示氫原子、鹵素原子、碳數1~4的烷基、或碳數2~5的烷氧基羰基,X表示鹵素原子、氰基、碳數1~4的烷基、碳數2~5的烷氧基羰基或碳數2~5的鹵烷基時,Y表示鹵素原子、氰基、碳數1~4的烷基、碳數2~5的烷氧基羰基或碳數2~5的鹵烷基)表示的基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基]。 (Here X and Y are the same or different and represent a hydrogen atom, a halogen atom, a cyano group, a C 1-4 alkyl group, a C 2-5 alkoxycarbonyl group or a C 2-5 haloalkyl group , X represents a hydrogen atom, Y represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 4 carbon atoms, or an alkoxycarbonyl group having 2 to 5 carbon atoms, X represents a halogen atom, a cyano group, an alkyl group having 1 to 4 carbon atoms When a group, an alkoxycarbonyl group having 2 to 5 carbon atoms or a haloalkyl group having 2 to 5 carbon atoms, Y represents a halogen atom, a cyano group, an alkyl group having 1 to 4 carbon atoms, and an alkoxy group having 2 to 5 carbon atoms Carbonyl or haloalkyl having 2 to 5 carbon atoms), R 3 represents a hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, ethynyl or propyne base].

[3]、如[1]或[2]之酯化合物,其中R3是以氫原子表示。 [3]. The ester compound as in [1] or [2], wherein R 3 is represented by a hydrogen atom.

[4]、如[1]或[2]之酯化合物,其中R3是以甲基表示。 [4]. The ester compound as in [1] or [2], wherein R 3 is represented by a methyl group.

[5]、如[1]或[2]之酯化合物,其中R3是以甲氧基甲基表示。 [5]. The ester compound as in [1] or [2], wherein R 3 is represented by methoxymethyl.

[6]、如[1]之酯化合物,其中R3是以乙炔基表示。 [6]. The ester compound as in [1], wherein R 3 is represented by ethynyl.

[7]、一種酯化合物,以下列的化學式[化48](38)表示:

Figure 106111751-A0305-02-0006-89
[7]. An ester compound represented by the following chemical formula [Chemical 48] (38):
Figure 106111751-A0305-02-0006-89

[8]、一種有害生物防除劑,含有以[1]至[7]中任一項的酯化合物作為有效成分。 [8]. A pest control agent containing the ester compound according to any one of [1] to [7] as an active ingredient.

[9]、一種有害生物的防除方法,將[1]至[7]中任一項的酯化合物施用於有害生物或有害生物的棲息地,該有害生物的防除方法排除使用於人體或動物。 [9]. A method for controlling harmful organisms. The ester compound according to any one of [1] to [7] is applied to harmful organisms or habitats of harmful organisms. The method for controlling harmful organisms excludes use in humans or animals.

本發明化合物因具有優良的有害生物防除效力,故作為有害生物防除劑的有效成分有用。 Since the compound of the present invention has an excellent pest control effect, it is useful as an effective ingredient of a pest control agent.

在本發明化合物有R1表示氫原子時,存在如下的情形:自存在於環丙烷環上的1位及3位的兩個不對稱碳(asymmetric carbon)原子衍生的光學異構物(optical isomer),及自存在於環丙烷環3位的取代基的1’位的雙鍵衍生的異構物的情形,在本發明包含有具有有害生物防除活性的各異構物及任意的比率的異構物混合物。 When the compound of the present invention has R 1 representing a hydrogen atom, there are cases in which an optical isomer derived from two asymmetric carbon atoms at the 1 and 3 positions on the cyclopropane ring ), and in the case of isomers derived from the double bond at the 1′ position of the substituent present at the 3-position of the cyclopropane ring, the present invention includes each isomer having pest control activity and an arbitrary ratio of Structure mixture.

<含Cl酯化合物的製造法> <Production method of Cl-containing ester compound>

就本發明化合物(含Cl酯化合物)的製造法進行說明。 The method for producing the compound of the present invention (Cl-containing ester compound) will be described.

本發明化合物若是製造通常的酯化合物的方法,則未被特別限定,惟例如可藉由以下所示的方法製造。 The compound of the present invention is not particularly limited as long as it is a method for producing a general ester compound, but it can be produced by the method shown below, for example.

(參考製造法1) (Refer to Manufacturing Method 1)

藉由使以下列的式[化5](3):[化5]

Figure 106111751-A0305-02-0008-8
表示的醇化合物(式中R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基),與以下列的式[化6](4):
Figure 106111751-A0305-02-0008-9
By using the following formula [Chem 5] (3): [Chem 5]
Figure 106111751-A0305-02-0008-8
The alcohol compound represented (wherein R 3 represents a hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, ethynyl or propynyl), and the following formula [ Change 6] (4):
Figure 106111751-A0305-02-0008-9

[式中R1是表示氫原子或甲基,R1表示甲基時R2也表示甲基,而且R1表示氫原子時R2為以下列通式[化7](2)

Figure 106111751-A0305-02-0008-10
[Where R 1 represents a hydrogen atom or a methyl group, when R 1 represents a methyl group, R 2 also represents a methyl group, and when R 1 represents a hydrogen atom, R 2 represents the following general formula [Chem 7] (2)
Figure 106111751-A0305-02-0008-10

(此處X及Y為同一或不同,表示氫原子、鹵素原子、氰基、碳數1~4的烷基、碳數2~5的烷氧基羰基或碳數1~4的鹵烷基)表示的基]表示的羧酸化合物或其反應性衍生物反應得到本發明化合物。 (Here X and Y are the same or different, and represent a hydrogen atom, a halogen atom, a cyano group, a C 1-4 alkyl group, a C 2-5 alkoxycarbonyl group or a C 1-4 haloalkyl group The group represented by )] the carboxylic acid compound represented by or the reactive derivative thereof is reacted to obtain the compound of the present invention.

作為該反應性衍生物可舉出:以式(4)表示的羧酸化合物的酸鹵化物(acid halide)、該羧酸化合物的酸酐及該羧酸化合物的酯等。作為該酸鹵化物可舉出酸性氯化物(acid chloride)化合物,作為酯可舉出甲酯、乙酯等。 Examples of the reactive derivative include an acid halide of the carboxylic acid compound represented by formula (4), an acid anhydride of the carboxylic acid compound, and an ester of the carboxylic acid compound. Examples of the acid halide include acid chloride compounds, and examples of the ester include methyl ester and ethyl ester.

該反應通常在縮合劑或鹼的存在下在溶劑中進行。 This reaction is usually carried out in a solvent in the presence of a condensing agent or a base.

作為縮合劑例如可舉出:二環己碳二亞胺(dicyclohexylcarbodiimide)、1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride)。而且,作為鹼可舉出:三乙胺(triethylamine)、吡啶(pyridine)、4-二甲胺基吡啶(4-dimethylaminopyridine)、二異丙基乙胺(diisopropylethylamine)等的有機鹼。 Examples of the condensing agent include dicyclohexylcarbodiimide and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (1-ethyl-3- (3-dimethylaminopropyl)carbodiimide hydrochloride). In addition, examples of the base include organic bases such as triethylamine, pyridine, 4-dimethylaminopyridine, and diisopropylethylamine.

作為溶劑例如可舉出:甲苯及己烷等的烴;四氫呋喃(tetrahydrofuran)等的醚;乙酸乙酯(ethyl acetate)等的酯以及氯苯(chlorobenzene)等的鹵化烴及該等的混合溶劑等。 Examples of the solvent include hydrocarbons such as toluene and hexane; ethers such as tetrahydrofuran; esters such as ethyl acetate; halogenated hydrocarbons such as chlorobenzene; and mixed solvents thereof. .

在該反應中,以式(3)表示的醇化合物與以式(4)表示的羧酸化合物或其反應性衍生物之使用莫耳比可任意設定,較佳為等莫耳或接近其之比例。 In this reaction, the molar ratio of the alcohol compound represented by the formula (3) to the carboxylic acid compound represented by the formula (4) or its reactive derivative can be arbitrarily set, preferably equal to or close to it proportion.

縮合劑或鹼相對於1莫耳以式(3)表示的醇化合物,通常能以0.25莫耳到過量任意的比例使用,較佳為0.5莫耳~2莫耳。該等縮合劑或鹼係依照以式(4)表示的羧酸化合物或其反應性衍生物的種類適宜選擇。 The alcohol compound represented by the formula (3) with respect to 1 mole of the condensing agent or base can generally be used in any ratio from 0.25 mole to an excess, preferably 0.5 mole to 2 mole. These condensing agents or bases are appropriately selected according to the type of carboxylic acid compound represented by formula (4) or its reactive derivative.

反應結束後的反應混合物可藉由將其過濾並將濾液濃 縮,或者將水注加到反應混合物後施以有機溶劑萃取、濃縮等的通常的後處理操作,得到本發明化合物。所得到的本發明化合物可藉由層析法(chromatography)、蒸餾等的操作而精製。 After the reaction, the reaction mixture can be filtered and the filtrate concentrated The compound of the present invention can be obtained by adding water to the reaction mixture or subjecting it to ordinary post-treatment operations such as organic solvent extraction and concentration. The obtained compound of the present invention can be purified by operations such as chromatography and distillation.

(參考製造法2) (Refer to Manufacturing Method 2)

在上述參考製造法1中以式(3)表示的醇化合物(式中R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)可藉由例如下列合成路徑(synthetic pathway)[化8](5)→(3)製造:

Figure 106111751-A0305-02-0010-11
也就是說,可藉由在不活性溶劑(例如己烷、甲苯、四氫呋喃、乙醚等)中,使酯化合物(5)(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)與還原劑(例如鋁氫化鋰(lithium aluminum hydride)、二異丁基氫化鋁(diisobutylaluminium hydride)等)在-30~20℃反應1~10小時而製造。 The alcohol compound represented by the formula (3) in the above Reference Manufacturing Method 1 (wherein R 3 represents a hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, ethynyl Or propynyl) can be produced by, for example, the following synthetic pathway [Chem 8] (5) → (3):
Figure 106111751-A0305-02-0010-11
That is, the ester compound (5) (where R is an alkyl group having 1 to 4 carbon atoms and R 3 is represented by an inactive solvent (such as hexane, toluene, tetrahydrofuran, ether, etc.) Hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, ethynyl or propynyl) and reducing agents (such as lithium aluminum hydride, diisobutyl Aluminum hydride (diisobutylaluminium hydride) is produced by reacting at -30~20℃ for 1~10 hours.

(參考製造法3) (Refer to Manufacturing Method 3)

在上述參考製造法2中以式(5)表示的酯化合物(式中R 是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)可藉由例如下列合成路徑[化9](6)→(5)製造:

Figure 106111751-A0305-02-0011-12
也就是說,可藉由對酯化合物(6)透過Sandmeyer反應進行氯化而製造。具體上可藉由在醋酸與濃鹽酸的混合溶劑中慢慢地加入亞硝酸鈉的水溶液並在冰冷下使酯化合物(6)反應30分~1小時調製重氮鎓鹽中間物(diazonium salt intermediate),在此處分割添加氯化銅(I)(cuprous chloride),在20~60℃使其反應1~10小時而製造。 The ester compound represented by formula (5) in the above Reference Production Method 2 (where R is an alkyl group having 1 to 4 carbon atoms, R 3 is a hydrogen atom, trifluoromethyl, methyl, methoxy, (Methoxymethyl, allyl, ethynyl or propynyl) can be produced by, for example, the following synthetic route [Chem. 9] (6) → (5):
Figure 106111751-A0305-02-0011-12
That is, it can be produced by chlorination of the ester compound (6) through Sandmeyer reaction. Specifically, a diazonium salt intermediate can be prepared by slowly adding an aqueous solution of sodium nitrite to a mixed solvent of acetic acid and concentrated hydrochloric acid, and reacting the ester compound (6) under ice cooling for 30 minutes to 1 hour. ), where copper chloride (I) (cuprous chloride) is added separately, and reacted at 20 to 60°C for 1 to 10 hours.

(參考製造法4) (Refer to Manufacturing Method 4)

在上述參考製造法3中以式(6)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)可藉由例如下列合成路徑[化10](7)→(6)製造:[化10]

Figure 106111751-A0305-02-0012-13
也就是說,可藉由在有機溶劑(例如乙酸乙酯、己烷、甲苯、四氫呋喃、乙醚、碳數1~3的醇等)中在金屬觸媒(例如鈀碳、鉑、銠、釕等)存在下於氫環境下在10~30℃使酯化合物(7)反應1~10小時而製造。 The ester compound represented by the formula (6) in the above Reference Production Method 3 (where R is an alkyl group having 1 to 4 carbon atoms, R 3 is a hydrogen atom, trifluoromethyl, methyl, methoxy, (Methoxymethyl, allyl, ethynyl or propynyl) can be produced by, for example, the following synthetic route [Chem 10] (7) → (6): [Chem 10]
Figure 106111751-A0305-02-0012-13
That is to say, it can be done by using metal catalysts (such as palladium on carbon, platinum, rhodium, ruthenium, etc.) in organic solvents (such as ethyl acetate, hexane, toluene, tetrahydrofuran, diethyl ether, alcohols with 1 to 3 carbon atoms, etc.) ) It is produced by reacting the ester compound (7) in a hydrogen environment at 10 to 30°C for 1 to 10 hours.

(參考製造法5) (Refer to Manufacturing Method 5)

在上述參考製造法4中以式(7)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)可藉由例如下列合成路徑[化11](8)→(7)製造:

Figure 106111751-A0305-02-0012-14
也就是說,可藉由在不活性溶劑(例如己烷、甲苯、四氫呋 喃、乙醚等)中在鹼(例如三乙胺、乙基二異丙胺(ethyldiisopropylamine))存在下使酯化合物(8)與苯甲胺(benzylamine)在60~100℃反應5~15小時而製造。 The ester compound represented by the formula (7) in the above Reference Production Method 4 (where R is an alkyl group having 1 to 4 carbon atoms, R 3 is a hydrogen atom, trifluoromethyl, methyl, methoxy, (Methoxymethyl, allyl, ethynyl or propynyl) can be produced by, for example, the following synthetic route [Chem. 11] (8) → (7):
Figure 106111751-A0305-02-0012-14
That is to say, the ester compound (8) can be combined with an inactive solvent (such as hexane, toluene, tetrahydrofuran, ether, etc.) in the presence of a base (such as triethylamine, ethyldiisopropylamine). Benzylamine (benzylamine) is produced by reacting at 60-100°C for 5-15 hours.

另一方面,以式(4)表示的羧酸化合物或其反應性衍生物為眾所周知物質。 On the other hand, carboxylic acid compounds represented by formula (4) or reactive derivatives thereof are well-known substances.

作為本發明化合物例如可舉出如以下的化合物。 Examples of the compound of the present invention include the following compounds.

本發明化合物A1;2-氯-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物B1;2-氯-3,5,6-三氟苄基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物C1;2-氯-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物D1;2-氯-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物E1;2-氯-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物F1;2-氯-3,5,6-三氟苄基(1RS)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物G1;2-氯-3,5,6-三氟苄基(1RS)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物H1;2-氯-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物I1;2-氯-3,5,6-三氟苄基(1R)-反式 -3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物J1;2-氯-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物K1;2-氯-3,5,6-三氟苄基(1R)-順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物L1;2-氯-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-氯-3,3,3-三氟-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物M1;2-氯-3,5,6-三氟苄基(1RS)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物N1;2-氯-3,5,6-三氟苄基(1R)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物O1;2-氯-3,5,6-三氟苄基(1R)-反式,順式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物(isomer)的比率:Z/E=約8/1)、本發明化合物P1;2-氯-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物Q1;2-氯-3,5,6-三氟苄基(1R)-反式,順式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物R1;2-氯-3,5,6-三氟苄基(1R)-反式 -3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物S1;2-氯-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物T1;2-氯-3,5,6-三氟苄基(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物U1;2-氯-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-氰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物V1;2-氯-3,5,6-三氟苄基(1R)-反式-3-[(Z)-(2-氰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物W1;2-氯-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯、本發明化合物A2;2-氯-4-甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物B2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物C2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物D2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物E2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物F2;2-氯-4-甲基-3,5,6-三氟苄基(1RS)- 反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物G2;2-氯-4-甲基-3,5,6-三氟苄基(1RS)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物H2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物I2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物J2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物K2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物L2;2-氯-4-甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-氯-3,3,3-三氟-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物M2;2-氯-4-甲基-3,5,6-三氟苄基(1RS)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物N2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物O2;2-氯-4-甲基-3,5,6-三氟苄基(1R)- 反式,順式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物P2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物Q2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物R2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物S2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物T2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物U2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-氰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物V2;2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式-3-[(Z)-(2-氰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物W2;2-氯-4-甲基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯、 本發明化合物A3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物B3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物C3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物D3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物E3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物F3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物G3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物H3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1RS)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物I3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基 (1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物J3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物K3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物L3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-氯-3,3,3-三氟-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物M3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1RS)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物N3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物O3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物P3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物Q3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基 (1R)-反式,順式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物R3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物S3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物T3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物U3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-氰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物V3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-[(Z)-(2-氰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物W3;2-氯-4-甲氧基甲基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯、本發明化合物A4;2-氯-4-乙炔基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物B4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧 酸酯、本發明化合物C4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物D4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物E4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物F4;2-氯-4-乙炔基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物G4;2-氯-4-乙炔基-3,5,6-三氟苄基(1RS)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物H4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物I4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物J4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物K4;2-氯-4-乙炔基-3,5,6-三氟苄基 (1R)-順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物L4;2-氯-4-乙炔基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-氯-3,3,3-三氟-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物M4;2-氯-4-乙炔基-3,5,6-三氟苄基(1RS)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物N4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物O4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式,順式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物P4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物Q4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式,順式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物R4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物S4;2-氯-4-乙炔基-3,5,6-三氟苄基 (1R)-反式,順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物T4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物U4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-氰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物V4;2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式-3-[(Z)-(2-氰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物W4;2-氯-4-乙炔基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯、本發明化合物A5;2-氯-3,5,6-三氟-4-三氟甲基苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物B5;4-烯丙基-2-氯-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物C5;2-氯-4-丙炔基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物D5;2-氯-4-甲氧基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯。 Compound A1 of the present invention; 2-chloro-3,5,6-trifluorobenzyl (1RS)-trans, cis-3-(2-methyl-1-propenyl)-2,2-dimethyl Cyclopropane carboxylate, compound B1 of the invention; 2-chloro-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2-methyl-1-propenyl)-2 ,2-dimethylcyclopropane carboxylate, compound C1 of the invention; 2-chloro-3,5,6-trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl )-2,2-dimethylcyclopropane carboxylate, compound D1 of the invention; 2-chloro-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2 -Difluoro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound E1 of the present invention; 2-chloro-3,5,6-trifluorobenzyl (1R)-trans-3 -(2,2-difluoro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound F1 of the invention; 2-chloro-3,5,6-trifluorobenzyl (1RS) -Trans, cis-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound G1 of the invention; 2-chloro-3,5,6 -Trifluorobenzyl (1RS)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound H1 of the present invention; 2-chloro- 3,5,6-Trifluorobenzyl (1R)-trans, cis-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, this Invention compound I1; 2-chloro-3,5,6-trifluorobenzyl (1R)-trans -3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound J1 of the present invention; 2-chloro-3,5,6-trifluorobenzyl ( 1R)-trans, cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound K1 of the invention; 2-chloro-3,5 ,6-trifluorobenzyl (1R)-cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound L1 of the invention; 2- Chloro-3,5,6-trifluorobenzyl (1RS)-trans, cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl Cyclopropane carboxylate, compound M1 of the invention; 2-chloro-3,5,6-trifluorobenzyl (1RS)-cis-3-[(Z)-2-chloro-3,3,3- Trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound N1 of the present invention; 2-chloro-3,5,6-trifluorobenzyl (1R)-cis-3- [(Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound O1 of the invention; 2-chloro-3,5, 6-trifluorobenzyl (1R)-trans, cis-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomers to double bonds) : Z/E=about 8/1), compound P1 of the present invention; 2-chloro-3,5,6-trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2- Dimethylcyclopropane carboxylate (ratio of isomers with respect to double bond: Z/E=about 8/1), compound Q1 of the present invention; 2-chloro-3,5,6-trifluorobenzyl (1R )-Trans, cis-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound R1 of the invention; 2-chloro -3,5,6-trifluorobenzyl (1R)-trans -3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound S1 of the invention; 2-chloro-3,5,6- Trifluorobenzyl (1R)-trans, cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate, the present invention Compound T1; 2-chloro-3,5,6-trifluorobenzyl (1R)-cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-di Methylcyclopropane carboxylate, compound U1 of the present invention; 2-chloro-3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(Z)-(2-cyano- 1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound V1 of the invention; 2-chloro-3,5,6-trifluorobenzyl (1R)-trans-3-[( Z)-(2-cyano-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound W1 of the invention; 2-chloro-3,5,6-trifluorobenzyl 2, 2,3,3-tetramethylcyclopropane carboxylate, compound A2 of the invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1RS)-trans, cis-3 -(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound B2 of the invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound C2 of the invention; 2-chloro-4-methyl -3,5,6-trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound D2 of the present invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-difluoro-1-vinyl)-2,2-di Methylcyclopropane carboxylate, compound E2 of the present invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2,2-difluoro-1 -Vinyl)-2,2-dimethylcyclopropane carboxylate, compound F2 of the invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1RS)- Trans, cis-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound G2 of the invention; 2-chloro-4-methyl-3 ,5,6-trifluorobenzyl (1RS)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound H2 of the present invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-dichloro-1-vinyl)-2,2-di Methylcyclopropane carboxylate, compound I2 of the invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1 -Vinyl)-2,2-dimethylcyclopropane carboxylate, compound J2 of the invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans, cis Formula-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound K2 of the present invention; 2-chloro-4-methyl-3,5,6 -Trifluorobenzyl (1R)-cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound L2 of the present invention; 2-chloro- 4-methyl-3,5,6-trifluorobenzyl (1RS)-trans, cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2 -Dimethylcyclopropane carboxylate, compound M2 of the invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1RS)-cis-3-[(Z)-2- Chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound N2 of the invention; 2-chloro-4-methyl-3,5,6- Trifluorobenzyl (1R)-cis-3-[(Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, Compound O2 of the present invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)- Trans, cis-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E=about 8/1), the present invention Compound P2; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (Regarding the ratio of double bond isomers: Z/E=about 8/1), the compound Q2 of the present invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans Formula, cis-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound R2 of the present invention; 2-chloro-4- Methyl-3,5,6-trifluorobenzyl (1R)-trans-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane Carboxylic acid ester, compound S2 of the present invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(Z)-(2-methoxy (Carbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate, compound T2 of the invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)- Cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate, compound U2 of the invention; 2-chloro-4-methyl -3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(Z)-(2-cyano-1-propenyl)]-2,2-dimethylcyclopropane Carboxylic acid ester, compound V2 of the present invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3-[(Z)-(2-cyano-1- Propenyl)]-2,2-dimethylcyclopropane carboxylate, compound W2 of the invention; 2-chloro-4-methyl-3,5,6-trifluorobenzyl 2,2,3,3- Tetramethylcyclopropane carboxylate, Compound A3 of the present invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1RS)-trans, cis-3-(2-methyl-1-propenyl) -2,2-dimethylcyclopropane carboxylate, compound B3 of the invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis -3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound C3 of the invention; 2-chloro-4-methoxymethyl-3,5,6 -Trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound D3 of the invention; 2-chloro-4- Methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-difluoro-1-vinyl)-2,2-dimethyl ring Propane carboxylate, compound E3 of the present invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2,2-difluoro-1 -Vinyl)-2,2-dimethylcyclopropane carboxylate, compound F3 of the invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1RS)-trans Formula, cis-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound G3 of the present invention; 2-chloro-4-methoxymethyl -3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, Compound H3 of the present invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1RS)-trans-3-(2,2-dichloro-1-vinyl)- 2,2-dimethylcyclopropane carboxylate, compound I3 of the present invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound J3 of the invention; 2-chloro-4-methoxy Methyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropanecarboxylic acid Ester, compound K3 of the present invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-cis-3-(2,2-dibromo-1-vinyl )-2,2-dimethylcyclopropane carboxylate, compound L3 of the invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1RS)-trans, cis Formula-3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound M3 of the invention; 2-chloro-4-methoxy Methyl-3,5,6-trifluorobenzyl (1RS)-cis-3-[(Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2 -Dimethylcyclopropane carboxylate, compound N3 of the present invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-cis-3-[(Z) -2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound O3 of the present invention; 2-chloro-4-methoxymethyl- 3,5,6-trifluorobenzyl (1R)-trans, cis-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (for double bond isomers) Ratio: Z/E=about 8/1), compound P3 of the present invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans-3-(1 -Propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E=about 8/1), the compound of the present invention Q3; 2-chloro-4-methyl Oxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound R3 of the invention; 2 -Chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2 ,2-dimethylcyclopropane carboxylate, compound S3 of the present invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3 -[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate, compound T3 of the invention; 2-chloro-4-methoxymethyl- 3,5,6-Trifluorobenzyl (1R)-cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate The compound U3 of the present invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(Z)-(2-cyano -1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound V3 of the invention; 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl (1R )-Trans-3-[(Z)-(2-cyano-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound W3 of the invention; 2-chloro-4-methyl Oxymethyl-3,5,6-trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate, compound A4 of the invention; 2-chloro-4-ethynyl-3,5, 6-trifluorobenzyl (1RS)-trans, cis-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound B4 of the invention; 2- Chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane Carboxyl Acid ester, compound C4 of the present invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2, 2-Dimethylcyclopropane carboxylate, compound D4 of the invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2, 2-difluoro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound E4 of the invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R )-Trans-3-(2,2-difluoro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound F4 of the invention; 2-chloro-4-ethynyl-3, 5,6-trifluorobenzyl (1RS)-trans, cis-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compounds of the invention G4; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1RS)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethyl Cyclopropane carboxylate, compound H4 of the present invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-dichloro -1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound I4 of the invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans -3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound J4 of the present invention; 2-chloro-4-ethynyl-3,5,6- Trifluorobenzyl (1R)-trans, cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound K4 of the invention; 2- Chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound L4 of the invention; 2-chloro-4-ethynyl- 3,5,6-Trifluorobenzyl (1RS)-trans, cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl ring Propane carboxylate, compound M4 of the invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1RS)-cis-3-[(Z)-2-chloro-3,3 ,3-trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound N4 of the present invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl ( 1R)-cis-3-[(Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound O4 of the present invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (Regarding the ratio of double bond isomers: Z/E=about 8/1), the compound P4 of the present invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans Formula-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E=about 8/1), compound Q4 of the present invention; 2 -Chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2 ,2-dimethylcyclopropane carboxylate, compound R4 of the present invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans-3-[(E)- (2-Methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound S4 of the invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl base (1R)-trans, cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate, compound T4 of the invention; 2 -Chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2- Dimethylcyclopropane carboxylate, compound U4 of the invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(Z)- (2-cyano-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound V4 of the invention; 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl (1R)-trans-3-[(Z)-(2-cyano-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound W4 of the invention; 2-chloro-4 -Ethynyl-3,5,6-trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate, compound A5 of the invention; 2-chloro-3,5,6-trifluoro-4 -Trifluoromethylbenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound B5 of the present invention; 4- Allyl-2-chloro-3,5,6-trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (about double bond Ratio of isomers: Z/E=about 8/1), compound C5 of the present invention; 2-chloro-4-propynyl-3,5,6-trifluorobenzyl (1R)-trans-3 -(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound D5 of the invention; 2-chloro-4-methoxy-3,5,6-tri Fluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate.

<含Br酯化合物的製造法> <Manufacturing method of Br-containing ester compound>

就本發明化合物(含Br酯化合物)的製造法進行說明。 The method for producing the compound of the present invention (Br-containing ester compound) will be described.

本發明化合物若是製造通常的酯化合物的方法,則未被特別限定,惟例如可藉由以下所示的方法製造。 The compound of the present invention is not particularly limited as long as it is a method for producing a general ester compound, but it can be produced by the method shown below, for example.

(參考製造法1) (Refer to Manufacturing Method 1)

藉由使以下列的式[化12](III):

Figure 106111751-A0305-02-0024-15
表示的醇化合物(式中R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基),與以下列的式[化13](IV):
Figure 106111751-A0305-02-0024-16
By using the following formula [Chem 12] (III):
Figure 106111751-A0305-02-0024-15
The alcohol compound represented (wherein R 3 represents a hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, ethynyl or propynyl), and the following formula [ Change 13] (IV):
Figure 106111751-A0305-02-0024-16

[式中R1是表示氫原子或甲基,R1表示甲基時R2也表示甲基,而且R1表示氫原子時R2為以下列通式[化14](V) [化14]

Figure 106111751-A0305-02-0025-17
[Where R 1 represents a hydrogen atom or a methyl group, when R 1 represents a methyl group, R 2 also represents a methyl group, and when R 1 represents a hydrogen atom, R 2 represents the following general formula ]
Figure 106111751-A0305-02-0025-17

(此處X及Y為同一或不同,表示氫原子、鹵素原子、氰基、碳數1~4的烷基、碳數2~5的烷氧基羰基或碳數1~5的鹵烷基)表示的基]表示的羧酸化合物或其反應性衍生物反應得到本發明化合物。 (Here X and Y are the same or different, and represent a hydrogen atom, a halogen atom, a cyano group, a C 1-4 alkyl group, a C 2-5 alkoxycarbonyl group or a C 1-5 haloalkyl group The group represented by )] the carboxylic acid compound represented by or the reactive derivative thereof is reacted to obtain the compound of the present invention.

作為該反應性衍生物可舉出:以式(IV)表示的羧酸化合物的酸鹵化物、該羧酸化合物的酸酐及該羧酸化合物的酯等。作為該酸鹵化物可舉出酸性氯化物化合物,作為酯可舉出甲酯、乙酯等。 Examples of the reactive derivative include an acid halide of the carboxylic acid compound represented by formula (IV), an acid anhydride of the carboxylic acid compound, and an ester of the carboxylic acid compound. Examples of the acid halide include acid chloride compounds, and examples of the ester include methyl ester and ethyl ester.

該反應通常在縮合劑或鹼的存在下在溶劑中進行。 This reaction is usually carried out in a solvent in the presence of a condensing agent or a base.

作為縮合劑例如可舉出:二環己碳二亞胺、1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽。而且,作為鹼可舉出:三乙胺、吡啶、4-二甲胺基吡啶、二異丙基乙胺等的有機鹼。 Examples of the condensing agent include dicyclohexylcarbodiimide and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride. In addition, examples of the base include organic bases such as triethylamine, pyridine, 4-dimethylaminopyridine, and diisopropylethylamine.

作為溶劑例如可舉出:甲苯及己烷等的烴;四氫呋喃等的醚;乙酸乙酯等的酯以及氯苯等的鹵化烴及該等的混合溶劑等。 Examples of the solvent include hydrocarbons such as toluene and hexane; ethers such as tetrahydrofuran; esters such as ethyl acetate; halogenated hydrocarbons such as chlorobenzene; and mixed solvents thereof.

在該反應中,以式(III)表示的醇化合物與以式(IV)表示的羧酸化合物或其反應性衍生物之使用莫耳比可任意設定,較佳為等莫耳或接近其之比例。 In this reaction, the molar ratio of the alcohol compound represented by the formula (III) to the carboxylic acid compound represented by the formula (IV) or its reactive derivative can be arbitrarily set, preferably equal to or close to it proportion.

縮合劑或鹼相對於1莫耳以通式(III)表示的醇化合物,通常能以0.25莫耳到過量任意的比例使用,較佳為0.5莫耳~2莫耳。該等縮合劑或鹼係依照以通式(IV)表示的羧 酸化合物或其反應性衍生物的種類適宜選擇。 The alcohol compound represented by the general formula (III) per 1 mole of the condensing agent or base can generally be used in any ratio from 0.25 mole to an excess, preferably 0.5 mole to 2 mole. These condensing agents or bases are based on the carboxyl groups represented by the general formula (IV) The kind of acid compound or its reactive derivative is appropriately selected.

反應結束後的反應混合物可藉由將其過濾並將濾液濃縮,或者將水注加到反應混合物後施以有機溶劑萃取、濃縮等的通常的後處理操作,得到本發明化合物。所得到的本發明化合物可藉由層析法、蒸餾等的操作而精製。 The reaction mixture after completion of the reaction can be obtained by filtering it and concentrating the filtrate, or by adding water to the reaction mixture and then subjecting it to usual post-treatment operations such as organic solvent extraction and concentration. The obtained compound of the present invention can be purified by operations such as chromatography and distillation.

(參考製造法2) (Refer to Manufacturing Method 2)

在上述參考製造法1中以通式(III)表示的醇化合物(式中R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)可藉由例如下列合成路徑[化15](VI)→(III)製造:

Figure 106111751-A0305-02-0026-18
也就是說,可藉由在不活性溶劑(例如己烷、甲苯、四氫呋喃、乙醚等)中,使以通式(VI)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)與還原劑(例如鋁氫化鋰、二異丁基氫化鋁等)在-30~20℃反應1~10小時而製造。 The alcohol compound represented by the general formula (III) in the above Reference Manufacturing Method 1 (wherein R 3 represents a hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, acetylene Group or propynyl group) can be produced by, for example, the following synthetic route [Chem. 15] (VI) → (III):
Figure 106111751-A0305-02-0026-18
That is, the ester compound represented by the general formula (VI) (where R is an alkyl group having 1 to 4 carbon atoms) can be used in an inactive solvent (such as hexane, toluene, tetrahydrofuran, ether, etc.) , R 3 represents a hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, ethynyl or propynyl) and a reducing agent (such as lithium aluminum hydride, diisobutyl Aluminum hydride, etc.) -30 ~ 20 ℃ reaction for 1 to 10 hours to produce.

(參考製造法3) (Refer to Manufacturing Method 3)

在上述參考製造法2中以通式(VI)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)可藉由例如下列合成路徑[化16](VII)→(VI)製造:

Figure 106111751-A0305-02-0027-19
也就是說,可藉由對以通式(VII)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)透過Sandmeyer反應進行溴化而製造。具體上可藉由在室溫下將溴化四丁銨(tetrabutylammonium bromide)、樟腦磺酸(camphorsulfonic acid)、亞硝酸鈉、二價溴化銅依次添加到以通式(VII)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)的乙腈(acetonitrile)溶液,在20~60℃使其反應1~48小時而製造。 The ester compound represented by the general formula (VI) in the above Reference Manufacturing Method 2 (where R is an alkyl group having 1 to 4 carbon atoms, and R 3 is a hydrogen atom, trifluoromethyl, methyl, methoxy , Methoxymethyl, allyl, ethynyl or propynyl) can be produced by, for example, the following synthetic route [Chem. 16](VII)→(VI):
Figure 106111751-A0305-02-0027-19
That is, the ester compound represented by the general formula (VII) (where R is an alkyl group having 1 to 4 carbon atoms and R 3 is a hydrogen atom, trifluoromethyl group, methyl group, and methoxy group) Group, methoxymethyl group, allyl group, ethynyl group or propynyl group) is produced by bromination by Sandmeyer reaction. Specifically, tetrabutylammonium bromide, camphorsulfonic acid, sodium nitrite, and divalent copper bromide can be sequentially added to the ester compound represented by the general formula (VII) at room temperature (Where R is an alkyl group having 1 to 4 carbon atoms, R 3 is a hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, ethynyl or propynyl ) Acetonitrile (acetonitrile) solution, at 20 ~ 60 ℃ for 1 ~ 48 hours to produce.

(參考製造法4) (Refer to Manufacturing Method 4)

在上述參考製造法3中以通式(VII)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔 基)可藉由例如下列合成路徑[化17](VIII)→(VII)製造:

Figure 106111751-A0305-02-0028-20
也就是說,可藉由在有機溶劑(例如乙酸乙酯、己烷、甲苯、四氫呋喃、乙醚、碳數1~3的醇等)中在金屬觸媒(例如鈀碳、鉑、銠、釕等)存在下於氫環境下在10~30℃使以通式(VIII)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)反應1~10小時而製造。 The ester compound represented by the general formula (VII) in the above Reference Manufacturing Method 3 (where R is an alkyl group having 1 to 4 carbon atoms, R 3 is a hydrogen atom, trifluoromethyl, methyl, methoxy , Methoxymethyl, allyl, ethynyl or propynyl) can be produced by, for example, the following synthetic route [Chem. 17] (VIII) → (VII):
Figure 106111751-A0305-02-0028-20
That is to say, it can be done by using metal catalysts (such as palladium on carbon, platinum, rhodium, ruthenium, etc.) in organic solvents (such as ethyl acetate, hexane, toluene, tetrahydrofuran, diethyl ether, alcohols with 1 to 3 carbon atoms, etc.) ) An ester compound represented by the general formula (VIII) (where R is an alkyl group having 1 to 4 carbon atoms, R 3 is a hydrogen atom, trifluoromethyl, Methyl, methoxy, methoxymethyl, allyl, ethynyl or propynyl) reacted for 1 to 10 hours to produce.

(參考製造法5) (Refer to Manufacturing Method 5)

在上述參考製造法4中以通式(VIII)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)可藉由例如下列合成路徑[化18](IX)→(VIII)製造:[化18]

Figure 106111751-A0305-02-0029-21
也就是說,可藉由在不活性溶劑(例如己烷、甲苯、四氫呋喃、乙醚等)中在鹼(例如三乙胺、乙基二異丙胺)存在下使以通式(IX)表示的酯化合物(式中R是表示碳數1~4的烷基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基)與苯甲胺在60~100℃反應5~15小時而製造。 The ester compound represented by the general formula (VIII) in the above Reference Manufacturing Method 4 (where R is an alkyl group having 1 to 4 carbon atoms, and R 3 is a hydrogen atom, trifluoromethyl, methyl, methoxy , Methoxymethyl, allyl, ethynyl or propynyl) can be produced by, for example, the following synthetic route [Chem 18] (IX) → (VIII): [Chem 18]
Figure 106111751-A0305-02-0029-21
That is, the ester represented by the general formula (IX) can be used in the presence of a base (eg, triethylamine, ethyldiisopropylamine) in an inactive solvent (eg, hexane, toluene, tetrahydrofuran, diethyl ether, etc.) Compound (where R is an alkyl group having 1 to 4 carbon atoms, R 3 is a hydrogen atom, trifluoromethyl, methyl, methoxy, methoxymethyl, allyl, ethynyl or propyne Base) and benzylamine reacted at 60~100℃ for 5~15 hours.

另一方面,以通式(IV)表示的羧酸化合物或其反應性衍生物為眾所周知物質。 On the other hand, carboxylic acid compounds represented by the general formula (IV) or reactive derivatives thereof are well-known substances.

作為本發明化合物例如可舉出如以下的化合物。 Examples of the compound of the present invention include the following compounds.

本發明化合物1;2-溴-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物2;2-溴-3,5,6-三氟苄基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物3;2-溴-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物4;2-溴-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、 本發明化合物5;2-溴-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物6;2-溴-3,5,6-三氟苄基(1RS)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物7;2-溴-3,5,6-三氟苄基(1RS)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物8;2-溴-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物9;2-溴-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物10;2-溴-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物11;2-溴-3,5,6-三氟苄基(1R)-順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物12;2-溴-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-氯-3,3,3-三氟-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物13;2-溴-3,5,6-三氟苄基(1RS)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物14;2-溴-3,5,6-三氟苄基(1R)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物15;2-溴-3,5,6-三氟苄基(1R)-反式,順 式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物(isomer)的比率:Z/E=約8/1)、本發明化合物16;2-溴-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物17;2-溴-3,5,6-三氟苄基(1R)-反式,順式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物18;2-溴-3,5,6-三氟苄基(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物19;2-溴-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物20;2-溴-3,5,6-三氟苄基(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物21;2-溴-3,5,6-三氟苄基(1R)-反式,順式-3-(2-氰基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約2/1)、本發明化合物22;2-溴-3,5,6-三氟苄基(1R)-反式-3-(2-氰基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約2/1)、本發明化合物23;2-溴-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯、本發明化合物24;2-溴-4-甲基-3,5,6-三氟苄基(1RS)- 反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物25;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物26;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物27;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物28;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物29;2-溴-4-甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物30;2-溴-4-甲基-3,5,6-三氟苄基(1RS)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物31;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物32;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物33;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物34;2-溴-4-甲基-3,5,6-三氟苄基(1R)- 順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物35;2-溴-4-甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-氯-3,3,3-三氟-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物36;2-溴-4-甲基-3,5,6-三氟苄基(1RS)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物37;2-溴-4-甲基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物38;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物39;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物40;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物41;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物42;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙 烷羧酸酯、本發明化合物43;2-溴-4-甲基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物44;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2-氰基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約2/1)、本發明化合物45;2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2-氰基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約2/1)、本發明化合物46;2-溴-4-甲基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯、本發明化合物47;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物48;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物49;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物50;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物51;2-溴-4-甲氧基甲基-3,5,6-三氟苄基 (1R)-反式-3-(2,2-二氟-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物52;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物53;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1RS)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物54;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物55;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物56;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物57;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-順式-3-(2,2-二溴-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物58;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1RS)-反式,順式-3-(2-氯-3,3,3-三氟-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物59;2-溴-4-甲氧基甲基-3,5,6-三氟苄基 (1RS)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物60;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯、本發明化合物61;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物62;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物63;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物64;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物65;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式,順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物66;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯、本發明化合物67;2-溴-4-甲氧基甲基-3,5,6-三氟苄基 (1R)-反式,順式-3-(2-氰基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約2/1)、本發明化合物68;2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(2-氰基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約2/1)、本發明化合物69;2-溴-4-甲氧基甲基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯、本發明化合物70;2-溴-3,5,6-三氟-4-三氟甲基苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物71;4-烯丙基-2-溴-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物72;4-烯丙基-2-溴-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(關於雙鍵的異構物的比率:Z/E=約8/1)、本發明化合物73;2-溴-4-丙炔基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯、本發明化合物74;2-溴-4-甲氧基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯、 Compound 1 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1RS)-trans, cis-3-(2-methyl-1-propenyl)-2,2-dimethyl Cyclopropane carboxylate, compound 2 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2-methyl-1-propenyl)-2 ,2-dimethylcyclopropane carboxylate, compound 3 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl )-2,2-dimethylcyclopropane carboxylate, compound 4 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2 -Difluoro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, Compound 5 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans-3-(2,2-difluoro-1-vinyl)-2,2-dimethyl ring Propane carboxylate, compound 6 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1RS)-trans, cis-3-(2,2-dichloro-1-vinyl)- 2,2-dimethylcyclopropane carboxylate, compound 7 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1RS)-trans-3-(2,2-dichloro-1 -Vinyl)-2,2-dimethylcyclopropane carboxylate, compound 8 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans, cis-3-( 2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 9 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans Formula-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 10 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 11 of the present invention; 2-bromo-3, 5,6-trifluorobenzyl (1R)-cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 12 of the present invention; 2 -Bromo-3,5,6-trifluorobenzyl (1RS)-trans, cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-di Methylcyclopropane carboxylate, compound 13 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1RS)-cis-3-[(Z)-2-chloro-3,3,3 -Trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound 14 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-cis-3 -[(Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound 15 of the present invention; 2-bromo-3,5 ,6-trifluorobenzyl (1R)-trans, cis Formula-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomer with respect to double bond: Z/E=about 8/1), the compound of the present invention 16; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate Structure ratio: Z/E = about 8/1), compound 17 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(E) -(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound 18 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R) -Trans-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound 19 of the present invention; 2-bromo-3,5 ,6-Trifluorobenzyl (1R)-trans, cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate The compound 20 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2, 2-dimethylcyclopropane carboxylate, compound 21 of the present invention; 2-bromo-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2-cyano-1- Propenyl)-2,2-dimethylcyclopropane carboxylate (ratio of isomers with respect to double bond: Z/E=about 2/1), the compound 22 of the present invention; 2-bromo-3,5, 6-trifluorobenzyl (1R)-trans-3-(2-cyano-1-propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E=about 2/1), compound 23 of the present invention; 2-bromo-3,5,6-trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylic acid ester, compound 24 of the present invention ; 2-Bromo-4-methyl-3,5,6-trifluorobenzyl (1RS)- Trans, cis-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound 25 of the present invention; 2-bromo-4-methyl-3,5 ,6-trifluorobenzyl (1R)-trans, cis-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound 26 of the present invention; 2 -Bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid Ester, compound 27 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-difluoro-1-vinyl )-2,2-dimethylcyclopropane carboxylate, compound 28 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2 ,2-difluoro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 29 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl ( 1RS)-trans, cis-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 30 of the present invention; 2-bromo-4-methyl -3,5,6-trifluorobenzyl (1RS)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, the present invention Compound 31; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-dichloro-1-vinyl)-2, 2-dimethylcyclopropane carboxylate, compound 32 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2,2-di (Chloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 33 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans Formula, cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 34 of the present invention; 2-bromo-4-methyl-3, 5,6-trifluorobenzyl (1R)- Cis-3-(2,2-dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 35 of the present invention; 2-bromo-4-methyl-3,5, 6-trifluorobenzyl (1RS)-trans, cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropane carboxylate 3. Compound 36 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1RS)-cis-3-[(Z)-2-chloro-3,3,3-tri Fluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound 37 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-cis Formula-3-[(Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound 38 of the present invention; 2-bromo- 4-methyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (about double bond Ratio of isomers: Z/E = about 8/1), compound 39 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3- (1-propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E=about 8/1), the present compound 40; 2-bromo-4 -Methyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-di Methylcyclopropane carboxylate, compound 41 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3-[(E)-(2-methyl Oxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound 42 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R) -Trans, cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane Alkyl carboxylate, compound 43 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-cis-3-[(Z)-(2-methoxycarbonyl- 1-vinyl)]-2,2-dimethylcyclopropane carboxylate, compound 44 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans , Cis-3-(2-cyano-1-propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E=about 2/1) 2. Compound 45 of the present invention; 2-bromo-4-methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2-cyano-1-propenyl)-2,2- Dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E=about 2/1), the present compound 46; 2-bromo-4-methyl-3,5,6-tri Fluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate, compound 47 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1RS) -Trans, cis-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound 48 of the present invention; 2-bromo-4-methoxymethyl -3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate, the present invention Compound 49; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2- Dimethylcyclopropane carboxylate, compound 50 of the invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2 ,2-difluoro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 51 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluoro Benzyl (1R)-trans-3-(2,2-difluoro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 52 of the present invention; 2-bromo-4-methoxy Methyl-3,5,6-trifluorobenzyl (1RS)-trans, cis-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropanecarboxylic acid Ester, compound 53 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1RS)-trans-3-(2,2-dichloro-1-vinyl )-2,2-dimethylcyclopropane carboxylate, compound 54 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis Formula-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 55 of the present invention; 2-bromo-4-methoxymethyl-3, 5,6-trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 56 of the present invention; 2 -Bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2,2-dibromo-1-vinyl)-2,2 -Dimethylcyclopropane carboxylate, compound 57 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-cis-3-(2,2 -Dibromo-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 58 of the invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1RS)-trans, cis-3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropane carboxylate, compound 59 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1RS)-cis-3-[(Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound 60 of the present invention ; 2-Bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-cis-3-[(Z)-2-chloro-3,3,3-trifluoro- 1-propenyl]-2,2-dimethylcyclopropane carboxylate, compound 61 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)- Trans, cis-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E=about 8/1), the present invention Compound 62; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane Carboxylic acid ester (ratio of isomers with respect to double bond: Z/E = about 8/1), compound 63 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate, compound 64 of the present invention; 2-Bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans-3-[(E)-(2-methoxycarbonyl-1-propenyl)]- 2,2-dimethylcyclopropane carboxylate, compound 65 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis- 3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate, compound 66 of the invention; 2-bromo-4-methoxymethyl -3,5,6-Trifluorobenzyl (1R)-cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropanecarboxylic acid Ester, compound 67 of the present invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans, cis-3-(2-cyano-1-propenyl)-2,2-dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E = About 2/1), compound 68 of the invention; 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2-cyano-1 -Propenyl)-2,2-dimethylcyclopropane carboxylate (ratio of isomers with respect to double bond: Z/E=about 2/1), compound 69 of the present invention; 2-bromo-4-methyl Oxymethyl-3,5,6-trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate, compound 70 of the present invention; 2-bromo-3,5,6-trifluoro- 4-trifluoromethylbenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 71 of the present invention; 4 -Allyl-2-bromo-3,5,6-trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethyl ring Propane carboxylate, compound 72 of the present invention; 4-allyl-2-bromo-3,5,6-trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2- Dimethylcyclopropane carboxylate (the ratio of isomers with respect to double bonds: Z/E=about 8/1), the present compound 73; 2-bromo-4-propynyl-3,5,6- Trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate, compound 74 of the present invention; 2-bromo-4 -Methoxy-3,5,6-trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate,

<含Cl酯化合物、含Br酯化合物的製劑化> <Formulation of Cl-containing ester compound and Br-containing ester compound>

本發明的有害生物防除劑也能僅本發明化合物(含Cl酯化合物、含Br酯化合物)本身單獨使用,但也能當作如 下列的製劑使用。作為該等製劑例如可舉出:蚊香、蚊香片或像蚊香液的加熱蒸散劑、風扇式蚊香、油劑、乳劑、噴霧劑(aerosols)、碳酸氣製劑、可濕性粉劑(wettable powder)、流動劑(flowable agent)(水中懸濁劑、水中乳濁劑等)、微膠囊劑、粉劑、粒劑、錠劑、壓電(piezo)式殺蟲製劑、加熱燻煙劑(自燃型燻煙劑、化學反應型燻煙劑、多孔陶瓷板燻煙劑等)、非加熱蒸散劑(樹脂蒸散劑、紙蒸散劑、不織布蒸散劑、編織物蒸散劑、昇華性錠劑等)、煙霧劑(霧化劑(fogging agent))、直接接觸劑(片狀接觸劑、膠帶狀接觸劑、網狀接觸劑等)、ULV劑及毒餌等。 The pest control agent of the present invention can also be used alone as the compound of the present invention (Cl-containing ester compound, Br-containing ester compound) itself, but can also be used as The following preparations are used. Examples of such preparations include mosquito coils, mosquito coils or mosquito coil-like liquid heating evapotranspiration agents, fan-type mosquito coils, oils, emulsions, aerosols, carbon dioxide gas preparations, wettable powders (wettable powder), Flowable agent (suspending agent in water, emulsifying agent in water, etc.), microcapsules, powder, granules, lozenges, piezo type insecticides, heating smoker (self-ignition smoker) Agent, chemical reaction type smoke agent, porous ceramic board smoke agent, etc.), non-heated evapotranspiration agent (resin evaporator, paper evaporator, nonwoven evaporator, woven evaporator, sublimation lozenge, etc.), aerosol ( Fogging agent, direct contact agent (sheet contact agent, tape contact agent, mesh contact agent, etc.), ULV agent and poison bait.

作為製劑化的方法例如可舉出以下的方法。 Examples of the method of formulation include the following methods.

[1]、依照需要將本發明化合物與固體載體(carrier)、液體載體、氣體狀載體、餌等混合,添加、加工界面活性劑(surfactant)和其他的製劑用輔助劑的方法。 [1]. A method of mixing the compound of the present invention with a solid carrier, liquid carrier, gaseous carrier, bait, etc. as needed, and adding and processing a surfactant and other auxiliary agents for formulation.

[2]、將本發明化合物含浸於不含有有效成分的基材的方法。 [2]. A method of impregnating a base material that does not contain an active ingredient with the compound of the present invention.

[3]、在混合了本發明化合物及基材後進行成形加工的方法。 [3]. A method of forming after mixing the compound of the present invention and a substrate.

在該等製劑也取決於製劑形態,通常以重量比含有0.001~98%的本發明化合物。 These preparations also depend on the form of the preparation, and usually contain 0.001 to 98% of the compound of the present invention in a weight ratio.

作為在製劑化時使用的固體載體例如可舉出:黏土類(高嶺黏土(kaolin clay)、矽藻土(diatomaceous earth)、膨土(bentonite)、文挾黏土(Fubasami clay)、酸性白土(acid clay)等);合成含水氧化矽;滑石(talc);陶瓷;其 他的無機礦物(絹雲母(sericite)、活性碳、碳酸鈣、矽石(silica)等)等的微粉末及粒狀物;常溫下固體的物質(2,4,6-三異丙基-1,3,5-三噁烷(2,4,6-triisopropyl-1,3,5-trioxane)、萘(naphthalene)、對二氯苯(p-dichlorobenzene)、樟腦、金剛烷(adamantine)等)以及由如下的一種或兩種以上構成的氈(felt):羊毛、絹、棉、麻、紙漿、合成樹脂(例如低密度聚乙烯、線性低密度聚乙烯(linear low density polyethylene)、高密度聚乙烯等的聚乙烯系樹脂;乙烯-乙酸乙烯酯共聚物(ethylene vinyl acetate copolymer)等的乙烯-乙烯酯共聚物(ethylene-vinyl ester copolymer);乙烯-甲基丙烯酸甲酯共聚物(ethylene-methyl methacrylate copolymer)、乙烯-甲基丙烯酸乙酯共聚物(ethylene-ethyl methacrylate copolymer)等的乙烯-甲基丙烯酸酯共聚物(ethylene methacrylic acid ester copolymer);乙烯-丙烯酸甲酯共聚物(ethylene-methyl acrylate copolymer)、乙烯-丙烯酸乙酯共聚物(ethylene-ethyl acrylate copolymer)等的乙烯-丙烯酸酯共聚物(ethylene acrylate copolymer);乙烯-丙烯酸共聚物(ethylene-acrylic acid copolymer)等的乙烯-乙烯基羧酸共聚物(ethylene-vinyl carboxylic acid copolymer);聚丙烯、丙烯-乙烯共聚物(propylene-ethylene copolymer)等的聚丙烯系樹脂;聚-4-甲基戊烯-1(poly-4-methylpentene-1)、聚丁烯-1(polybutene-1)、聚丁二烯(polybutadiene)、聚苯乙烯(polystyrene)、丙烯腈-苯乙烯樹脂(acrylonitrile-styrene resin);丙烯腈-丁二烯-苯乙烯樹脂 (acrylonitrile-butadiene-styrene resin)、苯乙烯-共軛二烯嵌段共聚物(styrene-conjugated diene block copolymer)、苯乙烯-共軛二烯嵌段共聚物加氫物等的苯乙烯系彈性體(elastomer);氟樹脂(fluoro resin);聚甲基丙烯酸甲酯(polymethyl methacrylate)等的丙烯酸系樹脂(acrylic resin);尼龍6(nylon 6)、尼龍66等的聚醯胺(polyamide)系樹脂;聚對酞酸乙二酯(polyethylene terephthalate)、聚萘二甲酸乙二酯(polyethylene naphthalate)、聚對苯二甲酸丁二酯(polybutylene terephthalate)等的聚酯(polyester)系樹脂;聚碳酸酯(polycarbonate)、聚縮醛(polyacetal)、聚芳酸酯(polyarylate)、羥基苯甲酸聚酯(hydroxybenzoic acid polyester)、聚醚醯亞胺(polyetherimide)、聚酯碳酸酯(polyester carbonate)、聚苯醚(polyphenylene ether)樹脂、聚氯乙烯、聚二氯亞乙烯(polyvinylidene chloride)、聚氨酯(polyurethane)、發泡聚氨酯、發泡聚丙烯、發泡乙烯等的多孔樹脂)、玻璃、金屬、陶瓷等;纖維;布;針織物;板片(sheet);紙;紗;發泡體(foam);多孔體(porous body)及複絲(multifilament)。 Examples of solid carriers used in the formulation include clays (kaolin clay, diatomaceous earth, bentonite, fubasami clay, acid clay) ) Etc.); synthetic hydrous silica; talc; ceramic; its Fine powders and granules of his inorganic minerals (sericite, activated carbon, calcium carbonate, silica, etc.); solid materials at room temperature (2,4,6-triisopropyl- 1,3,5-trioxane (2,4,6-triisopropyl-1,3,5-trioxane), naphthalene, p-dichlorobenzene, camphor, adamantine, etc. ) And felts consisting of one or more of the following: wool, silk, cotton, hemp, pulp, synthetic resins (eg low density polyethylene, linear low density polyethylene, high density) Polyethylene-based resins such as polyethylene; ethylene-vinyl ester copolymers such as ethylene vinyl acetate copolymer; ethylene-methyl methacrylate copolymers (ethylene-vinyl ester copolymer) Ethylene methacrylic acid copolymer such as methyl methacrylate copolymer, ethylene-ethyl methacrylate copolymer, etc.; ethylene-methyl acrylate copolymer acrylate copolymer, ethylene-ethyl acrylate copolymer, etc. ethylene-acrylate copolymer (ethylene acrylate copolymer); ethylene-acrylic acid copolymer (ethylene-acrylic acid copolymer), etc. Carboxylic acid copolymers (ethylene-vinyl carboxylic acid copolymer); polypropylene resins such as polypropylene and propylene-ethylene copolymers; poly-4-methylpentene-1 (poly-4-methylpentene-1 -1), polybutene-1, polybutadiene, polystyrene, acrylonitrile-styrene resin; acrylonitrile-butadiene- Styrene resin (acrylonitrile-butadiene-styrene resin), styrene-conjugated diene block copolymer, styrene-conjugated diene block copolymer hydrogenated products such as styrene-based elastomer (elastomer); fluoro resin; acrylic resins such as polymethyl methacrylate; polyamide resins such as nylon 6 and nylon 66 ; Polyester resins such as polyethylene terephthalate, polyethylene naphthalate, and polybutylene terephthalate; polycarbonate (polycarbonate), polyacetal, polyarylate, hydroxybenzoic acid polyester, polyetherimide, polyester carbonate, polybenzene Porous resins such as polyphenylene ether resin, polyvinyl chloride, polyvinylidene chloride, polyurethane, foamed polyurethane, foamed polypropylene, foamed ethylene, etc.), glass, metal, ceramics, etc. Fiber; Cloth; Knitted fabric; Sheet; Paper; Yarn; Foam; Porous body and multifilament.

作為液體載體例如可舉出:芳香族或脂族烴類(二甲苯、烷基萘(alkylnaphthalene)、苯基二甲苯基乙烷(phenyl xylyl ethane)、煤油(kerosene)、輕油、己烷、環己烷等);醇類(甲醇、乙醇、異丙醇、丁醇、己醇、苄醇、乙二醇等);醚類(二乙醚、乙二醇二甲醚(ethylene glycol dimethyl ether)、二乙二醇單乙醚(diethylene glycol monoethyl ether)、二乙二醇單丁醚(diethylene glycol monobutyl ether)、丙二醇單甲醚(propylene glycol monomethyl ether)、四氫呋喃等);酯類(乙酸乙酯、乙酸丁酯等);酮類(丙酮、甲基乙基酮、甲基異丁基酮、環己酮等);腈(nitrile)類(乙腈(acetonitrile)、異丁腈(isobutyronitrile)等);亞碸(sulfoxide)類(二甲亞碸(dimethyl sulfoxide)等);醯胺(acid amide)類(N,N-二甲基甲醯胺(N,N-dimethylformamide)、N-甲基-吡咯啶酮(N-methyl-pyrrolidone)等)、碳酸亞烷酯(alkylidene carbonate)類(碳酸丙烯酯(propylene carbonate)等);植物油(大豆油、棉籽油(cottonseed oil)等);植物精油(橙油(orange oil)、牛膝草油(hyssop oil)、檸檬油(lemon oil)等)及水。 Examples of the liquid carrier include aromatic or aliphatic hydrocarbons (xylene, alkylnaphthalene, phenyl xylyl ethane, kerosene, light oil, hexane, Cyclohexane, etc.); alcohols (methanol, ethanol, isopropanol, butanol, hexanol, benzyl alcohol, ethylene glycol, etc.); ethers (diethyl ether, ethylene glycol dimethyl ether) , Diethylene glycol monoethyl ether monoethyl ether), diethylene glycol monobutyl ether, propylene glycol monomethyl ether, tetrahydrofuran, etc.); esters (ethyl acetate, butyl acetate, etc.); ketones (acetone , Methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, etc.); nitriles (acetonitrile, isobutyronitrile, etc.); sulfoxides (dimethyl sulfoxide) (Dimethyl sulfoxide), etc.; acid amides (N,N-dimethylformamide), N-methyl-pyrrolidone, etc. ), alkylidene carbonates (propylene carbonate, etc.); vegetable oils (soybean oil, cottonseed oil, etc.); vegetable essential oils (orange oil, hyssopoid oil) (hyssop oil), lemon oil (lemon oil), etc.) and water.

作為氣體狀載體例如可舉出:丁烷氣、氟氯碳化物氣體(chlorofluorocarbon)、液化石油氣(LPG(Liquefied Petroleum Gas)、二甲醚及碳酸氣等的壓縮氣體。 Examples of the gaseous carrier include compressed gas such as butane gas, chlorofluorocarbon gas, liquefied petroleum gas (LPG (Liquefied Petroleum Gas), dimethyl ether, and carbonic acid gas).

作為界面活性劑例如可舉出:烷基硫酸酯鹽、烷基磺酸鹽、烷基芳基磺酸鹽、烷基芳基醚類、烷基芳基醚類的聚氧乙烯化物、聚乙二醇醚類、多元醇酯類及糖醇衍生物。 Examples of the surfactant include alkyl sulfate ester salts, alkyl sulfonate salts, alkyl aryl sulfonate salts, alkyl aryl ethers, polyoxyethylene compounds of alkyl aryl ethers, and polyethylene glycol. Glycol ethers, polyol esters and sugar alcohol derivatives.

作為其他的製劑用輔助劑可舉出固定劑、分散劑及穩定劑等,具體上例如可舉出:酪蛋白(casein)、明膠(gelatin)、多醣類(澱粉、阿拉伯膠(gum arabic)、纖維素衍生物、藻酸(alginic acid)等)、木質素(lignin)衍生物、膨 土、醣類、合成水溶性聚合物(聚乙烯醇(polyvinyl alcohol)、聚乙烯吡咯啶酮(polyvinylpyrrolidone)、聚丙烯酸等、BHT(2,6-二-三級丁基-4-甲苯酚(2,6-di-tert-butyl-4-methylphenol)及BHA(2-三級丁基-4-甲氧苯酚(2-tert-butyl-4-methoxyphenol)與3-三級丁基-4-甲氧苯酚之混合物)。進而依照需要適宜配合著色劑或香料等也無妨。 Examples of other auxiliary agents for formulations include fixatives, dispersants, stabilizers, and the like, and specific examples include casein, gelatin, and polysaccharides (starch, gum arabic). , Cellulose derivatives, alginic acid, etc.), lignin derivatives, bulking Earth, sugars, synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone), polyacrylic acid, etc., BHT (2,6-di-tertiary butyl-4-cresol ( 2,6-di-tert-butyl-4-methylphenol) and BHA (2-tert-butyl-4-methoxyphenol) and 3-tert-butyl-4-methoxyphenol A mixture of methoxyphenol). It may be appropriate to mix colorants, fragrances, etc. as needed.

作為蚊香的基材例如可舉出:木粉、除蟲菊萃取糟粉等的植物性粉末與紅楠粉、澱粉、羧甲基纖維素(carboxymethyl cellulose)、麩質(gluten)等的結合劑(bonding agent)的混合物。 Examples of the base material for mosquito coils include plant powders such as wood powder and pyrethrum extract powder, and binders such as red powder, starch, carboxymethyl cellulose and gluten. (bonding agent).

作為蚊香片的基材例如可舉出:將棉籽絨(cotton linters)凝固成板狀者,及將棉籽絨與紙漿的混合物的原纖維(fibril)凝固成板狀者。 Examples of the base material of the mosquito coil sheet include those in which cotton linters are coagulated into plates, and those in which fibrils of a mixture of cotton linters and pulp are coagulated into plates.

作為自燃型燻煙劑的基材例如可舉出:硝酸鹽、亞硝酸鹽、胍鹽(guanidine salt)、氯酸鉀、硝化纖維素(nitrocellulose)、乙基纖維素、木粉等的燃燒發熱劑;鹼金屬鹽、鹼土金屬鹽的熱分解刺激劑;硝酸鉀等的氧載體(oxygen carrier);三聚氰胺(melamine)、小麥澱粉等的助燃劑;矽藻土等的增量劑及合成糊料等的結合劑。 Examples of the base material of the self-ignition type smoke agent include: nitrate, nitrite, guanidine salt, potassium chlorate, nitrocellulose, ethyl cellulose, wood powder, and other combustion exothermic agents; Thermal decomposition stimulants for alkali metal salts and alkaline earth metal salts; oxygen carriers such as potassium nitrate; combustion aids such as melamine and wheat starch; extenders such as diatomaceous earth and synthetic pastes Binding agent.

作為化學反應型燻煙劑的基材例如可舉出:鹼金屬的硫化物、多硫化物、硫氫化物、氧化鈣等的發熱劑;碳化鐵、活化黏土(activated clay)等的觸媒(catalyzer);偶氮二甲醯胺(azodicarbonamide)、苯磺醯肼 (benzenesulfonyl hydrazide)、二硝基五亞甲基四胺(dinitropentamethylenetetramine)、聚苯乙烯、聚氨酯等的有機發泡劑及天然纖維片、合成纖維片等的填充劑。 Examples of the base material of the chemical reaction type smoke agent include: heat generating agents such as alkali metal sulfides, polysulfides, hydrosulfides, and calcium oxide; and catalysts such as iron carbide and activated clay ( catalyzer); azodicarbonamide, azodicarbonamide (benzenesulfonyl hydrazide), dinitropentamethylenetetramine (dinitropentamethylenetetramine), polystyrene, polyurethane and other organic blowing agents and natural fiber sheets, synthetic fiber sheets and other fillers.

作為樹脂蒸散劑等的基材所使用的樹脂例如可舉出:低密度聚乙烯、線性低密度聚乙烯、高密度聚乙烯等的聚乙烯系樹脂;乙烯-乙酸乙烯酯共聚物等的乙烯-乙烯酯共聚物;乙烯-甲基丙烯酸甲酯共聚物、乙烯-甲基丙烯酸乙酯共聚物等的乙烯-甲基丙烯酸酯共聚物;乙烯-丙烯酸甲酯共聚物、乙烯-丙烯酸乙酯共聚物等的乙烯-丙烯酸酯共聚物;乙烯-丙烯酸共聚物等的乙烯-乙烯基羧酸共聚物;聚丙烯、丙烯-乙烯共聚物等的聚丙烯系樹脂;聚-4-甲基戊烯-1、聚丁烯-1、聚丁二烯、聚苯乙烯、丙烯腈-苯乙烯樹脂;丙烯腈-丁二烯-苯乙烯樹脂、苯乙烯-共軛二烯嵌段共聚物、苯乙烯-共軛二烯嵌段共聚物加氫物等的苯乙烯系彈性體;氟樹脂;聚甲基丙烯酸甲酯等的丙烯酸樹脂;尼龍6、尼龍66等的聚醯胺系樹脂;聚對酞酸乙二酯、聚萘二甲酸乙二酯、聚對苯二甲酸丁二酯等的聚酯系樹脂;聚碳酸酯、聚縮醛、聚芳酸酯、羥基苯甲酸聚酯、聚醚醯亞胺、聚酯碳酸酯、聚苯醚樹脂、聚氯乙烯、聚二氯亞乙烯、聚氨酯等,該等基材可單獨使用或以兩種以上的混合物使用,也可以依照需要在該等基材添加鄰苯二甲酸酯(phthalate ester)類(酞酸二甲酯(dimethyl phthalate)、酞酸二辛酯(dioctyl phthalate)等)、己二酸酯(adipic acid ester)類、硬脂酸等的塑化劑。樹脂蒸散劑可藉由將本發明化合物混 練於上述基材中後,透過射出成型、擠壓成型、沖壓成型等進行成型而得到。所得到的樹脂製劑依照需要也可更進一步經過成型、剪裁等的程序,加工成板狀、膜狀、膠帶狀、網狀、繩狀等的形狀。該等樹脂製劑例如可當作非加熱蒸散劑、動物用頸圈、動物用耳標、片製劑、引誘膠帶(attractive tape)、引誘繩、園藝用支柱、長期持續性殺蟲網而被加工。 Examples of resins used as base materials for resin evaporating agents include polyethylene resins such as low-density polyethylene, linear low-density polyethylene, and high-density polyethylene; and ethylene-vinyl acetate copolymers and other ethylene-based resins. Vinyl ester copolymer; ethylene-methyl acrylate copolymer such as ethylene-methyl methacrylate copolymer, ethylene-ethyl methacrylate copolymer; ethylene-methyl acrylate copolymer, ethylene-ethyl acrylate copolymer Ethylene-acrylic acid ester copolymer; ethylene-vinyl carboxylic acid copolymer such as ethylene-acrylic acid copolymer; polypropylene-based resins such as polypropylene and propylene-ethylene copolymer; poly-4-methylpentene-1 , Polybutene-1, polybutadiene, polystyrene, acrylonitrile-styrene resin; acrylonitrile-butadiene-styrene resin, styrene-conjugated diene block copolymer, styrene-copolymer Styrene-based elastomers such as hydrogenated products of conjugated diene block copolymers; fluororesins; acrylic resins such as polymethyl methacrylate; polyamide-based resins such as nylon 6 and nylon 66; polyethylene terephthalate Polyester resins such as diesters, polyethylene naphthalate, and polybutylene terephthalate; polycarbonate, polyacetal, polyarylate, hydroxybenzoic acid polyester, polyetheramide , Polyester carbonate, polyphenylene ether resin, polyvinyl chloride, polyvinylidene chloride, polyurethane, etc., these substrates can be used alone or in a mixture of two or more, or can be added to these substrates as needed Phthalate esters (dimethyl phthalate, dioctyl phthalate, etc.), adipic acid esters, stearic acid, etc. Plasticizer. Resin evaporating agent can be prepared by mixing the compound of the present invention After training in the above-mentioned base material, it is obtained by injection molding, extrusion molding, press molding and the like. The obtained resin preparation may be further processed into a shape such as a plate shape, a film shape, a tape shape, a mesh shape, a rope shape, and the like through further procedures such as molding and cutting. Such resin preparations can be processed as non-heating evapotranspiration agents, animal collars, animal ear tags, sheet preparations, attractive tapes, attractive ropes, horticultural pillars, and long-lasting insecticide nets, for example.

作為毒餌的基材例如可舉出:穀物粉、植物油、醣、結晶纖維素等的餌成分;BHT、降二氫癒創木酸(nordihydroguaiaretic acid)等的抗氧化劑;去氫乙酸(dehydroacetic acid)等的保存劑;辣椒粉末等的防止小孩或寵物誤食之誤食防止劑及起司(cheese)香料、洋蔥香料、花生油等的害蟲引誘性香料。 Examples of the base material for poison bait include: bait components such as grain flour, vegetable oil, sugar, and crystalline cellulose; antioxidants such as BHT, nordihydroguaiaretic acid; and dehydroacetic acid Preservatives such as chili powder; ingestion preventives to prevent children or pets from eating by mistake; pest-attractive spices such as cheese spices, onion spices, peanut oil, etc.

本發明化合物也能與其他的殺蟲劑、殺蟎劑、殺菌劑、除草劑、忌避劑(repellent)、協力劑(synergist)、肥料、土壤改良材混用或並用而使用。 The compound of the present invention can also be used in combination or in combination with other insecticides, acaricides, fungicides, herbicides, repellents, synergists, fertilizers, and soil improvement materials.

作為如此的殺蟲劑、殺蟎劑的有效成分例如可舉出: Examples of the active ingredients of such insecticides and acaricides include:

[1]、擬除蟲菊酯(pyrethroid)系化合物 [1], pyrethroid (pyrethroid) compounds

除蟲菊酯(pyrethrin)、丙烯除蟲菊(allethrin)、普亞列寧(prallethrin)、炔呋菊酯(furamethrin)、列滅寧(resmethrin)、胺菊酯(phthalthrin)、治滅寧(tetramethrin)、依普寧(imiprothrin)、益避寧(empenthrin)、拜富寧(transfluthrin)、美特寧(metofluthrin)、丙氟菊酯 (profluthrin)、酚丁滅寧(phenothrin)、賽酚寧(cyphenothrin)、百滅寧(permethrin)、賽滅寧(cypermethrin)、賽扶寧(cyfluthrin)、β-賽扶寧(beta-cyfluthrin)、芬普寧(fenpropathrin)、畢芬寧(bifenthrin)、乙氰菊酯(cycloprothrin)、第滅寧(deltamethrin)、氟氯苯菊酯(flumethrin)、阿納寧(acrinathrin)、泰滅寧(tralomethrin)、賽洛寧(cyhalothrin)、λ-賽洛寧(lambda-cyhalothrin)、汰福寧(tefluthrin)、芬化利(fenvalerate)、福化利(fluvalinate)、依芬寧(etofenprox)、矽護芬(silafluofen)、沒氟菊酯(momfluorothrin)、四氟甲醚菊酯(dimefluthrin)等; Pyrethrin, allethrin, prallethrin, furamethrin, resmethrin, phthalthrin, tetramethrin ), imiprothrin, empenthrin, transfluthrin, metofluthrin, profluthrin (profluthrin), phenothrin, cyphenothrin, permethrin, cypermethrin, cyfluthrin, beta-cyfluthrin , Fenpropathrin, bifenthrin, cycloprothrin, deltamethrin, flumethrin, anacrinathrin, tralomethrin, sairin Cyhalothrin, lambda-cyhalothrin, tefluthrin, fenvalerate, fluvalinate, etofenprox, silafluofen ), momfluorothrin, dimefluthrin, etc.;

[2]、有機磷系化合物 [2], organic phosphorus compounds

乙醯甲胺磷(acephate)、特嘧硫磷(butathiofos)、大利松(diazinon)、二氯松(dichlorvos:DDVP)、大滅松(dimethoate)、芬殺松(fenthion:MPP)、撲滅松(fenitrothion:MEP)、馬拉松(malathion)、必芬松(pyridaphenthion)、加護松(propaphos)、三氯松(triclorfon:DEP)等; Acetate, butathiofos, diazinon, dichlorvos (DDVP), dimethoate, dimethoate, fenthion (MPP), promethone (fenitrothion: MEP), marathon (malathion), bifenson (pyridaphenthion), plus pine (propaphos), triclosan (triclorfon: DEP), etc.;

[3]、胺甲酸酯(carbamate)系化合物 [3], carbamate (carbamate) compounds

加保利(carbaryl)、加保扶(carbofuran)、丁基滅必蝨(fenobucarb)、滅必蝨(isoprocarb:MIP)、納乃得(methomyl)、NAC、安丹(propoxur:PHC)等; Carbaryl, carbofuran, fenobucarb, isoprocarb (MIP), metomyl, NAC, propoxur (PHC), etc.;

[4]、沙蠶毒素(nereis toxin)系化合物 [4]. Nereis toxin compounds

培丹(cartap)、免速達(bensultap)等; Cartap, bensultap, etc.;

[5]、新菸鹼(neonicotinoid)系化合物 [5], neonicotinoid compounds

益達胺(imidacloprid)、烯啶蟲胺(nitenpyram)、亞滅培 (acetamiprid)、賽速安(thiamethoxam)、賽果培(thiacloprid)、達特南(dinotefuran)、可尼丁(clothianidin)等; Imidacloprid, nitenpyram, miclopyr (acetamiprid), thiamethoxam, thiacloprid, dinotefuran, clothianidin, etc.;

[6]、苯甲醯脲(benzoylurea)系化合物 [6], benzoylurea (benzoylurea) compounds

克福隆(chlorfluazuron)、雙三氟蟲脲(bistrifluron)、二福隆(diflubenzuron)、氟芬隆(flufenoxuron)、六伏隆(hexaflumuron)、得福隆(teflubenzuron)、三福隆(triflumuron)等; Chlorfluazuron, bistrifluron, diflubenzuron, flufenoxuron, hexaflumuron, teflubenzuron, triflumuron Wait;

[7]、苯基吡唑(phenylpyrazole)系化合物 [7], phenylpyrazole (phenylpyrazole) compounds

芬普尼(fipronil)、吡啶氟蟲腈(pyriprole)、氟蟲腈(pyrafluprole)等; Fipronil, pyriprole, pyrafluprole, etc.;

[8]、肼(hydrazine)系化合物 [8], hydrazine compounds

可芬諾(chromafenozide)、合芬隆(halofenozide)、滅芬諾(methoxyfenozide)等; Chromafenozide, halofenozide, methoxyfenozide, etc.;

[9]、天然系殺蟲劑 [9] Natural pesticides

機油(machine oil)、硫酸化菸鹼(nicotine sulfate); Machine oil, nicotine sulfate;

[10]、其他的殺蟲劑 [10], Other pesticides

阿維菌素-B(avermectin-B)、布芬淨(buprofezin)、克凡派(chlorphenapyr)、烯蟲乙酯(hydroprene)、美賜平(methoprene)、因得克(indoxacarb)、惡蟲酮(metoxadiazone)、密滅汀-A(milbemycin-A)、啶蟲丙醚(pyridalyl)、百利普芬(pyriproxyfen)、賜諾殺(spinosad)、氟蟲胺(sulfluramid)、脫芬瑞(tolfenpyrad)、氟大滅(flubendiamide)、賽芬蟎(cyflumetofen)、溴甲烷(methyl bromide)、油酸鉀(potassium oleate)等。 Avermectin-B, buprofezin, chlorphenapyr, hydroprene, metoprene, indoxacarb, evil insects Ketone (metoxadiazone), milbemycin-A (milbemycin-A), pyridalyl (pyridalyl), pyriproxyfen (pyriproxyfen), spinosad (spinosad), sulfluramid (sulfluramid), desfenrex tolfenpyrad), flubendiamide, cyflumetofen, methyl bromide, potassium oleate, etc.

作為忌避劑的有效成分例如可舉出:N,N-二乙基-間-甲苯醯胺(N,N-diethyl-m-toluamide)、薴(limonene)、沈香醇(linalool)、香茅醛(citronellal)、薄荷腦(menthol)、薄荷酮(menthone)、扁柏醇(hinokitiol)、香葉醇(geraniol)、對薄荷烷-3,8-二醇(p-menthane-3,8-diol)、桉油醇(eucalyptol)、長松針烷-3,4-二醇(carane-3,4-diol)、埃卡瑞丁(icaridin)、IR-3535、MGK-R-326、MGK-R-874等。 Examples of effective ingredients of the repellent include N,N-diethyl-m-toluamide, limonene, linalool, and citronellal. (citronellal), menthol (menthol), menthone (menthone), hinokitiol (hinokitiol), geraniol (geraniol), p-menthane-3,8-diol (p-menthane-3,8-diol) , Eucalyptol, carane-3,4-diol, icaridin, IR-3535, MGK-R-326, MGK-R- 874 etc.

作為協力劑的有效成分例如可舉出:5-[2-(2-丁氧基乙氧基)乙氧基甲基]-6-丙基-1,3-苯并二噁唑(5-[2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxole)、N-(2-乙基己基)雙環[2.2.1]庚-5-烯-2,3-二羧醯亞胺(N-(2-ethylhexyl)bicyclo[2.2.1]hept-5-en-2,3-dicarboximide)、八氯二丙醚(octachlorodipropyl ether)、硫氰乙酸異莰酯(isobornyl thiocyanoacetate)、N-(2-乙基己基)-1-異丙基-4-甲基雙環[2.2.2]辛-5-烯-2,3-二羧基醯亞胺(N-(2-ethylhexyl)-1-isopropyl-4-methylbicyclo[2.2.2]oct-5-en-2,3-dicarboximide)等。 As an active ingredient of a synergist, for example, 5-[2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxazole (5- [2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxole), N-(2-ethylhexyl) bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyl N-(2-ethylhexyl)bicyclo[2.2.1]hept-5-en-2,3-dicarboximide, octachlorodipropyl ether, isobornyl thiocyanoacetate, N-(2-ethylhexyl)-1-isopropyl-4-methylbicyclo[2.2.2]oct-5-ene-2,3-dicarboxyamide (N-(2-ethylhexyl)- 1-isopropyl-4-methylbicyclo[2.2.2]oct-5-en-2,3-dicarboximide), etc.

作為本發明化合物具有效力的有害生物例如可舉出有害昆蟲或有害蟎等的有害節胺動物,具體上可舉出以下者。 Examples of the harmful organisms to which the compounds of the present invention are effective include harmful insects and harmful mites such as harmful insects and mites. Specifically, the following may be mentioned.

雙翅目害蟲:淡色庫蚊、三斑家蚊、地下家蚊、熱帶家蚊等的家蚊類;埃及斑蚊、白線斑蚊等的斑蚊類;雷氏按蚊、中華按蚊等的瘧蚊類;搖蚊類;家蠅、畜廄腐蠅、黃腹廁蠅等的家蠅類;綠頭蠅類;肉蠅類;種蠅、蔥蠅等 的花蠅類;果蠅類;潛蠅類;醋蠅類;蝶蠅類;蚤蠅類;虻類;黑蚊類;螫蠅類;蠓類等;網翅目害蟲:德國蟑螂、煙色蟑螂、美洲蟑螂、褐色蟑螂、東方蟑螂等;膜翅目害蟲:蟻類、大黃蜂類、蟻形蜂類、菜葉蜂等的葉蜂類;隱翅目害蟲:狗蚤、貓蚤、人蚤等;蝨亞目害蟲:人蝨、陰蝨、頭蝨、體蝨等;等翅目害蟲:散白蟻、家白蟻等;半翅目害蟲:斑飛蝨、稻褐飛蝨等的飛蝨類;黑尾葉蟬等的葉蟬類;棉蚜等的蚜蟲類;椿象類;臭蟲等的臭蟲類等;鱗翅目害蟲:二化螟蛾、瘤野螟蛾等的螟蛾類;斜紋夜蛾、夜盜蛾、甘藍夜蛾等的夜盜蛾類;蘋果蠹蛾、潛葉蛾、黃毒蛾類;小菜蛾、稻弄蝶、衣蛾、袋衣蛾等;鞘翅目害蟲:姬鰹節蟲、姬圓鰹節蟲、米象鼻蟲、小豆象鼻蟲等的象鼻蟲類;大黃粉蟲、擬榖盜等的擬步行蟲類;番死蟲類;粉蠹蟲類等;蟎類:美洲室塵蟎、歐洲室塵螨等的室塵蟎類;腐食酪蟎、橢圓斑白蟎等的粉蟎類;食甜蟎、家食甜蟎、粉塵蟎等的食甜蟎類;馬六甲肉食蟎(cheyletus malaccensis)、馬六甲肉食蟎(cheyletus malaccensis oudemans)等的肉食蟎類;細蟎類;嗜草蟎類;簡單縫甲蟎類;長角血蜱等的硬蜱類;北部禽蟎、雞皮刺蟎等的雞皮刺蟎類。 Diptera pests: house mosquitoes such as Culex pipiens pallens, house mosquitoes, house mosquitoes, and house mosquitoes; spotted mosquitoes such as Egyptian spotted mosquitoes, white line mosquitoes; Malaria mosquitoes; rocking mosquitoes; houseflies such as house flies, livestock-rotting flies, yellow-bellied toilet flies, etc.; blowflies; meat flies; seed flies, onion flies, etc. Flower flies, fruit flies, latent flies, vinegar flies, butterfly flies, flea flies, gadfly, black mosquitoes, sting flies, midges, etc. Reticera pests: German cockroaches, smoke Cockroaches, American cockroaches, brown cockroaches, oriental cockroaches, etc.; Hymenoptera pests: leaf wasps such as ants, hornets, ant-shaped bees, cabbage leaf bees, etc.; Cryptozoan pests: dog fleas, cat fleas, humans Fleas, etc.; Licea pests: human lice, pubic lice, head lice, body lice, etc.; Isoptera pests: termites, domestic termites, etc.; Hemiptera pests: planthoppers, brown planthoppers, etc.; Leafhoppers such as black-tailed leafhoppers; aphids such as cotton aphids; stink bugs; bed bugs such as bed bugs; lepidopteran pests: borer moths such as stem borer moths and borer borers; Spodoptera litura, Burglar moths such as Spodoptera exigua, Brassica oleracea, etc.; Codling moths, leaf leaf moths, yellow poisonous moths; diamondback moths, rice nymphs, cloth moths, bag moths, etc.; Coleoptera pests: Bombycidae, Ji Weevils such as Bombycidae, rice weevils, adzuki weevils, rhododendrons such as rhubarb mealworms, and rice robberies; fanworms; mealworms, etc.; mites: American room House dust mites such as dust mites and European house dust mites; powder mites such as carrion mite mite and white spot mite; sweet mites such as sweet mites, domestic sweet mites and dust mites; carnivorous mites (Cheyletus) carnivorous mites such as malaccensis) and malacca mites (cheyletus malaccensis oudemans); fine mites; grasshopper mites; simple snail beetles; hard ticks such as Haematopsus longicornis; northern fowl mites and chicken skin mites Chicken skin mites.

本發明的有害生物的防除方法是藉由在通常本發明的有害生物防除劑的形態中,將本發明化合物的有效量施用於有害生物或有害生物的棲息地而進行。 The pest control method of the present invention is carried out by applying an effective amount of the compound of the present invention to a pest or a habitat of a pest in the form of the pest control agent of the present invention.

作為本發明的有害生物防除劑的施用方法例如可舉出以下的方法,可依照本發明的有害生物防除劑的形態、使用場所等適宜選擇。 Examples of the method for applying the pest control agent of the present invention include the following methods, which can be appropriately selected according to the form and use place of the pest control agent of the present invention.

[1]、在有害生物或有害生物的棲息地原封不動地對本發明的有害生物防除劑進行處理之方法。 [1]. A method for treating the pest control agent of the present invention intact in a pest or pest habitat.

[2]、在以水等的溶劑將本發明的有害生物防除劑稀釋後,在有害生物或有害生物的棲息地對本發明的有害生物防除劑進行散布處理之方法。 [2] A method for dispersing the pest control agent of the present invention in a pest or a habitat of the pest after diluting the pest control agent of the present invention with a solvent such as water.

在此情形下,通常將被製劑化成乳劑、可濕性粉劑、流動劑、微膠囊劑製劑等的本發明的有害生物防除劑稀釋以使本發明化合物的濃度成為0.1~10000ppm。 In this case, the pest control agent of the present invention which is formulated into an emulsion, wettable powder, flowing agent, microcapsule preparation, etc. is usually diluted so that the concentration of the compound of the present invention becomes 0.1 to 10000 ppm.

[3]、在有害生物的棲息地藉由加熱等的手段(means)使本發明的有害生物防除劑的有效成分揮散之方法。 [3] A method of dispersing the effective ingredient of the pest control agent of the present invention by means such as heating in the habitat of pests.

此情形,本發明化合物的施用量、施用濃度都可依照本發明的有害生物防除劑的形態、施用時期、施用場所、施用方法、有害生物的種類、被害狀況等適宜決定。 In this case, the application amount and application concentration of the compound of the present invention can be appropriately determined according to the form, application period, application site, application method, type of pest, and damage status of the pest control agent of the present invention.

以本發明化合物當作害蟲防除用使用的情形其施用量適用於空間時為作為本發明化合物的量通常為0.001~100mg/m3,適用於平面時為0.001~100mg/m2。蚊香、蚊香片等是依照其製劑形態藉由加熱使有效成分揮散而施用。樹脂蒸散劑、紙蒸散劑、不織布蒸散劑、編織物蒸散 劑、昇華性錠劑等可藉由原封不動地放置於例如施用的空間,以及在送風下設置於該製劑而使用。 When the compound of the present invention is used as a pest control application, the amount of the compound of the present invention is usually 0.001 to 100 mg/m 3 when it is applied to a space, and 0.001 to 100 mg/m 2 when it is applied to a flat surface. Mosquito-repellent incense, mosquito-repellent incense tablets, etc. are applied according to the form of the preparation by heating to evaporate the active ingredient. Resin evaporating agents, paper evaporating agents, non-woven evaporating agents, woven fabric evaporating agents, sublimable lozenges, etc. can be used by being placed intact, for example, in the space of application, and placed in the preparation under air supply.

作為以本發明的有害生物防除組成物當作害蟲防除用而施用的空間,例如可舉出:起居室、餐廳、臥室、儲藏室(closet)、壁櫥、日式衣櫃、櫥櫃、廁所、澡堂、庫房、倉庫、車內等,進而也能在野外的開放空間施用。 Examples of the space in which the pest control composition of the present invention is applied for pest control include: living room, dining room, bedroom, closet, closet, Japanese wardrobe, cupboard, toilet, bathhouse, In warehouses, warehouses, cars, etc., it can also be used in open spaces in the wild.

將本發明的有害生物防除組成物使用於牛、馬、豬、羊、山羊、雞等的家畜,狗、貓、大鼠、小鼠等的小動物的外部寄生蟲防除的情形,能以獸醫學上眾所周知的方法使用於動物。作為具體的使用方法,在以全身抑制(systemic control)作為目的的情形下,例如藉由錠劑、飼料混入、栓劑、注射(筋肉內、皮下、靜脈內、腹腔內等)進行給藥,在以非全身的抑制(non-systemic control)作為目的的情形下,例如藉由噴霧油劑或水性液劑之澆注(pour-on)處理或點注(spot-on)處理之以洗毛製劑清洗動物或將樹脂蒸散劑作成頸圈或耳標裝在動物等之方法使用。給藥在動物體的情形之本發明化合物的量通常相對於動物之體重1kg為0.01~100mg的範圍。 When the pest control composition of the present invention is used for domestic parasites such as cattle, horses, pigs, sheep, goats, chickens, and other small animals such as dogs, cats, rats, and mice, it can be controlled by veterinary medicine. The well-known methods above are used for animals. As a specific method of use, for the purpose of systemic control, for example, by lozenge, feed mix, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.), in In the case of non-systemic control, for example, by pour-on treatment or spot-on treatment of spray oil or aqueous liquid, the hair preparation is cleaned Animals or the method of using resin evapotranspiration agent as a collar or ear tag and installing it on animals. When administered to an animal, the amount of the compound of the present invention is usually in the range of 0.01 to 100 mg relative to 1 kg of the animal's body weight.

[實施例] [Example]

以下藉由製造例、製劑例及效果試驗例等更詳細地說明本發明,但本發明不是被限定於該等的例子。 Hereinafter, the present invention will be described in more detail through production examples, preparation examples, effect test examples, etc., but the present invention is not limited to these examples.

<含Cl酯化合物的實施例> <Example of Cl-containing ester compound>

顯示本發明化合物(含Cl酯化合物)的製造例。 A production example of the compound of the present invention (Cl-containing ester compound) is shown.

製造例1:化合物(9)的製造 Production Example 1: Production of Compound (9)

在冰冷下將二異丁基氫化鋁(1.5M甲苯溶液、2.4mL、3.60mmol)滴下到甲基2-氯-3,5,6-三氟苯甲酸酯(316mg、1.41mmol)的甲苯(5mL)及四氫呋喃(5mL)的混合溶液。在冰冷下攪拌2小時後,將反應液注加到1N鹽酸水溶液及水,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析(silica gel column chromatography),得到以下列的式[化19](9)表示的2-氯-3,5,6-三氟苯甲醇266mg:

Figure 106111751-A0305-02-0051-22
Diisobutylaluminum hydride (1.5M toluene solution, 2.4mL, 3.60mmol) was added dropwise to toluene of methyl 2-chloro-3,5,6-trifluorobenzoate (316mg, 1.41mmol) under ice cooling (5mL) and a mixture of tetrahydrofuran (5mL). After stirring under ice cooling for 2 hours, the reaction solution was poured into 1N hydrochloric acid aqueous solution and water, and extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to silica gel column chromatography (silica gel column chromatography) to obtain 2-chloride represented by the following formula [Chem 19](9) -3,5,6-Trifluorobenzyl alcohol 266mg:
Figure 106111751-A0305-02-0051-22

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):2.04(t,1H)、4.88(dd,2H)、7.03(m,1H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.04 (t, 1H), 4.88 (dd, 2H), 7.03 (m, 1H)

製造例2:化合物(10)的製造 Production Example 2: Production of Compound (10)

在室溫下將三乙胺(1.9mL、13.65mmol)、苯甲胺(1.00g、9.33mmol)依次滴下到甲基4-甲基-2,3,5,6-四氟苯甲酸酯(1.01g、4.55mmol)的甲苯(15mL)溶液。在100℃下攪拌10小時後,將水注加到反應液,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化20](10)表 示的甲基2-苄胺基-4-甲基-3,5,6-三氟苯甲酸酯1.18g:

Figure 106111751-A0305-02-0052-23
Triethylamine (1.9mL, 13.65mmol) and benzylamine (1.00g, 9.33mmol) were added dropwise to methyl 4-methyl-2,3,5,6-tetrafluorobenzoate at room temperature (1.01 g, 4.55 mmol) in toluene (15 mL). After stirring at 100°C for 10 hours, water was added to the reaction liquid, and extraction was performed with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain methyl 2-benzylamino-4 represented by the following formula [Chem 20](10) -Methyl-3,5,6-trifluorobenzoate 1.18g:
Figure 106111751-A0305-02-0052-23

黃色液體:1H-NMR(CDCl3,TMS)δ(ppm):2.21(m,3H)、3.88(s,3H)、4.50(m,2H)、6.96(brs,1H)、7.29(m,5H) Yellow liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.21 (m, 3H), 3.88 (s, 3H), 4.50 (m, 2H), 6.96 (brs, 1H), 7.29 (m, 5H)

製造例3:化合物(11)的製造 Production Example 3: Production of Compound (11)

在室溫下將鈀碳(117mg)注加到甲基2-苄胺基-4-甲基-3,5,6-三氟苯甲酸酯(1.15g、3.72mmol)的乙酸乙酯(50mL)溶液,在氫環境下取代反應液。在氫環境下在室溫下攪拌3小時後,對反應液進行矽藻土過濾後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化21](11)表示的甲基2-胺基-4-甲基-3,5,6-三氟苯甲酸酯690mg:[化21]

Figure 106111751-A0305-02-0053-24
Palladium-carbon (117 mg) was added to methyl 2-benzylamino-4-methyl-3,5,6-trifluorobenzoate (1.15 g, 3.72 mmol) of ethyl acetate at room temperature ( 50mL) solution, replacing the reaction solution in a hydrogen environment. After stirring at room temperature for 3 hours under a hydrogen atmosphere, the reaction solution was filtered through diatomaceous earth, concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain the following formula [Chem. 21]( 11) 690 mg of methyl 2-amino-4-methyl-3,5,6-trifluorobenzoate represented by: [Chem 21]
Figure 106111751-A0305-02-0053-24

黃色液體:1H-NMR(CDCl3,TMS)δ(ppm):2.24(m,3H)、3.92(s,3H)、5.55(brs,2H) Yellow liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.24 (m, 3H), 3.92 (s, 3H), 5.55 (brs, 2H)

製造例4:化合物(12)的製造 Production Example 4: Production of Compound (12)

在冰冷下將亞硝酸鈉(213mg、3.10mmol)的水(7mL)溶液慢慢地添加到甲基2-胺基-4-甲基-3,5,6-三氟苯甲酸酯(678mg、3.10mmol)的醋酸(7mL)與濃鹽酸(14mL)的混合溶液。在反應液同溫度下攪拌50分。在冰冷下遍及2分將氯化銅(I)(612mg、3.10mmol)分割添加於反應液。在室溫下攪拌12小時後,將水注加到反應液,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化22](12)表示的甲基2-氯-4-甲基-3,5,6-三氟苯甲酸酯505mg:

Figure 106111751-A0305-02-0053-25
Under ice cooling, a solution of sodium nitrite (213 mg, 3.10 mmol) in water (7 mL) was slowly added to methyl 2-amino-4-methyl-3,5,6-trifluorobenzoate (678 mg , 3.10mmol) of acetic acid (7mL) and concentrated hydrochloric acid (14mL) mixed solution. The reaction solution was stirred at the same temperature for 50 minutes. Under ice cooling, copper(I) chloride (612 mg, 3.10 mmol) was added to the reaction solution in two portions. After stirring at room temperature for 12 hours, water was added to the reaction liquid, and extraction was performed with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain methyl 2-chloro-4-methyl represented by the following formula [Chem 22] (12) Yl-3,5,6-trifluorobenzoate 505mg:
Figure 106111751-A0305-02-0053-25

黃色液體:1H-NMR(CDCl3,TMS)δ(ppm):2.29(m,3H)、3.98(s,3H) Yellow liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.29 (m, 3H), 3.98 (s, 3H)

製造例5:化合物(13)的製造 Production Example 5: Production of Compound (13)

在冰冷下將二異丁基氫化鋁(1.5M甲苯溶液、3.5mL、5.25mmol)滴下到甲基2-氯-4-甲基-3,5,6-三氟苯甲酸酯(502mg、2.10mmol)的甲苯(5mL)及四氫呋喃(5mL)的混合溶液。在冰冷下攪拌1小時後,將反應液注加到1N鹽酸水溶液及水,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化23](13)表示的2-氯-4-甲基-3,5,6-三氟苯甲醇410mg:

Figure 106111751-A0305-02-0054-26
Under ice cooling, diisobutylaluminum hydride (1.5M toluene solution, 3.5 mL, 5.25 mmol) was dropped to methyl 2-chloro-4-methyl-3,5,6-trifluorobenzoate (502 mg, 2.10 mmol) of a mixed solution of toluene (5 mL) and tetrahydrofuran (5 mL). After stirring for 1 hour under ice cooling, the reaction solution was poured into 1N aqueous hydrochloric acid solution and water, and extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methyl- represented by the following formula [Chem 23](13) 3,5,6-Trifluorobenzyl alcohol 410mg:
Figure 106111751-A0305-02-0054-26

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):1.99(t,1H)、2.27(m,3H)、4.85(dd,2H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.99 (t, 1H), 2.27 (m, 3H), 4.85 (dd, 2H)

製造例6:化合物(14)的製造 Production Example 6: Production of Compound (14)

在室溫下將三乙胺(3.4mL、24.53mmol)、苯甲胺(1.73g、16.14mmol)依次滴下到甲基4-甲氧基甲基-2,3,5,6-四氟苯甲酸酯(2.03g、8.06mmol)的甲苯(20mL)溶液。在100℃下攪拌7小時後,將水注加到反應液,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮, 將殘渣附加於矽膠管柱層析,得到以下列的式[化24](14)表示的甲基2-苄胺基-4-甲氧基甲基-3,5,6-三氟苯甲酸酯2.32g:

Figure 106111751-A0305-02-0055-27
At room temperature, triethylamine (3.4 mL, 24.53 mmol) and benzylamine (1.73 g, 16.14 mmol) were added dropwise to methyl 4-methoxymethyl-2,3,5,6-tetrafluorobenzene A solution of formate (2.03 g, 8.06 mmol) in toluene (20 mL). After stirring at 100°C for 7 hours, water was added to the reaction liquid, and extraction was performed with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain methyl 2-benzylamino-4 represented by the following formula [Chem 24] (14) -Methoxymethyl-3,5,6-trifluorobenzoate 2.32g:
Figure 106111751-A0305-02-0055-27

黃色液體:1H-NMR(CDCl3,TMS)δ(ppm):3.35(s,3H)、3.89(s,3H)、4.50(m,2H)、4.52(m,2H)、6.90(brs,1H)、7.28(m,5H) Yellow liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 3.35 (s, 3H), 3.89 (s, 3H), 4.50 (m, 2H), 4.52 (m, 2H), 6.90 (brs, 1H), 7.28 (m, 5H)

製造例7:化合物(15)的製造 Production Example 7: Production of Compound (15)

在室溫下將鈀碳(230mg)注加到甲基2-苄胺基-4-甲氧基甲基-3,5,6-三氟苯甲酸酯(2.32g、6.84mmol)的乙酸乙酯(80mL)溶液,在氫環境下取代反應液。在氫環境下在室溫下攪拌3小時後,對反應液進行矽藻土過濾後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化25](15)表示的甲基2-胺基-4-甲氧基甲基-3,5,6-三氟苯甲酸酯1.12g:[化25]

Figure 106111751-A0305-02-0056-28
Add palladium on carbon (230 mg) to methyl 2-benzylamino-4-methoxymethyl-3,5,6-trifluorobenzoate (2.32 g, 6.84 mmol) of acetic acid at room temperature An ethyl acetate (80 mL) solution was used to replace the reaction solution under a hydrogen atmosphere. After stirring at room temperature for 3 hours under a hydrogen atmosphere, the reaction solution was filtered through diatomaceous earth and concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain the following formula [Chem. 25]( 15) Represented methyl 2-amino-4-methoxymethyl-3,5,6-trifluorobenzoate 1.12g: [Chem. 25]
Figure 106111751-A0305-02-0056-28

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):3.40(s,3H)、3.94(s,3H)、4.56(m,2H)、5.59(brs,2H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 3.40 (s, 3H), 3.94 (s, 3H), 4.56 (m, 2H), 5.59 (brs, 2H)

製造例8:化合物(16)的製造 Production Example 8: Production of Compound (16)

在冰冷下將亞硝酸鈉(91mg、1.32mmol)的水(4mL)溶液慢慢地添加到甲基2-胺基-4-甲氧基甲基-3,5,6-三氟苯甲酸酯(326mg、1.31mmol)的醋酸(4mL)與濃鹽酸(8mL)的混合溶液。在反應液同溫度下攪拌50分。在冰冷下遍及2分將氯化銅(I)(259mg、2.62mmol)分割添加於反應液。在室溫下攪拌5小時後,將水注加到反應液,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化26](16)表示的甲基2-氯-4-甲氧基甲基-3,5,6-三氟苯甲酸酯135mg:

Figure 106111751-A0305-02-0056-29
Under ice cooling, a solution of sodium nitrite (91 mg, 1.32 mmol) in water (4 mL) was slowly added to methyl 2-amino-4-methoxymethyl-3,5,6-trifluorobenzoic acid A mixed solution of ester (326 mg, 1.31 mmol) in acetic acid (4 mL) and concentrated hydrochloric acid (8 mL). The reaction solution was stirred at the same temperature for 50 minutes. Under ice cooling, copper (I) chloride (259 mg, 2.62 mmol) was added to the reaction solution in two portions. After stirring at room temperature for 5 hours, water was added to the reaction liquid, and extraction was performed with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain methyl 2-chloro-4-methyl represented by the following formula [Chem26](16) Oxymethyl-3,5,6-trifluorobenzoate 135mg:
Figure 106111751-A0305-02-0056-29

黃色液體:1H-NMR(CDCl3,TMS)δ(ppm):3.39(s,3H)、4.00(s,3H)、4.58(m,2H) Yellow liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 3.39 (s, 3H), 4.00 (s, 3H), 4.58 (m, 2H)

製造例9:化合物(17)的製造 Production Example 9: Production of Compound (17)

在冰冷下將二異丁基氫化鋁(1.5M甲苯溶液、1.0mL、1.50mmol)滴下到甲基2-氯-4-甲氧基甲基-3,5,6-三氟苯甲酸酯(130mg、0.48mmol)的甲苯(3mL)及四氫呋喃(3mL)的混合溶液。在冰冷下攪拌1小時後,將反應液注加到1N鹽酸水溶液及水,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化27](17)表示的2-氯-4-甲氧基甲基-3,5,6-三氟苯甲醇67mg:

Figure 106111751-A0305-02-0057-30
Under ice-cooling, diisobutylaluminum hydride (1.5M toluene solution, 1.0 mL, 1.50 mmol) was dropped to methyl 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzoate (130 mg, 0.48 mmol) of a mixed solution of toluene (3 mL) and tetrahydrofuran (3 mL). After stirring for 1 hour under ice cooling, the reaction solution was poured into 1N aqueous hydrochloric acid solution and water, and extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methoxy represented by the following formula [Chem27](17) Methyl-3,5,6-trifluorobenzyl alcohol 67mg:
Figure 106111751-A0305-02-0057-30

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):2.03(t,1H)、3.39(s,3H)、4.58(m,2H)、4.88(dd,2H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.03 (t, 1H), 3.39 (s, 3H), 4.58 (m, 2H), 4.88 (dd, 2H)

製造例10:本發明化合物C1的製造 Production Example 10: Production of Compound C1 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(54mg、0.28mmol)及4-二甲胺基吡啶(3mg)加到2-氯-3,5,6-三氟苯甲醇(50mg、0.26mmol)及(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷甲酸(47mg、0.28mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌24小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在 減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化28](18)表示的2-氯-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物C1)21mg:

Figure 106111751-A0305-02-0058-31
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (54mg, 0.28mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-3, 5,6-trifluorobenzyl alcohol (50mg, 0.26mmol) and (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid (47mg, 0.28 mmol) in chloroform (2 mL). After stirring at room temperature for 24 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-3,5,6 represented by the following formula [Chemical 28](18) -Trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (the present compound C1) 21 mg:
Figure 106111751-A0305-02-0058-31

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.12(s,3H)、1.26(s,3H)、1.46(d,1H)、1.69(s,3H)、1.70(s,3H)、2.08(t,1H)、4.87(d,1H)、5.28(m,2H)、7.07(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.12 (s, 3H), 1.26 (s, 3H), 1.46 (d, 1H), 1.69 (s, 3H), 1.70 (s, 3H), 2.08 (t, 1H), 4.87 (d, 1H), 5.28 (m, 2H), 7.07 (m, 1H)

製造例11:本發明化合物I1的製造 Production Example 11: Production of Compound I1 of the present invention

將吡啶(100mg、1.20mmol)、(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙甲醯氯(76mg、0.34mmol)及4-二甲胺基吡啶(3mg)依次加到2-氯-3,5,6-三氟苯甲醇(40mg、0.20mmol)的四氫呋喃溶液(2mL)。在室溫下攪拌19小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化29](19)表示的2-氯-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物I1)75mg:

Figure 106111751-A0305-02-0059-32
Pyridine (100mg, 1.20mmol), (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropylmethanyl chloride (76mg, 0.34mmol) And 4-dimethylaminopyridine (3 mg) was added sequentially to a solution (2 mL) of 2-chloro-3,5,6-trifluorobenzyl alcohol (40 mg, 0.20 mmol) in tetrahydrofuran. After stirring at room temperature for 19 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-3,5,6 represented by the following formula [Chem 29](19) -Trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate (Compound I1 of the present invention) 75 mg:
Figure 106111751-A0305-02-0059-32

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.18(s,3H)、1.29(s,3H)、1.61(d,1H)、2.26(m,1H)、5.31(m,2H)、5.60(d,1H)、7.08(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.18 (s, 3H), 1.29 (s, 3H), 1.61 (d, 1H), 2.26 (m, 1H), 5.31 (m, 2H), 5.60 (d, 1H), 7.08 (m, 1H)

製造例12:本發明化合物P1的製造 Production Example 12: Production of Compound P1 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(53mg、0.28mmol)及4-二甲胺基吡啶(3mg)加到2-氯-3,5,6-三氟苯甲醇(45mg、0.23mmol)及(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷甲酸(關於雙鍵的異構物的比率:Z/E=約8/1)(53mg、0.34mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌20小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化30](20)表示的2-氯-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物P1)(關於雙鍵的異構物的比率:Z/E=約8/1)29mg:[化30]

Figure 106111751-A0305-02-0060-33
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (53mg, 0.28mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-3, 5,6-trifluorobenzyl alcohol (45mg, 0.23mmol) and (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid (for double bond isomers Ratio: Z/E = about 8/1) (53 mg, 0.34 mmol) in chloroform solution (3 mL). After stirring at room temperature for 20 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-3,5,6 represented by the following formula [Chem 30](20) -Trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (compound P1 of the present invention) (regarding the ratio of double bond isomers: Z/E = about 8/1) 29mg: [Chem 30]
Figure 106111751-A0305-02-0060-33

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.14(s,3H,Z+E體)、1.28(s,3H,Z+E體)、1.46(d,1H,Z+E體)、1.70(dd,3H,Z+E體)、2.18(m,1H,Z+E體)、5.11(m,1H,Z+E體)、5.29(m,2H,Z+E體)、5.60(m,1H,Z+E體)、7.08(m,1H,Z+E體) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.14 (s, 3H, Z+E body), 1.28 (s, 3H, Z+E body), 1.46 (d, 1H, Z+ E body), 1.70 (dd, 3H, Z+E body), 2.18 (m, 1H, Z+E body), 5.11 (m, 1H, Z+E body), 5.29 (m, 2H, Z+E body) ), 5.60 (m, 1H, Z+E body), 7.08 (m, 1H, Z+E body)

製造例13:本發明化合物R1的製造 Production Example 13: Production of Compound R1 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(37mg、0.19mmol)及4-二甲胺基吡啶(3mg)加到2-氯-3,5,6-三氟苯甲醇(31mg、0.16mmol)及(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷甲酸(40mg、0.19mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌24小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化31](21)表示的2-氯-3,5,6-三氟苄基(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯(本發明化合物R1)33mg:[化31]

Figure 106111751-A0305-02-0061-34
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (37mg, 0.19mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-3, 5,6-trifluorobenzyl alcohol (31mg, 0.16mmol) and (1R)-trans-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethyl A solution of cyclopropanecarboxylic acid (40 mg, 0.19 mmol) in chloroform (2 mL). After stirring at room temperature for 24 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After the organic layer was dried with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-3,5,6 represented by the following formula [Chem 31](21) -Trifluorobenzyl (1R)-trans-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate (Compound R1 of the present invention) )33mg: [Chem 31]
Figure 106111751-A0305-02-0061-34

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.22(s,3H)、1.31(s,3H)、1.72(d,1H)、1.93(s,3H)、2.22(m,1H)、3.72(s,3H)、5.31(m,2H)、6.44(m,1H)、7.09(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.22 (s, 3H), 1.31 (s, 3H), 1.72 (d, 1H), 1.93 (s, 3H), 2.22 (m, 1H), 3.72 (s, 3H), 5.31 (m, 2H), 6.44 (m, 1H), 7.09 (m, 1H)

製造例14:本發明化合物T1的製造 Production Example 14: Production of Compound T1 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(37mg、0.19mmol)及4-二甲胺基吡啶(3mg)加到2-氯-3,5,6-三氟苯甲醇(30mg、0.15mmol)及(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷甲酸(40mg、0.20mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌24小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化32](22)表示的2-氯-3,5,6-三氟苄基(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯(本發明化合物T1)47mg:[化32]

Figure 106111751-A0305-02-0062-35
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (37mg, 0.19mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-3, 5,6-trifluorobenzyl alcohol (30mg, 0.15mmol) and (1R)-cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethyl A solution (2 mL) of cyclopropanecarboxylic acid (40 mg, 0.20 mmol) in chloroform. After stirring at room temperature for 24 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-3,5,6 represented by the following formula [Chem 32](22) -Trifluorobenzyl (1R)-cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate (Compound T1 of the present invention) )47mg: [Chem 32]
Figure 106111751-A0305-02-0062-35

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.27(s,3H)、1.31(s,3H)、1.94(d,1H)、3.26(t,1H)、3.71(s,3H)、5.27(m,2H)、5.91(d,1H)、6.62(t,1H)、7.08(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.27 (s, 3H), 1.31 (s, 3H), 1.94 (d, 1H), 3.26 (t, 1H), 3.71 (s, 3H), 5.27 (m, 2H), 5.91 (d, 1H), 6.62 (t, 1H), 7.08 (m, 1H)

製造例15:本發明化合物W1的製造 Production Example 15: Production of Compound W1 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(83mg、0.43mmol)及4-二甲胺基吡啶(3mg)加到2-氯-3,5,6-三氟苯甲醇(70mg、0.36mmol)及2,2,3,3-四甲基環丙烷甲酸(61mg、0.43mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌24小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化33](23)表示的2-氯-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯(本發明化合物W1)72mg:

Figure 106111751-A0305-02-0062-36
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (83mg, 0.43mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-3, A solution of 5,6-trifluorobenzyl alcohol (70 mg, 0.36 mmol) and 2,2,3,3-tetramethylcyclopropanecarboxylic acid (61 mg, 0.43 mmol) in chloroform (3 mL). After stirring at room temperature for 24 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-3,5,6 represented by the following formula [Chem 33](23) -Trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate (Compound W1 of the present invention) 72 mg:
Figure 106111751-A0305-02-0062-36

白色固體:1H-NMR(CDCl3,TMS)δ(ppm): 1.17(s,7H)、1.25(s,6H)、5.24(m,2H)、7.08(m,1H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.17 (s, 7H), 1.25 (s, 6H), 5.24 (m, 2H), 7.08 (m, 1H)

製造例16:本發明化合物C2的製造 Production Example 16: Production of Compound C2 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(59mg、0.31mmol)及4-二甲胺基吡啶(3mg)加到2-氯-4-甲基-3,5,6-三氟苯甲醇(50mg、0.24mmol)及(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷甲酸(52mg、0.31mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌6小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化34](24)表示的2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物C2)53mg:

Figure 106111751-A0305-02-0063-37
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (59mg, 0.31mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-4- Methyl-3,5,6-trifluorobenzyl alcohol (50mg, 0.24mmol) and (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane A chloroform solution (3 mL) of formic acid (52 mg, 0.31 mmol). After stirring at room temperature for 6 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methyl- represented by the following formula [Chem 34](24) 3,5,6-Trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (Compound C2 of the present invention) 53mg :
Figure 106111751-A0305-02-0063-37

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.12(s,3H)、1.26(s,3H)、1.38(d,1H)、1.69(s,3H)、1.70(s,3H)、2.07(t,1H)、2.28(m,3H)、4.87(d,1H)、5.26(m,2H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.12 (s, 3H), 1.26 (s, 3H), 1.38 (d, 1H), 1.69 (s, 3H), 1.70 (s, 3H), 2.07 (t, 1H), 2.28 (m, 3H), 4.87 (d, 1H), 5.26 (m, 2H)

製造例17:本發明化合物I2的製造 Production Example 17: Production of Compound I2 of the present invention

將吡啶(112mg、1.42mmol)、(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙甲醯氯(191mg、0.36mmol)及4-二 甲胺基吡啶(3mg)依次加到2-氯-4-甲基-3,5,6-三氟苯甲醇(50mg、0.24mmol)的四氫呋喃溶液(2mL)。在室溫下攪拌7小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化35](25)表示的2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物I2)60mg:

Figure 106111751-A0305-02-0064-38
Pyridine (112mg, 1.42mmol), (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropylmethanyl chloride (191mg, 0.36mmol) And 4-dimethylaminopyridine (3 mg) was sequentially added to a solution (2 mL) of 2-chloro-4-methyl-3,5,6-trifluorobenzyl alcohol (50 mg, 0.24 mmol) in tetrahydrofuran. After stirring at room temperature for 7 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methyl- represented by the following formula [Chem 35](25) 3,5,6-Trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate (Compound I2 of the invention) )60mg:
Figure 106111751-A0305-02-0064-38

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):1.17(s,3H)、1.29(s,3H)、1.60(d,1H)、2.25(m,1H)、2.29(m,3H)、5.28(m,2H)、5.59(d,1H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.17 (s, 3H), 1.29 (s, 3H), 1.60 (d, 1H), 2.25 (m, 1H), 2.29 (m, 3H), 5.28 (m, 2H), 5.59 (d, 1H)

製造例18:本發明化合物P2的製造 Production Example 18: Production of the compound P2 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(49mg、0.26mmol)及4-二甲胺基吡啶(2mg)加到2-氯-4-甲基-3,5,6-三氟苯甲醇(41mg、0.19mmol)及(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷甲酸(關於雙鍵的異構物的比率:Z/E=約8/1)(39mg、0.25mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌19小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮, 將殘渣附加於矽膠管柱層析,得到以下列的式[化36](26)表示的2-氯-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物P2)(關於雙鍵的異構物的比率:Z/E=約8/1)24mg:

Figure 106111751-A0305-02-0065-39
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (49mg, 0.26mmol) and 4-dimethylaminopyridine (2mg) to 2-chloro-4- Methyl-3,5,6-trifluorobenzyl alcohol (41 mg, 0.19 mmol) and (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid (about double bond The ratio of isomers: Z/E = about 8/1) (39 mg, 0.25 mmol) in chloroform solution (3 mL). After stirring at room temperature for 19 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methyl- represented by the following formula [Chem 36](26) 3,5,6-Trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (Compound P2 of the present invention) Structure ratio: Z/E = about 8/1) 24mg:
Figure 106111751-A0305-02-0065-39

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.13(s,3H,Z+E體)、1.28(s,3H,Z+E體)、1.45(d,1H,Z+E體)、1.70(dd,3H,Z+E體)、2.17(m,1H,Z+E體)、2.28(m,3H,Z+E體)、5.11(m,1H,Z+E體)、5.27(m,2H,Z+E體)、5.59(m,1H,Z+E體) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.13 (s, 3H, Z+E body), 1.28 (s, 3H, Z+E body), 1.45 (d, 1H, Z+ E body), 1.70 (dd, 3H, Z+E body), 2.17 (m, 1H, Z+E body), 2.28 (m, 3H, Z+E body), 5.11 (m, 1H, Z+E body) ), 5.27 (m, 2H, Z+E body), 5.59 (m, 1H, Z+E body)

製造例19:本發明化合物R2的製造 Production Example 19: Production of the compound R2 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(41mg、0.21mmol)及4-二甲胺基吡啶(3mg)加到2-氯-4-甲基-3,5,6-三氟苯甲醇(35mg、0.17mmol)及(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷甲酸(46mg、0.22mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌21小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化37](27)表示的2-氯-4- 甲基-3,5,6-三氟苄基(1R)-反式-3-[(E)-(2-甲氧羰基-1-丙烯基)]-2,2-二甲基環丙烷羧酸酯(本發明化合物R2)58mg:

Figure 106111751-A0305-02-0066-40
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (41mg, 0.21mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-4- Methyl-3,5,6-trifluorobenzyl alcohol (35mg, 0.17mmol) and (1R)-trans-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2, A solution of 3-dimethylcyclopropanecarboxylic acid (46 mg, 0.22 mmol) in chloroform (3 mL). After stirring at room temperature for 21 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methyl- represented by the following formula [Chem 37] (27) 3,5,6-Trifluorobenzyl (1R)-trans-3-[(E)-(2-methoxycarbonyl-1-propenyl)]-2,2-dimethylcyclopropane carboxylate (Compound R2 of the present invention) 58 mg:
Figure 106111751-A0305-02-0066-40

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.21(s,3H)、1.31(s,3H)、1.71(d,1H)、1.93(s,3H)、2.22(m,1H)、2.29(m,3H)、3.72(s,3H)、5.28(m,2H)、6.43(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.21 (s, 3H), 1.31 (s, 3H), 1.71 (d, 1H), 1.93 (s, 3H), 2.22 (m, 1H), 2.29 (m, 3H), 3.72 (s, 3H), 5.28 (m, 2H), 6.43 (m, 1H)

製造例20:本發明化合物T2的製造 Production Example 20: Production of Compound T2 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(36mg、0.19mmol)及4-二甲胺基吡啶(3mg)加到2-氯-4-甲基-3,5,6-三氟苯甲醇(30mg、0.14mmol)及(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷甲酸(37mg、0.19mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌14小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化38](28)表示的2-氯-4-甲基-3,5,6-三氟苄基(1R)-順式-3-[(Z)-(2-甲氧羰基-1-乙烯基)]-2,2-二甲基環丙烷羧酸酯(本發明化合物T2)38mg:

Figure 106111751-A0305-02-0067-41
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (36mg, 0.19mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-4- Methyl-3,5,6-trifluorobenzyl alcohol (30mg, 0.14mmol) and (1R)-cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2, A solution (2-mL) of 2-dimethylcyclopropanecarboxylic acid (37 mg, 0.19 mmol) in chloroform. After stirring at room temperature for 14 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methyl- represented by the following formula [Chem 38] (28) 3,5,6-Trifluorobenzyl (1R)-cis-3-[(Z)-(2-methoxycarbonyl-1-vinyl)]-2,2-dimethylcyclopropane carboxylate (Compound T2 of the present invention) 38 mg:
Figure 106111751-A0305-02-0067-41

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.26(s,3H)、1.30(s,3H)、1.93(d,1H)、2.28(m,3H)、3.25(t,1H)、3.71(s,3H)、5.24(m,2H)、5.91(d,1H)、6.43(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.26 (s, 3H), 1.30 (s, 3H), 1.93 (d, 1H), 2.28 (m, 3H), 3.25 (t, 1H), 3.71 (s, 3H), 5.24 (m, 2H), 5.91 (d, 1H), 6.43 (m, 1H)

製造例21:本發明化合物W2的製造 Production Example 21: Production of Compound W2 of the invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(41mg、0.21mmol)及4-二甲胺基吡啶(3mg)加到2-氯-4-甲基-3,5,6-三氟苯甲醇(35mg、0.17mmol)及2,2,3,3-四甲基環丙烷甲酸(31mg、0.22mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌19小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化39](29)表示的2-氯-4-甲基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯(本發明化合物W2)49mg:

Figure 106111751-A0305-02-0067-42
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (41mg, 0.21mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-4- A solution of methyl-3,5,6-trifluorobenzyl alcohol (35 mg, 0.17 mmol) and 2,2,3,3-tetramethylcyclopropanecarboxylic acid (31 mg, 0.22 mmol) in chloroform (2 mL). After stirring at room temperature for 19 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methyl- represented by the following formula [Chem 39] (29) 3,5,6-Trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate (Compound W2 of the present invention) 49 mg:
Figure 106111751-A0305-02-0067-42

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):1.17(s,7H)、1.25(s,6H)、2.28(m,3H)、5.22(m,2H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.17 (s, 7H), 1.25 (s, 6H), 2.28 (m, 3H), 5.22 (m, 2H)

製造例22:本發明化合物C3的製造 Production Example 22: Production of Compound C3 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(20mg、0.10mmol)及4-二甲胺基吡啶(2mg)加到2-氯-4-甲氧基甲基-3,5,6-三氟苯甲醇(16mg、0.07mmol)及(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷甲酸(17mg、0.10mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌15小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化40](30)表示的2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物C3)14mg:

Figure 106111751-A0305-02-0068-43
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (20mg, 0.10mmol) and 4-dimethylaminopyridine (2mg) to 2-chloro-4- Methoxymethyl-3,5,6-trifluorobenzyl alcohol (16mg, 0.07mmol) and (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethyl Cyclopropanecarboxylic acid (17 mg, 0.10 mmol) in chloroform (2 mL). After stirring at room temperature for 15 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methoxy represented by the following formula [Chem 40] (30) Methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (compound of the present invention) C3) 14mg:
Figure 106111751-A0305-02-0068-43

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.12(s,3H)、1.26(s,3H)、1.38(d,1H)、1.69(s,3H)、1.70(s,3H)、2.08(t,1H)、3.40(s,3H)、4.58(m,2H)、4.87(m,1H)、5.28(m,2H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.12 (s, 3H), 1.26 (s, 3H), 1.38 (d, 1H), 1.69 (s, 3H), 1.70 (s, 3H), 2.08 (t, 1H), 3.40 (s, 3H), 4.58 (m, 2H), 4.87 (m, 1H), 5.28 (m, 2H)

製造例23:本發明化合物I3的製造 Production Example 23: Production of Compound I3 of the present invention

將吡啶(130mg、1.65mmol)、(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙甲醯氯(250mg、0.47mmol)及4-二甲胺基吡啶(3mg)依次加到2-氯-4-甲氧基甲基-3,5,6-三氟苯甲醇(56mg、0.23mmol)的四氫呋喃溶液(5mL)。在室溫下攪拌18小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化41](31)表示的2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物I3)42mg:

Figure 106111751-A0305-02-0069-44
Pyridine (130mg, 1.65mmol), (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropylmethanyl chloride (250mg, 0.47mmol) And 4-dimethylaminopyridine (3 mg) was sequentially added to a solution (5 mL) of 2-chloro-4-methoxymethyl-3,5,6-trifluorobenzyl alcohol (56 mg, 0.23 mmol) in tetrahydrofuran. After stirring at room temperature for 18 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methoxy represented by the following formula [Chem 41] (31) Methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate (this Inventive compound I3) 42 mg:
Figure 106111751-A0305-02-0069-44

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.18(s,3H)、1.29(s,3H)、1.60(d,1H)、2.26(m,1H)、3.40(s,3H)、4.58(m,2H)、5.30(m,2H)、5.59(d,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.18 (s, 3H), 1.29 (s, 3H), 1.60 (d, 1H), 2.26 (m, 1H), 3.40 (s, 3H), 4.58 (m, 2H), 5.30 (m, 2H), 5.59 (d, 1H)

製造例24:本發明化合物P3的製造 Production Example 24: Production of Compound P3 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(80mg、0.42mmol)及4-二甲胺基吡啶(3mg)加到2-氯-4-甲氧基甲基-3,5,6-三氟苯甲醇(67mg、0.28mmol)及(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷甲酸(關於雙鍵的異構物 的比率:Z/E=約8/1)(64mg、0.42mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌22小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化42](32)表示的2-氯-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物P3)(關於雙鍵的異構物的比率:Z/E=約8/1)25mg:

Figure 106111751-A0305-02-0070-45
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (80mg, 0.42mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-4- Methoxymethyl-3,5,6-trifluorobenzyl alcohol (67mg, 0.28mmol) and (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid ( Regarding the ratio of double bond isomers: Z/E = about 8/1) (64 mg, 0.42 mmol) in chloroform solution (3 mL). After stirring at room temperature for 22 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to silica gel column chromatography to obtain 2-chloro-4-methoxy represented by the following formula [Chem 42] (32) Methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (compound P3 of the present invention) (about bis Ratio of bond isomers: Z/E = about 8/1) 25 mg:
Figure 106111751-A0305-02-0070-45

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.14(s,3H,Z+E體)、1.28(s,3H,Z+E體)、1.45(d,1H,Z+E體)、1.70(dd,3H,Z+E體)、2.18(m,1H,Z+E體)、3.40(s,3H,Z+E體)、4.58(m,2H,Z+E體)、5.11(m,1H,Z+E體)、5.29(m,2H,Z+E體)、5.60(m,1H,Z+E體) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.14 (s, 3H, Z+E body), 1.28 (s, 3H, Z+E body), 1.45 (d, 1H, Z+ E body), 1.70 (dd, 3H, Z+E body), 2.18 (m, 1H, Z+E body), 3.40 (s, 3H, Z+E body), 4.58 (m, 2H, Z+E body) ), 5.11 (m, 1H, Z+E body), 5.29 (m, 2H, Z+E body), 5.60 (m, 1H, Z+E body)

製造例25:本發明化合物W3的製造 Production Example 25: Production of Compound W3 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(60mg、0.32mmol)及4-二甲胺基吡啶(3mg)加到2-氯-4-甲氧基甲基-3,5,6-三氟苯甲醇(50mg、0.21mmol)及2,2,3,3-四甲基環丙烷甲酸(45mg、0.32mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌24小時後,將水注加到反應液,以乙酸乙酯萃 取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化43](33)表示的2-氯-4-甲氧基甲基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯(本發明化合物W3)52mg:

Figure 106111751-A0305-02-0071-46
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (60mg, 0.32mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-4- A solution of methoxymethyl-3,5,6-trifluorobenzyl alcohol (50mg, 0.21mmol) and 2,2,3,3-tetramethylcyclopropanecarboxylic acid (45mg, 0.32mmol) in chloroform (2mL) ). After stirring at room temperature for 24 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methoxy represented by the following formula [Chem 43] (33) Methyl-3,5,6-trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate (Compound W3 of the invention) 52mg:
Figure 106111751-A0305-02-0071-46

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.17(s,7H)、1.25(s,6H)、3.40(s,3H)、4.58(m,2H)、5.29(m,2H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.17 (s, 7H), 1.25 (s, 6H), 3.40 (s, 3H), 4.58 (m, 2H), 5.29 (m, 2H)

製造例26:本發明化合物C4的製造 Production Example 26: Production of Compound C4 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(67mg、0.35mmol)及4-二甲胺基吡啶(4mg)加到2-氯-4-乙炔基-3,5,6-三氟苯甲醇(65mg、0.29mmol)及(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷甲酸(59mg、0.35mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌17小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化44](34)表示的2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物C4)45mg:

Figure 106111751-A0305-02-0072-47
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (67mg, 0.35mmol) and 4-dimethylaminopyridine (4mg) to 2-chloro-4- Ethynyl-3,5,6-trifluorobenzyl alcohol (65mg, 0.29mmol) and (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane A chloroform solution (3 mL) of formic acid (59 mg, 0.35 mmol). After stirring at room temperature for 17 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was attached to a silica gel column chromatography to obtain 2-chloro-4-ethynyl- represented by the following formula [Chem 44] (34) 3,5,6-Trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (Compound C4 of the present invention) 45mg :
Figure 106111751-A0305-02-0072-47

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.13(s,3H)、1.27(s,3H)、1.38(d,1H)、1.69(s,3H)、1.70(s,3H)、2.07(t,1H)、3.66(s,1H)、4.87(d,1H)、5.28(m,2H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.13 (s, 3H), 1.27 (s, 3H), 1.38 (d, 1H), 1.69 (s, 3H), 1.70 (s, 3H), 2.07 (t, 1H), 3.66 (s, 1H), 4.87 (d, 1H), 5.28 (m, 2H)

製造例27:本發明化合物I4的製造 Production Example 27: Production of Compound I4 of the present invention

將吡啶(100mg、1.27mmol)、(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙甲醯氯(191mg、0.36mmol)及4-二甲胺基吡啶(3mg)依次加到2-氯-4-乙炔基-3,5,6-三氟苯甲醇(40mg、0.18mmol)的四氫呋喃溶液(3mL)。在室溫下攪拌19小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化45](35)表示的2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物I4)32mg:[化45]

Figure 106111751-A0305-02-0073-48
Pyridine (100mg, 1.27mmol), (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropylmethanyl chloride (191mg, 0.36mmol) And 4-dimethylaminopyridine (3 mg) was sequentially added to a solution (3 mL) of 2-chloro-4-ethynyl-3,5,6-trifluorobenzyl alcohol (40 mg, 0.18 mmol) in tetrahydrofuran. After stirring at room temperature for 19 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was attached to a silica gel column chromatography to obtain 2-chloro-4-ethynyl- represented by the following formula [Chem 45](35) 3,5,6-Trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate (Compound I4 of the present invention) )32mg: [Chem 45]
Figure 106111751-A0305-02-0073-48

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.18(s,3H)、1.30(s,3H)、1.61(d,1H)、2.26(m,1H)、3.67(s,1H)、5.29(m,2H)、5.60(d,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.18 (s, 3H), 1.30 (s, 3H), 1.61 (d, 1H), 2.26 (m, 1H), 3.67 (s, 1H), 5.29 (m, 2H), 5.60 (d, 1H)

製造例28:本發明化合物P4的製造 Production Example 28: Production of Compound P4 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(50mg、0.26mmol)及4-二甲胺基吡啶(3mg)加到2-氯-4-乙炔基-3,5,6-三氟苯甲醇(48mg、0.22mmol)及(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷甲酸(關於雙鍵的異構物的比率:Z/E=約8/1)(40mg、0.26mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌23小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化46](36)表示的2-氯-4-乙炔基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物P4)(關於雙鍵的異構物的比率:Z/E=約8/1)36mg:[化46]

Figure 106111751-A0305-02-0074-50
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (50mg, 0.26mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-4- Ethynyl-3,5,6-trifluorobenzyl alcohol (48mg, 0.22mmol) and (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid (about double bond The ratio of isomers: Z/E = about 8/1) (40 mg, 0.26 mmol) in chloroform solution (3 mL). After stirring at room temperature for 23 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-ethynyl- represented by the following formula [Chem46](36) 3,5,6-Trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (Compound P4 of the present invention) Structure ratio: Z/E = about 8/1) 36 mg: [Chem 46]
Figure 106111751-A0305-02-0074-50

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.12(s,3H,Z+E體)、1.27(s,3H,Z+E體)、1.45(d,1H,Z+E體)、1.79(dd,3H,Z+E體)、2.16(m,1H,Z+E體)、3.66(s,1H,Z+E體)、5.11(m,1H,Z+E體)、5.26(m,2H,Z+E體)、5.58(m,1H,Z+E體) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.12 (s, 3H, Z+E body), 1.27 (s, 3H, Z+E body), 1.45 (d, 1H, Z+ E body), 1.79 (dd, 3H, Z+E body), 2.16 (m, 1H, Z+E body), 3.66 (s, 1H, Z+E body), 5.11 (m, 1H, Z+E body) ), 5.26 (m, 2H, Z+E body), 5.58 (m, 1H, Z+E body)

製造例29:本發明化合物W4的製造 Production Example 29: Production of Compound W4 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(46mg、0.24mmol)及4-二甲胺基吡啶(3mg)加到2-氯-4-乙炔基-3,5,6-三氟苯甲醇(45mg、0.20mmol)及2,2,3,3-四甲基環丙烷甲酸(34mg、0.24mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌25小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化47](37)表示的2-氯-4-乙炔基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯(本發明化合物W4)28mg:[化47]

Figure 106111751-A0305-02-0075-51
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (46mg, 0.24mmol) and 4-dimethylaminopyridine (3mg) to 2-chloro-4- A solution of ethynyl-3,5,6-trifluorobenzyl alcohol (45 mg, 0.20 mmol) and 2,2,3,3-tetramethylcyclopropanecarboxylic acid (34 mg, 0.24 mmol) in chloroform (3 mL). After stirring at room temperature for 25 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-ethynyl- represented by the following formula [Chem 47] (37) 3,5,6-trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate (Compound W4 of the present invention) 28 mg: [Chem. 47]
Figure 106111751-A0305-02-0075-51

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):1.18(s,7H)、1.26(s,6H)、3.66(s,1H)、5.23(m,2H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.18 (s, 7H), 1.26 (s, 6H), 3.66 (s, 1H), 5.23 (m, 2H)

製造例30:本發明化合物M2的製造 Production Example 30: Production of Compound M2 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(55mg、0.286mmol)及4-二甲胺基吡啶(5mg)加到2-氯-4-甲基-3,5,6-三氟苯甲醇(40mg、0.190mmol)及(1RS)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷甲酸(46mg、0.190mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌17小時後,將水注加到反應液,以乙酸乙酯萃取反應液。 以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化48](38)表示的2-氯-4-甲基-3,5,6-三氟苄基(1RS)-順式-3-[(Z)-2-氯-3,3,3-三氟-1-丙烯基]-2,2-二甲基環丙烷羧酸酯(本發明化合物M2)63mg:

Figure 106111751-A0305-02-0075-52
。 Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (55mg, 0.286mmol) and 4-dimethylaminopyridine (5mg) to 2-chloro-4- Methyl-3,5,6-trifluorobenzyl alcohol (40mg, 0.190mmol) and (1RS)-cis-3-[(Z)-2-chloro-3,3,3-trifluoro-1-propene Base]-2,2-dimethylcyclopropanecarboxylic acid (46 mg, 0.190 mmol) in chloroform (2 mL). After stirring at room temperature for 17 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-chloro-4-methyl- represented by the following formula [Chem48](38) 3,5,6-Trifluorobenzyl (1RS)-cis-3-[(Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethyl Cyclopropane carboxylate (Compound M2 of the present invention) 63mg:
Figure 106111751-A0305-02-0075-52
.

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.29(s,3H)、1.30(s,3H)、1.97(d,1H)、2.17(m,1H)、2.29(m,3H)、5.27(m,2H)、6.89(d,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.29 (s, 3H), 1.30 (s, 3H), 1.97 (d, 1H), 2.17 (m, 1H), 2.29 (m, 3H), 5.27 (m, 2H), 6.89 (d, 1H)

其次,顯示製劑例。此外,份是表示質量份。 Next, the preparation examples are shown. In addition, part means mass part.

製劑例1 Preparation Example 1

將本發明化合物C1,I1,P1,R1,T1,W1,C2,I2,M2,P2,R2,T2,W2,C3,I3,P3,W3,C4,I4,P4及W4的各0.1份溶解於二甲苯(xylene)10份,將其混合於脫臭煤油89.9份,得到油劑。 Dissolve 0.1 parts of each compound of the invention C1, I1, P1, R1, T1, W1, C2, I2, M2, P2, R2, T2, W2, C3, I3, P3, W3, C4, I4, P4 and W4 10 parts of xylene was mixed with 89.9 parts of deodorized kerosene to obtain an oil agent.

製劑例2 Preparation Example 2

將混合溶解了本發明化合物C1,I1,P1,R1,T1,W1,C2,I2,M2,P2,R2,T2,W2,C3,I3,P3,W3,C4,I4,P4及W4的各0.1份及脫臭煤油39.9份之物填充於噴霧罐(aerosol)容器,安裝了閥部分後,經由該閥部分加壓填充噴射劑(液化石油氣)60份,得到油性噴霧罐。 Mix and dissolve each of the compounds C1, I1, P1, R1, T1, W1, C2, I2, M2, P2, R2, T2, W2, C3, I3, P3, W3, C4, I4, P4 and W4 of the present invention 0.1 parts and 39.9 parts of deodorized kerosene are filled in an aerosol container. After the valve part is installed, 60 parts of the propellant (liquefied petroleum gas) are pressurized and filled through the valve part to obtain an oily spray can.

製劑例3 Preparation Example 3

將混合溶解了本發明化合物C1,I1,P1,R1,T1,W1,C2,I2,M2,P2,R2,T2,W2,C3,I3,P3,W3,C4,I4,P4及W4的各0.6份、二甲苯5份、脫臭煤油3.4份及RHEODOL MO-60(乳化劑,花王股份有限公司註冊商標)1份之物,與水50份填充於噴霧罐容器,經由閥部分加壓填充噴射劑(液化石油氣)40份,得到水性噴霧罐。 Mix and dissolve each of the compounds C1, I1, P1, R1, T1, W1, C2, I2, M2, P2, R2, T2, W2, C3, I3, P3, W3, C4, I4, P4 and W4 of the present invention 0.6 parts, 5 parts of xylene, 3.4 parts of deodorized kerosene, and 1 part of RHEODOL MO-60 (emulsifier, registered trademark of Kao Co., Ltd.), filled with 50 parts of water in a spray can container, and filled under pressure through a valve 40 parts of propellant (liquefied petroleum gas) were used to obtain an aqueous spray can.

製劑例4 Preparation Example 4

將本發明化合物C1,I1,P1,R1,T1,W1,C2,I2,M2,P2,R2,T2,W2,C3,I3,P3,W3,C4,I4,P4及W4的各0.3g及BHT0.5g均勻攪拌混合於蚊香用基材(混合了除蟲菊萃取糟粉、木粉、紅楠粉及澱粉之物)99.2g後,將加入包含作為著色劑的孔雀綠(malachite green)的水100mL,充分混練後之物成型乾燥,得到蚊香。 0.3g each of the compounds C1, I1, P1, R1, T1, W1, C2, I2, M2, P2, R2, T2, W2, C3, I3, P3, W3, C4, I4, P4 and W4 of the present invention and 0.5g of BHT was evenly mixed and mixed with 99.2g of the base material for mosquito coils (the mixture of pyrethrum extract grains, wood powder, red ash powder and starch), and the mixture containing malachite green as a coloring agent was added 100mL of water, after fully kneaded, the product was shaped and dried to obtain a mosquito coil.

製劑例5 Preparation Example 5

將脫臭煤油加到本發明化合物C1,I1,P1,R1,T1,W1,C2,I2,M2,P2,R2,T2,W2,C3,I3,P3,W3,C4,I4,P4及W4的各0.8g、胡椒基丁醚(piperonyl butoxide)0.4g及染料並溶解,全部以10mL。將該溶液0.5mL均勻含浸於22mm×35mm、厚度2.8mm的蚊香片用基材(將棉籽絨與紙漿的混合物的原纖維凝固成板狀者),得到蚊香片劑。 Add deodorized kerosene to the compounds C1, I1, P1, R1, T1, W1, C2, I2, M2, P2, R2, T2, W2, C3, I3, P3, W3, C4, I4, P4 and W4 Each 0.8g, piperonyl butoxide 0.4g and the dye were dissolved and dissolved in 10mL. 0.5 mL of this solution was uniformly impregnated with a base material for mosquito coils of 22 mm×35 mm and a thickness of 2.8 mm (those in which fibrils of a mixture of cotton seed wool and pulp were coagulated into a plate shape) to obtain mosquito coil tablets.

製劑例6 Preparation Example 6

將本發明化合物C1,I1,P1,R1,T1,W1,C2,I2,M2,P2,R2,T2,W2,C3,I3,P3,W3,C4,I4,P4及W4的各0.7份及BHT0.3份溶解於界面活性劑(二乙二醇單丁醚)50份與淨化水(purified water)49份而得的液劑放入聚酯製容器,藉由插入能以加熱器(heater)將上部加熱的吸液芯(將無機粉體燒成者),得到加熱蒸散裝置所使用的水性蚊香液劑。 The compounds of the invention C1, I1, P1, R1, T1, W1, C2, I2, M2, P2, R2, T2, W2, C3, I3, P3, W3, C4, I4, P4 and W4 each 0.7 parts and 0.3 parts of BHT dissolved in 50 parts of surfactant (diethylene glycol monobutyl ether) and 49 parts of purified water were placed in a polyester container, and a heater (heater) ) The liquid-absorbent wick heated by the upper part (who burned the inorganic powder) to obtain an aqueous mosquito repellent used in the heating evapotranspiration device.

製劑例7 Preparation Example 7

將本發明化合物C1,I1,P1,R1,T1,W1,C2,I2, M2,P2,R2,T2,W2,C3,I3,P3,W3,C4,I4,P4及W4的各3.0份、惡蟲酮3.0份及偶氮二甲醯胺94.0份充分混合後,將其20g填充到塑膠膜(plastic film)袋,將其收納於耐熱容器並裝填點火器得到燻煙劑。 The compounds of the invention C1, I1, P1, R1, T1, W1, C2, I2, After 3.0 parts each of M2, P2, R2, T2, W2, C3, I3, P3, W3, C4, I4, P4, and W4, 3.0 parts of oxadiazon, and 94.0 parts of azodimethanamide, mix them 20g is filled into a plastic film bag, stored in a heat-resistant container and filled with an igniter to obtain a smoker.

製劑例8 Preparation Example 8

將本發明化合物C1,I1,P1,R1,T1,W1,C2,I2,M2,P2,R2,T2,W2,C3,I3,P3,W3,C4,I4,P4及W4的各10mg溶解於適量的丙酮,均勻塗佈於5cm×5cm、厚度0.3mm的不織布後,將丙酮風乾,得到常溫揮散劑。 10 mg each of the compounds C1, I1, P1, R1, T1, W1, C2, I2, M2, P2, R2, T2, W2, C3, I3, P3, W3, C4, I4, P4 and W4 of the present invention were dissolved in Appropriate amount of acetone is evenly coated on a non-woven fabric of 5 cm×5 cm and a thickness of 0.3 mm, and then the acetone is air-dried to obtain a room temperature dispersant.

製劑例9 Preparation Example 9

將本發明化合物C1,I1,P1,R1,T1,W1,C2,I2,M2,P2,R2,T2,W2,C3,I3,P3,W3,C4,I4,P4及W4的各10份、包含聚氧乙烯烷基醚硫酸銨鹽(polyoxyethylene alkyl ether sulfate ammonium salt)50份的白碳(white carbon)35份及水55份混合,藉由以濕式粉碎法進行微粉碎,得到10%流動劑。 The compound of the present invention C1, I1, P1, R1, T1, W1, C2, I2, M2, P2, R2, T2, W2, C3, I3, P3, W3, C4, I4, P4 and W4 each 10 parts, 35 parts of white carbon containing 50 parts of polyoxyethylene alkyl ether sulfate ammonium salt and 55 parts of water are mixed and finely pulverized by a wet pulverization method to obtain a 10% flow Agent.

其次,顯示以本發明化合物作為有害生物防除劑的有效成分有效當作試驗例。 Next, it was shown that the compound of the present invention was effectively used as an active ingredient of a pest control agent as a test example.

效果試驗例1(使用淡色庫蚊的接觸試驗) Effect test example 1 (contact test using Culex pipiens pallens)

將包含0.1mg的本發明化合物C1,I1,P1,R1,T1,W1,C4,I4,P4及W4的0.2%丙酮溶液0.05mL滴下到直徑28mm、內高13mm、底面積6.15cm2之培養皿(petri dish),均勻地擴展於底面後,以二連球去除丙酮。將淡色庫蚊的雌6隻放入各試樣被保持於底面的培養皿,以開孔的膜覆 蓋上側後,每1分記錄擊倒(knock-down)數,測定且記錄了KT50(50%擊倒的時間)與24小時後的致死率。關於就擊倒率顯示規定以上的數值的試樣係更將丙酮加到前述0.2%丙酮溶液稀釋成10倍,當作0.02%丙酮溶液,依次重複了前述的各器具(培養皿)、試驗方法。 0.05 mL of 0.2% acetone solution containing 0.1 mg of the compounds of the present invention C1, I1, P1, R1, T1, W1, C4, I4, P4 and W4 was dropped to a culture of 28 mm in diameter, 13 mm internal height and 6.15 cm 2 bottom area After the petri dish spreads evenly on the bottom surface, the acetone is removed with a double ball. Six females of Culex pipiens pallens were placed in petri dishes where each sample was held on the bottom surface, and the upper side was covered with a perforated film. The number of knock-downs was recorded every 1 minute, and the KT 50 was measured and recorded ( 50% knockdown time) and lethality after 24 hours. For the sample system showing the above-mentioned value for the knockdown rate, acetone was added to the aforementioned 0.2% acetone solution to dilute it 10 times as a 0.02% acetone solution, and the aforementioned various instruments (petri dishes) and test methods were repeated in sequence. .

而且,作為比較對照使用胺菊酯:1,3,4,5,6,7-六氫-1,3-二氧代-2H-異吲哚-2-基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(以下記為比較化合物A),同樣地進行了試驗。 Furthermore, as a comparative control, pyrethrin was used: 1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl(1R)-trans, cis The formula-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (hereinafter referred to as Comparative Compound A) was tested in the same manner.

將結果顯示於表1 Show the results in Table 1

【表1】

Figure 106111751-A0305-02-0080-54
【Table 1】
Figure 106111751-A0305-02-0080-54

試驗的結果得知本發明化合物C1,I1,P1,R1,T1,W1,C4,I4,P4及W4都顯示超過比較化合物A(胺菊酯)之高的擊倒率(knock-down activity)。 As a result of the test, it was found that the compounds C1, I1, P1, R1, T1, W1, C4, I4, P4 and W4 of the present invention all showed a higher knock-down activity than that of the comparative compound A (Pyrethrin) .

效果試驗例2(使用淡色庫蚊的接觸試驗) Effect test example 2 (contact test using Culex pipiens pallens)

將包含0.1mg的本發明化合物C2,I2,P2,R2,T2,W2,C3,I3,P3及W3的0.2%丙酮溶液0.05mL滴下到直徑28mm、內高13mm、底面積6.15cm2之培養皿,均勻地擴展於底面後,以二連球去除丙酮。將淡色庫蚊的雌6隻放入各試樣被保持於底面的培養皿,以開孔的膜覆蓋上側後,每1分記錄擊倒數,測定且記錄了KT50(50%擊倒的時 間)與24小時後的致死率。關於就擊倒率顯示規定以上的數值的試樣係更將丙酮加到前述0.2%丙酮溶液稀釋成10倍,當作0.02%丙酮溶液,依次重複了前述的各器具(培養皿)、試驗方法。 0.05 mL of 0.2% acetone solution containing 0.1 mg of the compounds of the present invention C2, I2, P2, R2, T2, W2, C3, I3, P3 and W3 was dropped to a culture of 28 mm diameter, 13 mm internal height and 6.15 cm 2 bottom area After the dish spreads evenly on the bottom surface, the acetone is removed with a double ball. Six females of Culex pipiens pallens were placed in petri dishes where each sample was held on the bottom surface, and the upper side was covered with a perforated membrane. The number of knockdowns was recorded every 1 minute, and KT 50 (50% knocked down) was measured and recorded. Time) and lethality after 24 hours. For the sample system showing the above-mentioned value for the knockdown rate, acetone was added to the aforementioned 0.2% acetone solution to dilute it 10 times as a 0.02% acetone solution, and the aforementioned various instruments (petri dishes) and test methods were repeated in sequence. .

而且,作為比較對照使用胺菊酯:1,3,4,5,6,7-六氫-1,3-二氧代-2H-異吲哚-2-基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(以下記為比較化合物A),同樣地進行了試驗。 Furthermore, as a comparative control, pyrethrin was used: 1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl(1R)-trans, cis The formula-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (hereinafter referred to as Comparative Compound A) was tested in the same manner.

將結果顯示於表2 Display the results in Table 2

【表2】

Figure 106111751-A0305-02-0082-56
【Table 2】
Figure 106111751-A0305-02-0082-56

試驗的結果得知本發明化合物C2,I2,P2,R2,T2,W2,C3,I3,P3及W3都顯示超過比較化合物A(胺菊酯)之高的擊倒率。 As a result of the test, it was found that the compounds C2, I2, P2, R2, T2, W2, C3, I3, P3, and W3 of the present invention all exhibited a higher knockdown rate than that of Comparative Compound A (Pyrethrin).

效果試驗例3(使用淡色庫蚊的常溫揮散性試驗) Effect test example 3 (normal temperature swellability test using Culex pipiens pallens)

將淡色庫蚊的雌10隻放入直徑9cm、內高1.9cm、底面積63.6cm2之培養皿,以16網目的金屬絲網覆蓋。將包含0.09mg的所調製的藥劑的本發明化合物I1,P1,W1,I2,P2,W2,I3,P3,W3,P4及W4的2%丙酮溶液0.5mL 滴下到相同尺寸的培養皿(直徑9cm、內高1.9cm、底面積63.6cm2),將丙酮風乾。接著,將塗佈了該藥劑的培養皿倒置於上述金屬絲網之上。然後每1分調查擊倒的淡色庫蚊雌成蟲的數,求擊倒率。 Ten female Culex pipiens pallens were placed in a petri dish with a diameter of 9 cm, an internal height of 1.9 cm, and a bottom area of 63.6 cm 2 , and were covered with a 16-mesh wire mesh. 0.5 mL of a 2% acetone solution of the compound I1, P1, W1, I2, P2, W2, I3, P3, W3, P4 and W4 containing 0.09 mg of the prepared agent was dropped into a Petri dish of the same size (diameter 9cm, inner height 1.9cm, bottom area 63.6cm 2 ), air-dried acetone. Next, the petri dish coated with the medicine was placed upside down on the wire mesh. Then, every 1 minute, the number of female adults of Culex pipiens pallens knocked down was investigated to find the knockdown rate.

而且,作為比較對照使用以下列的式[化49](39)表示的2-氯-6-氟苄基2,2,3,3-四甲基環丙烷羧酸酯(日本國特開昭57-165343號公報所記載的化合物。以下記為比較化合物B)及益避寧:(RS)-(EZ)-1-乙炔基-2-甲基-2-戊烯基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(以下記為比較化合物C),同樣地進行了試驗。 Furthermore, as a comparative control, 2-chloro-6-fluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate represented by the following formula [Chem 49] (39) (Japanese Patent Publication 57-165343. The compound described in Gazette No. 57-165343. The following is referred to as Comparative Compound B) and Yiyining: (RS)-(EZ)-1-ethynyl-2-methyl-2-pentenyl (1R)-trans The formula, cis-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (hereinafter referred to as comparative compound C), was similarly tested.

Figure 106111751-A0305-02-0083-57
Figure 106111751-A0305-02-0083-57

將其結果顯示於表3 The results are shown in Table 3

【表3】

Figure 106111751-A0305-02-0084-59
【table 3】
Figure 106111751-A0305-02-0084-59

試驗的結果得知本發明化合物之I1,P1,W1,I2,P2,W2,I3,P3,W3,P4及W4都顯示超過比較化合 物B及比較化合物C(益避寧)之高的擊倒率。 As a result of the test, it is known that the compounds of the present invention I1, P1, W1, I2, P2, W2, I3, P3, W3, P4 and W4 all show more than the comparative compounds High knockdown rate of Compound B and Comparative Compound C (Yininging).

效果試驗例4(利用蚊香進行的殺蟲試驗) Effect test example 4 (insecticide test using mosquito coils)

將淡色庫蚊成蟲約50隻釋放到70cm立方的玻璃箱(glass chamber)內,將電池式小型風扇(葉片的直徑13cm)設置於箱內使其旋轉。一將藉由製劑例4得到的本發明化合物C1,I1,P1,R1,T1,C2,I2,M2,P2,R2,C3,I3,P3,C4及I4的蚊香0.1g的兩端點火後放入玻璃箱,在15分以內就能使80%以上的淡色庫蚊擊倒,在翌日就能使其80%以上致死。 Approximately 50 adults of Culex pipiens pallens were released into a 70 cm cubic glass chamber, and a small battery-type fan (with a blade diameter of 13 cm) was installed in the chamber and rotated. First, after igniting both ends of 0.1g of the mosquito coils of the compounds C1, I1, P1, R1, T1, C2, I2, M2, P2, R2, C3, I3, P3, C4 and I4 obtained in Preparation Example 4 Putting it in a glass box can knock down more than 80% of Culex pipiens pallens within 15 minutes and kill more than 80% on the next day.

效果試驗例5(利用燻煙劑進行的殺蟲試驗) Effect test example 5 (insecticide test using smoke agent)

在6榻榻米的房間使用加熱器將比照製劑例7調製的本發明化合物C1,I1,P1,R1,T1,C2,I2,M2,P2,R2,T2,C3,I3,P3,C4,I4及P4的燻煙劑1袋加熱到約250℃的結果,成分由以塑膠膜形成的噴煙孔擴散到房間全體,對以蟑螂、蚤、臭蟲為首,以及室塵蟎或腐食酪蟎等的家塵蟎(house-dust mites)類的防除也有效。 In a 6-tatami room, the compound C1, I1, P1, R1, T1, C2, I2, M2, P2, R2, T2, C3, I3, P3, C4, I4 and the compound of the present invention prepared according to Preparation Example 7 were prepared using a heater As a result of heating a bag of P4 smoker to about 250°C, the components spread from the smoke hole formed by a plastic film to the entire room. For household dusts such as cockroaches, fleas, and bed bugs, and house dust mites or carrion mites, etc. The control of mites (house-dust mites) is also effective.

效果試驗例6(利用噴霧罐進行的殺蟲試驗) Effect test example 6 (insecticide test using spray can)

將家蠅雌成蟲約30隻釋放到60cm立方的玻璃箱內,由箱子的側壁的孔每一秒鐘將藉由製劑例2得到的本發明化合物C1,I1,P1,R1,T1,W1,C2,I2,M2,P2,R2,T2,W2,I3,P3,I4及P4的噴霧罐噴霧。其結果,在2分以內能使100%的家蠅擊倒,認定了本發明化合物具有高的擊倒效果。 Approximately 30 female adults of housefly were released into a 60 cm cubic glass box, and the compound C1, I1, P1, R1, T1, W1 of the present invention obtained by Formulation Example 2 every second from the hole in the side wall of the box C2, I2, M2, P2, R2, T2, W2, I3, P3, I4 and P4 spray can spray. As a result, it was possible to knock down 100% of house flies within 2 minutes, and it was confirmed that the compound of the present invention had a high knockdown effect.

<含Br酯化合物的實施例> <Example of Br-containing ester compound>

顯示本發明化合物(含Br酯化合物)的製造例。 A production example of the compound of the present invention (Br-containing ester compound) is shown.

製造例1:化合物(X)的製造 Production Example 1: Production of Compound (X)

在室溫下將溴化四丁銨(1440mg、4.47mmol)、樟腦磺酸(624mg、2.69mmol)、亞硝酸鈉(186mg、2.69mmol)、二價溴化銅(5mg、0.02mmol)依次添加到甲基2-胺基-3,5,6-三氟苯甲酸酯(558mg、2.72mmol)的乙腈(25mL)溶液。在60℃下攪拌24小時後,在室溫下將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化50](X)表示的甲基2-溴-3,5,6-三氟苯甲酸酯340mg:

Figure 106111751-A0305-02-0086-60
At room temperature, tetrabutylammonium bromide (1440mg, 4.47mmol), camphorsulfonic acid (624mg, 2.69mmol), sodium nitrite (186mg, 2.69mmol), divalent copper bromide (5mg, 0.02mmol) were added in sequence A solution of methyl 2-amino-3,5,6-trifluorobenzoate (558 mg, 2.72 mmol) in acetonitrile (25 mL). After stirring at 60°C for 24 hours, water was added to the reaction liquid at room temperature, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain methyl 2-bromo-3,5 represented by the following formula [Chem 50](X) ,6-Trifluorobenzoate 340mg:
Figure 106111751-A0305-02-0086-60

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):4.00(s,3H)、7.16(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 4.00 (s, 3H), 7.16 (m, 1H)

製造例2:化合物(XI)的製造 Production Example 2: Production of Compound (XI)

在冰冷下將二異丁基氫化鋁(1.5M甲苯溶液、2.8mL、4.19mmol)滴下到甲基2-溴-3,5,6-三氟苯甲酸酯(340mg、1.27mmol)的甲苯(4mL)及四氫呋喃(4mL)的混合溶液。在冰冷下攪拌2小時後,將反應液注加到1N鹽酸水溶液及水, 以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化51](XI)表示的2-溴-3,5,6-三氟苯甲醇262mg:

Figure 106111751-A0305-02-0087-61
Diisobutylaluminum hydride (1.5M toluene solution, 2.8mL, 4.19mmol) was dropped into toluene of methyl 2-bromo-3,5,6-trifluorobenzoate (340mg, 1.27mmol) under ice cooling. (4mL) and a mixture of tetrahydrofuran (4mL). After stirring under ice cooling for 2 hours, the reaction solution was poured into 1N hydrochloric acid aqueous solution and water, and extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-3,5,6 represented by the following formula [Chem 51](XI) -262mg of trifluorobenzyl alcohol:
Figure 106111751-A0305-02-0087-61

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):2.04(t,1H)、4.85(dd,2H)、7.04(m,1H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.04 (t, 1H), 4.85 (dd, 2H), 7.04 (m, 1H)

製造例3:化合物(XII)的製造 Production Example 3: Production of Compound (XII)

在室溫下將三乙胺(1.9mL、13.65mmol)、苯甲胺(1.00g、9.33mmol)依次滴下到甲基4-甲基-2,3,5,6-四氟苯甲酸酯(1.01g、4.55mmol)的甲苯(15mL)溶液。在100℃下攪拌10小時後,將水注加到反應液,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化52](XII)表示的甲基2-苄胺基-4-甲基-3,5,6-三氟苯甲酸酯1.18g:[化52]

Figure 106111751-A0305-02-0088-62
Triethylamine (1.9mL, 13.65mmol) and benzylamine (1.00g, 9.33mmol) were added dropwise to methyl 4-methyl-2,3,5,6-tetrafluorobenzoate at room temperature (1.01 g, 4.55 mmol) in toluene (15 mL). After stirring at 100°C for 10 hours, water was added to the reaction liquid, and extraction was performed with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain methyl 2-benzylamino-4 represented by the following formula [Chem 52] (XII) -Methyl-3,5,6-trifluorobenzoate 1.18g: [Chemical 52]
Figure 106111751-A0305-02-0088-62

黃色液體:1H-NMR(CDCl3,TMS)δ(ppm):2.21(m,3H)、3.88(s,3H)、4.50(m,2H)、6.96(brs,1H)、7.29(m,5H) Yellow liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.21 (m, 3H), 3.88 (s, 3H), 4.50 (m, 2H), 6.96 (brs, 1H), 7.29 (m, 5H)

製造例4:化合物(XIII)的製造 Production Example 4: Production of Compound (XIII)

在室溫下將鈀碳(117mg)注加到甲基2-苄胺基-4-甲基-3,5,6-三氟苯甲酸酯(1.15g、3.72mmol)的乙酸乙酯(50mL)溶液,在氫環境下取代反應液。在氫環境下在室溫下攪拌3小時後,對反應液進行矽藻土過濾後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化53](XIII)表示的甲基2-胺基-4-甲基-3,5,6-三氟苯甲酸酯690mg:

Figure 106111751-A0305-02-0088-63
。 Palladium-carbon (117 mg) was added to methyl 2-benzylamino-4-methyl-3,5,6-trifluorobenzoate (1.15 g, 3.72 mmol) of ethyl acetate at room temperature ( 50mL) solution, replacing the reaction solution in a hydrogen environment. After stirring at room temperature for 3 hours under a hydrogen atmosphere, the reaction solution was filtered through diatomaceous earth, concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain the following formula [Chem 53] ( XIII) methyl 2-amino-4-methyl-3,5,6-trifluorobenzoate 690mg:
Figure 106111751-A0305-02-0088-63
.

黃色液體:1H-NMR(CDCl3,TMS)δ(ppm):2.24(m,3H)、3.92(s,3H)、5.55(brs,2H) Yellow liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.24 (m, 3H), 3.92 (s, 3H), 5.55 (brs, 2H)

製造例5:化合物(XIV)的製造 Production Example 5: Production of Compound (XIV)

在室溫下將溴化四丁銨(1867mg、5.80mmol)、樟腦磺酸(809mg、3.49mmol)、亞硝酸鈉(290mg、4.20mmol)、二價溴化銅(18mg、0.08mmol)依次添加到甲基2-胺基-4-甲基-3,5,6-三氟苯甲酸酯(637mg、2.91mmol)的乙腈(30mL)溶液。在60℃下攪拌24小時後,在室溫下將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化54](XIV)表示的甲基2-溴-4-甲基-3,5,6-三氟苯甲酸酯354mg:

Figure 106111751-A0305-02-0089-64
At room temperature, tetrabutylammonium bromide (1867mg, 5.80mmol), camphorsulfonic acid (809mg, 3.49mmol), sodium nitrite (290mg, 4.20mmol), divalent copper bromide (18mg, 0.08mmol) were added in sequence A solution of methyl 2-amino-4-methyl-3,5,6-trifluorobenzoate (637 mg, 2.91 mmol) in acetonitrile (30 mL). After stirring at 60°C for 24 hours, water was added to the reaction liquid at room temperature, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain methyl 2-bromo-4-methyl represented by the following formula [Chem 54] (XIV) Benzyl-3,5,6-trifluorobenzoate 354mg:
Figure 106111751-A0305-02-0089-64

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):2.30(m,3H)、3.98(s,3H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.30 (m, 3H), 3.98 (s, 3H)

製造例6:化合物(XV)的製造 Production Example 6: Production of Compound (XV)

在冰冷下將二異丁基氫化鋁(1.5M甲苯溶液、2.5mL、 3.75mmol)滴下到甲基2-溴-4-甲基-3,5,6-三氟苯甲酸酯(354mg、1.25mmol)的甲苯(3mL)及四氫呋喃(3mL)的混合溶液。在冰冷下攪拌2小時後,將反應液注加到1N鹽酸水溶液及水,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化55](XV)表示的2-溴-4-甲基-3,5,6-三氟苯甲醇278mg:

Figure 106111751-A0305-02-0090-65
Under ice-cooling, diisobutylaluminum hydride (1.5M toluene solution, 2.5 mL, 3.75 mmol) was dropped to methyl 2-bromo-4-methyl-3,5,6-trifluorobenzoate (354 mg, 1.25 mmol) of a mixed solution of toluene (3 mL) and tetrahydrofuran (3 mL). After stirring under ice cooling for 2 hours, the reaction solution was poured into 1N hydrochloric acid aqueous solution and water, and extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-4-methyl- represented by the following formula [Chem 55] (XV) 3,5,6-Trifluorobenzyl alcohol 278mg:
Figure 106111751-A0305-02-0090-65

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):2.05(t,1H)、2.28(m,3H)、4.86(dd,2H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.05 (t, 1H), 2.28 (m, 3H), 4.86 (dd, 2H)

製造例7:化合物(XVI)的製造 Production Example 7: Production of Compound (XVI)

在室溫下將三乙胺(3.4mL、24.53mmol)、苯甲胺(1.73g、16.14mmol)依次滴下到甲基4-甲氧基甲基-2,3,5,6-四氟苯甲酸酯(2.03g、8.06mmol)的甲苯(20mL)溶液。在100℃下攪拌7小時後,將水注加到反應液,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化56](XVI)表示的甲基2-苄胺基-4-甲氧基甲基-3,5,6-三氟苯甲酸酯 2.32g:

Figure 106111751-A0305-02-0091-66
At room temperature, triethylamine (3.4 mL, 24.53 mmol) and benzylamine (1.73 g, 16.14 mmol) were added dropwise to methyl 4-methoxymethyl-2,3,5,6-tetrafluorobenzene A solution of formate (2.03 g, 8.06 mmol) in toluene (20 mL). After stirring at 100°C for 7 hours, water was added to the reaction liquid, and extraction was performed with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain methyl 2-benzylamino-4 represented by the following formula [Chem 56] (XVI) -Methoxymethyl-3,5,6-trifluorobenzoate 2.32g:
Figure 106111751-A0305-02-0091-66

黃色液體:1H-NMR(CDCl3,TMS)δ(ppm):3.35(s,3H)、3.89(s,3H)、4.50(m,2H)、4.52(m,2H)、6.90(brs,1H)、7.28(m,5H) Yellow liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 3.35 (s, 3H), 3.89 (s, 3H), 4.50 (m, 2H), 4.52 (m, 2H), 6.90 (brs, 1H), 7.28 (m, 5H)

製造例8:化合物(XVII)的製造 Production Example 8: Production of Compound (XVII)

在室溫下將鈀碳(230mg)注加到甲基2-苄胺基-4-甲氧基甲基-3,5,6-三氟苯甲酸酯(2.32g、6.84mmol)的乙酸乙酯(80mL)溶液,在氫環境下取代反應液。在氫環境下在室溫下攪拌3小時後,對反應液進行矽藻土過濾後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化57](XVII)表示的甲基2-胺基-4-甲氧基甲基-3,5,6-三氟苯甲酸酯1.12g:[化57]

Figure 106111751-A0305-02-0092-67
Add palladium on carbon (230 mg) to methyl 2-benzylamino-4-methoxymethyl-3,5,6-trifluorobenzoate (2.32 g, 6.84 mmol) of acetic acid at room temperature An ethyl acetate (80 mL) solution was used to replace the reaction solution under a hydrogen atmosphere. After stirring at room temperature for 3 hours under a hydrogen atmosphere, the reaction solution was filtered through diatomaceous earth and concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain the following formula [Chem 57] ( XVII) represented by methyl 2-amino-4-methoxymethyl-3,5,6-trifluorobenzoate 1.12g: [Chem 57]
Figure 106111751-A0305-02-0092-67

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):3.40(s,3H)、3.94(s,3H)、4.56(m,2H)、5.59(brs,2H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 3.40 (s, 3H), 3.94 (s, 3H), 4.56 (m, 2H), 5.59 (brs, 2H)

製造例9:化合物(XVIII)的製造 Production Example 9: Production of Compound (XVIII)

在室溫下將溴化四丁銨(811mg、2.52mmol)、樟腦磺酸(351mg、1.51mmol)、亞硝酸鈉(104mg、1.51mmol)、二價溴化銅(5mg、0.02mmol)依次添加到甲基2-胺基-4-甲氧基甲基-3,5,6-三氟苯甲酸酯(314mg、1.26mmol)的乙腈(15mL)溶液。在60℃下攪拌24小時後,在室溫下將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化58](XVIII)表示的甲基2-溴-4-甲氧基甲基-3,5,6-三氟苯甲酸酯121mg:

Figure 106111751-A0305-02-0092-68
At room temperature, tetrabutylammonium bromide (811mg, 2.52mmol), camphorsulfonic acid (351mg, 1.51mmol), sodium nitrite (104mg, 1.51mmol), divalent copper bromide (5mg, 0.02mmol) were added in sequence A solution of methyl 2-amino-4-methoxymethyl-3,5,6-trifluorobenzoate (314 mg, 1.26 mmol) in acetonitrile (15 mL). After stirring at 60°C for 24 hours, water was added to the reaction liquid at room temperature, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain methyl 2-bromo-4-methyl represented by the following formula [Chem 58] (XVIII) Oxymethyl-3,5,6-trifluorobenzoate 121mg:
Figure 106111751-A0305-02-0092-68

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):3.39(s,3H)、4.00(s,3H)、4.59(m,2H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 3.39 (s, 3H), 4.00 (s, 3H), 4.59 (m, 2H)

製造例10:化合物(XIX)的製造 Production Example 10: Production of Compound (XIX)

在冰冷下將二異丁基氫化鋁(1.5M甲苯溶液、0.8mL、1.20mmol)滴下到甲基2-溴-4-甲氧基甲基-3,5,6-三氟苯甲酸酯(121mg、0.39mmol)的甲苯(2mL)及四氫呋喃(2mL)的混合溶液。在冰冷下攪拌2小時後,將反應液注加到1N鹽酸水溶液及水,以乙酸乙酯進行了萃取。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化59](XIX)表示的2-溴-4-甲氧基甲基-3,5,6-三氟苯甲醇69mg:

Figure 106111751-A0305-02-0093-69
Diisobutylaluminum hydride (1.5M toluene solution, 0.8mL, 1.20mmol) was added dropwise to methyl 2-bromo-4-methoxymethyl-3,5,6-trifluorobenzoate under ice cooling (121 mg, 0.39 mmol) of a mixed solution of toluene (2 mL) and tetrahydrofuran (2 mL). After stirring under ice cooling for 2 hours, the reaction solution was poured into 1N hydrochloric acid aqueous solution and water, and extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-4-methoxy represented by the following formula [Chem 59] (XIX) Methyl-3,5,6-trifluorobenzyl alcohol 69mg:
Figure 106111751-A0305-02-0093-69

白色固體:1H-NMR(CDCl3,TMS)δ(ppm):2.08(t,1H)、3.39(s,3H)、4.58(m,2H)、4.89(dd,2H) White solid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 2.08 (t, 1H), 3.39 (s, 3H), 4.58 (m, 2H), 4.89 (dd, 2H)

製造例11:本發明化合物3的製造 Production Example 11: Production of Compound 3 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(59mg、0.31mmol)及4-二甲胺基吡啶(2mg)加到2-溴-3,5,6-三氟苯甲醇(49mg、0.20mmol)及(1R)-反式-3-(2-甲基-1-丙烯 基)-2,2-二甲基環丙烷甲酸(51mg、0.30mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌19小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化60](XX)表示的2-溴-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物3)17mg:

Figure 106111751-A0305-02-0094-70
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (59mg, 0.31mmol) and 4-dimethylaminopyridine (2mg) to 2-bromo-3, 5,6-trifluorobenzyl alcohol (49mg, 0.20mmol) and (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid (51mg, 0.30 mmol) in chloroform (3 mL). After stirring at room temperature for 19 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-3,5,6 represented by the following formula [Chem 60](XX) -Trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (Compound 3 of the present invention) 17 mg:
Figure 106111751-A0305-02-0094-70

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.12(s,3H)、1.27(s,3H)、1.39(d,1H)、1.68(s,3H)、1.71(s,3H)、2.08(t,1H)、4.88(m,1H)、5.29(m,2H)、7.06(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.12 (s, 3H), 1.27 (s, 3H), 1.39 (d, 1H), 1.68 (s, 3H), 1.71 (s, 3H), 2.08 (t, 1H), 4.88 (m, 1H), 5.29 (m, 2H), 7.06 (m, 1H)

製造例12:本發明化合物9的製造 Production Example 12: Production of Compound 9 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(91mg、0.47mmol)及4-二甲胺基吡啶(3mg)加到2-溴-3,5,6-三氟苯甲醇(88mg、0.37mmol)及(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷甲酸(99mg、0.48mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌18小時後,將水注加到反應 液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化61](XXI)表示的2-溴-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物9)118mg:

Figure 106111751-A0305-02-0095-71
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (91mg, 0.47mmol) and 4-dimethylaminopyridine (3mg) to 2-bromo-3, 5,6-trifluorobenzyl alcohol (88mg, 0.37mmol) and (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropanecarboxylic acid (99mg , 0.48mmol) in chloroform (3mL). After stirring at room temperature for 18 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-3,5,6 represented by the following formula [Chem61](XXI) -Trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate (Compound 9 of the present invention) 118 mg:
Figure 106111751-A0305-02-0095-71

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.18(s,3H)、1.29(s,3H)、1.61(d,1H)、2.27(m,1H)、5.31(m,2H)、5.60(d,1H)、7.09(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.18 (s, 3H), 1.29 (s, 3H), 1.61 (d, 1H), 2.27 (m, 1H), 5.31 (m, 2H), 5.60 (d, 1H), 7.09 (m, 1H)

製造例13:本發明化合物16的製造 Production Example 13: Production of Compound 16 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(50mg、0.26mmol)及4-二甲胺基吡啶(3mg)加到2-溴-3,5,6-三氟苯甲醇(41mg、0.17mmol)及(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷甲酸(關於雙鍵的異構物的比率:Z/E=約8/1)(40mg、0.26mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌24小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化62](XXII) 表示的2-溴-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物16)(關於雙鍵的異構物的比率:Z/E=約8/1)32mg:

Figure 106111751-A0305-02-0096-72
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (50mg, 0.26mmol) and 4-dimethylaminopyridine (3mg) to 2-bromo-3, 5,6-trifluorobenzyl alcohol (41 mg, 0.17 mmol) and (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid (for double bond isomers) Ratio: Z/E = about 8/1) (40 mg, 0.26 mmol) in chloroform solution (3 mL). After stirring at room temperature for 24 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-3,5,6 represented by the following formula [Chem62](XXII) -Trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (Compound 16 of the present invention) (regarding the ratio of isomers of double bonds: Z/E=about 8/1) 32mg:
Figure 106111751-A0305-02-0096-72

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.12(s,3H,Z+E體)、1.27(s,3H,Z+E體)、1.46(d,1H,Z+E體)、1.71(dd,3H,Z+E體)、2.18(m,1H,Z+E體)、5.12(m,1H,Z+E體)、5.30(m,2H,Z+E體)、5.62(m,1H,Z+E體)、7.07(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.12 (s, 3H, Z+E body), 1.27 (s, 3H, Z+E body), 1.46 (d, 1H, Z+ E body), 1.71 (dd, 3H, Z+E body), 2.18 (m, 1H, Z+E body), 5.12 (m, 1H, Z+E body), 5.30 (m, 2H, Z+E body) ), 5.62 (m, 1H, Z+E body), 7.07 (m, 1H)

製造例14:本發明化合物23的製造 Production Example 14: Production of Compound 23 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(44mg、0.23mmol)及4-二甲胺基吡啶(3mg)加到2-溴-3,5,6-三氟苯甲醇(35mg、0.15mmol)及2,2,3,3-四甲基環丙烷甲酸(33mg、0.23mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌20小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化63](XXIII)表示的2-溴-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯(本發明 化合物23)28mg:

Figure 106111751-A0305-02-0097-73
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (44mg, 0.23mmol) and 4-dimethylaminopyridine (3mg) to 2-bromo-3, A solution of 5,6-trifluorobenzyl alcohol (35 mg, 0.15 mmol) and 2,2,3,3-tetramethylcyclopropanecarboxylic acid (33 mg, 0.23 mmol) in chloroform (2 mL). After stirring at room temperature for 20 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-3,5,6 represented by the following formula [Chem63](XXIII) -Trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate (Compound 23 of the present invention) 28 mg:
Figure 106111751-A0305-02-0097-73

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.17(s,7H)、1.25(s,6H)、5.32(m,2H)、7.06(m,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.17 (s, 7H), 1.25 (s, 6H), 5.32 (m, 2H), 7.06 (m, 1H)

製造例15:本發明化合物26的製造 Production Example 15: Production of Compound 26 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(34mg、0.18mmol)及4-二甲胺基吡啶(2mg)加到2-溴-4-甲基-3,5,6-三氟苯甲醇(30mg、0.12mmol)及(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷甲酸(30mg、0.18mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌20小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化64](XXIV)表示的2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物26)22mg:[化64]

Figure 106111751-A0305-02-0098-74
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (34mg, 0.18mmol) and 4-dimethylaminopyridine (2mg) to 2-bromo-4- Methyl-3,5,6-trifluorobenzyl alcohol (30mg, 0.12mmol) and (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane Formic acid (30 mg, 0.18 mmol) in chloroform (2 mL). After stirring at room temperature for 20 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-4-methyl- represented by the following formula [Chem64](XXIV) 3,5,6-Trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (Compound 26 of the present invention) 22 mg : [Chem64]
Figure 106111751-A0305-02-0098-74

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.12(s,3H)、1.27(s,3H)、1.38(d,1H)、1.69(s,3H)、1.70(s,3H)、2.08(t,1H)、2.29(m,3H)、4.88(m,1H)、5.26(m,2H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.12 (s, 3H), 1.27 (s, 3H), 1.38 (d, 1H), 1.69 (s, 3H), 1.70 (s, 3H), 2.08 (t, 1H), 2.29 (m, 3H), 4.88 (m, 1H), 5.26 (m, 2H)

製造例16:本發明化合物32的製造 Production Example 16: Production of Compound 32 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(35mg、0.18mmol)及4-二甲胺基吡啶(3mg)加到2-溴-4-甲基-3,5,6-三氟苯甲醇(30mg、0.12mmol)及(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷甲酸(37mg、0.18mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌16小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化65](XXV)表示的2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物32)35mg:[化65]

Figure 106111751-A0305-02-0099-75
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (35mg, 0.18mmol) and 4-dimethylaminopyridine (3mg) to 2-bromo-4- Methyl-3,5,6-trifluorobenzyl alcohol (30mg, 0.12mmol) and (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethyl A solution (2 mL) of cyclopropanecarboxylic acid (37 mg, 0.18 mmol) in chloroform. After stirring at room temperature for 16 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-4-methyl- represented by the following formula [Chem 65] (XXV) 3,5,6-Trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate (Compound 32 of the present invention) )35mg: [Chem 65]
Figure 106111751-A0305-02-0099-75

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.17(s,3H)、1.29(s,3H)、1.60(d,1H)、2.27(m,1H)、2.29(m,3H)、5.28(m,2H)、5.59(d,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.17 (s, 3H), 1.29 (s, 3H), 1.60 (d, 1H), 2.27 (m, 1H), 2.29 (m, 3H), 5.28 (m, 2H), 5.59 (d, 1H)

製造例17:本發明化合物39的製造 Production Example 17: Production of Compound 39 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(82mg、0.43mmol)及4-二甲胺基吡啶(5mg)加到2-溴-4-甲基-3,5,6-三氟苯甲醇(84mg、0.33mmol)及(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷甲酸(關於雙鍵的異構物的比率:Z/E=約8/1)(66mg、0.43mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌18小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化66](XXVI)表示的2-溴-4-甲基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物39)(關於雙鍵的異構物的比率:Z/E=約8/1)42mg:[化66]

Figure 106111751-A0305-02-0100-76
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (82mg, 0.43mmol) and 4-dimethylaminopyridine (5mg) to 2-bromo-4- Methyl-3,5,6-trifluorobenzyl alcohol (84mg, 0.33mmol) and (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid (about double bond The ratio of isomers: Z/E = about 8/1) (66 mg, 0.43 mmol) in chloroform solution (3 mL). After stirring at room temperature for 18 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-4-methyl- represented by the following formula [Chem 66] (XXVI) 3,5,6-Trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (Compound 39 of the present invention) Structure ratio: Z/E = about 8/1) 42mg: [Chem 66]
Figure 106111751-A0305-02-0100-76

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.13(s,3H,Z+E體)、1.28(s,3H,Z+E體)、1.45(d,1H,Z+E體)、1.70(dd,3H,Z+E體)、2.18(m,1H,Z+E體)、2.29(m,3H,Z+E體)、5.12(m,1H,Z+E體)、5.28(m,2H,Z+E體)、5.59(m,1H,Z+E體) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.13 (s, 3H, Z+E body), 1.28 (s, 3H, Z+E body), 1.45 (d, 1H, Z+ E body), 1.70 (dd, 3H, Z+E body), 2.18 (m, 1H, Z+E body), 2.29 (m, 3H, Z+E body), 5.12 (m, 1H, Z+E body) ), 5.28 (m, 2H, Z+E body), 5.59 (m, 1H, Z+E body)

製造例18:本發明化合物46的製造 Production Example 18: Production of Compound 46 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(29mg、0.15mmol)及4-二甲胺基吡啶(3mg)加到2-溴-4-甲基-3,5,6-三氟苯甲醇(25mg、0.10mmol)及2,2,3,3-四甲基環丙烷甲酸(21mg、0.15mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌22小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化67](XXVII)表示的2-溴-4-甲基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯(本發明化合物46)18mg:[化67]

Figure 106111751-A0305-02-0101-77
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (29mg, 0.15mmol) and 4-dimethylaminopyridine (3mg) to 2-bromo-4- A solution of methyl-3,5,6-trifluorobenzyl alcohol (25 mg, 0.10 mmol) and 2,2,3,3-tetramethylcyclopropanecarboxylic acid (21 mg, 0.15 mmol) in chloroform (2 mL). After stirring at room temperature for 22 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-4-methyl- represented by the following formula [Chem67](XXVII) 3,5,6-trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate (Compound 46 of the present invention) 18 mg: [Chem 67]
Figure 106111751-A0305-02-0101-77

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.16(s,7H)、1.24(s,6H)、2.28(m,3H)、5.32(m,2H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.16 (s, 7H), 1.24 (s, 6H), 2.28 (m, 3H), 5.32 (m, 2H)

製造例19:本發明化合物49的製造 Production Example 19: Production of Compound 49 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(70mg、0.36mmol)及4-二甲胺基吡啶(2mg)加到2-溴-4-甲氧基甲基-3,5,6-三氟苯甲醇(69mg、0.24mmol)及(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷甲酸(80mg、0.48mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌23小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化68](XXVIII)表示的2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物49)17mg:

Figure 106111751-A0305-02-0101-78
。 Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (70mg, 0.36mmol) and 4-dimethylaminopyridine (2mg) to 2-bromo-4- Methoxymethyl-3,5,6-trifluorobenzyl alcohol (69mg, 0.24mmol) and (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethyl Cyclopropanecarboxylic acid (80 mg, 0.48 mmol) in chloroform (2 mL). After stirring at room temperature for 23 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-4-methoxy represented by the following formula [Chem 68](XXVIII) Methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (compound of the present invention) 49) 17mg:
Figure 106111751-A0305-02-0101-78
.

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.12(s,3H)、1.27(s,3H)、1.38(d,1H)、1.69(s,3H)、1.71(s,3H)、2.08(t,1H)、3.40(s,3H)、4.59(m,2H)、4.88(m,1H)、5.29(m,2H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.12 (s, 3H), 1.27 (s, 3H), 1.38 (d, 1H), 1.69 (s, 3H), 1.71 (s, 3H), 2.08 (t, 1H), 3.40 (s, 3H), 4.59 (m, 2H), 4.88 (m, 1H), 5.29 (m, 2H)

製造例20:本發明化合物55的製造 Production Example 20: Production of Compound 55 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(49mg、0.26mmol)及4-二甲胺基吡啶(3mg)加到2-溴-4-甲氧基甲基-3,5,6-三氟苯甲醇(48mg、0.17mmol)及(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷甲酸(53mg、0.25mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌20小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化69](XXIX)表示的2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(2,2-二氯-1-乙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物55)66mg:

Figure 106111751-A0305-02-0102-79
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (49mg, 0.26mmol) and 4-dimethylaminopyridine (3mg) to 2-bromo-4- Methoxymethyl-3,5,6-trifluorobenzyl alcohol (48mg, 0.17mmol) and (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2- A solution (2 mL) of dimethylcyclopropanecarboxylic acid (53 mg, 0.25 mmol) in chloroform. After stirring at room temperature for 20 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to silica gel column chromatography to obtain 2-bromo-4-methoxy represented by the following formula [Chem 69] (XXIX) Methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(2,2-dichloro-1-vinyl)-2,2-dimethylcyclopropane carboxylate (this Inventive compound 55) 66mg:
Figure 106111751-A0305-02-0102-79

無色液體:1H-NMR(CDCl3,TMS)δ(ppm): 1.18(s,3H)、1.29(s,3H)、1.60(d,1H)、2.26(m,1H)、3.40(s,3H)、4.59(m,2H)、5.31(m,2H)、5.60(d,1H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.18 (s, 3H), 1.29 (s, 3H), 1.60 (d, 1H), 2.26 (m, 1H), 3.40 (s, 3H), 4.59 (m, 2H), 5.31 (m, 2H), 5.60 (d, 1H)

製造例21:本發明化合物62的製造 Production Example 21: Production of Compound 62 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(38mg、0.20mmol)及4-二甲胺基吡啶(3mg)加到2-溴-4-甲氧基甲基-3,5,6-三氟苯甲醇(36mg、0.13mmol)及(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷甲酸(關於雙鍵的異構物的比率:Z/E=約8/1)(30mg、0.20mmol)的三氯甲烷溶液(3mL)。在室溫下攪拌18小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化70](XXX)表示的2-溴-4-甲氧基甲基-3,5,6-三氟苄基(1R)-反式-3-(1-丙烯基)-2,2-二甲基環丙烷羧酸酯(本發明化合物62)(關於雙鍵的異構物的比率:Z/E=約8/1)22mg:

Figure 106111751-A0305-02-0103-80
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (38mg, 0.20mmol) and 4-dimethylaminopyridine (3mg) to 2-bromo-4- Methoxymethyl-3,5,6-trifluorobenzyl alcohol (36mg, 0.13mmol) and (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid ( Regarding the ratio of isomers of double bonds: Z/E = about 8/1) (30 mg, 0.20 mmol) in chloroform solution (3 mL). After stirring at room temperature for 18 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-4-methoxy represented by the following formula [Chem 70](XXX) Methyl-3,5,6-trifluorobenzyl (1R)-trans-3-(1-propenyl)-2,2-dimethylcyclopropane carboxylate (Compound 62 of the present invention) (about bis Ratio of bond isomers: Z/E = about 8/1) 22 mg:
Figure 106111751-A0305-02-0103-80

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.12(s,3H,Z+E體)、1.26(s,3H,Z+E體)、1.46(d,1H,Z+E體)、1.71(dd,3H,Z+E體)、2.18(m,1H,Z+E體)、 3.40(s,3H,Z+E體)、4.58(m,2H,Z+E體)、5.11(m,1H,Z+E體)、5.30(m,2H,Z+E體)、5.61(m,1H,Z+E體) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.12 (s, 3H, Z+E body), 1.26 (s, 3H, Z+E body), 1.46 (d, 1H, Z+ E body), 1.71 (dd, 3H, Z+E body), 2.18 (m, 1H, Z+E body), 3.40 (s, 3H, Z+E body), 4.58 (m, 2H, Z+E body) ), 5.11 (m, 1H, Z+E body), 5.30 (m, 2H, Z+E body), 5.61 (m, 1H, Z+E body)

製造例22:本發明化合物69的製造 Production Example 22: Production of Compound 69 of the present invention

將1-乙基-3-(3-二甲胺基丙基)碳二亞胺鹽酸鹽(30mg、0.16mmol)及4-二甲胺基吡啶(3mg)加到2-溴-4-甲氧基甲基-3,5,6-三氟苯甲醇(30mg、0.11mmol)及2,2,3,3-四甲基環丙烷甲酸(23mg、0.16mmol)的三氯甲烷溶液(2mL)。在室溫下攪拌24小時後,將水注加到反應液,以乙酸乙酯萃取反應液。以硫酸鎂將該有機層乾燥後,在減壓條件下濃縮,將殘渣附加於矽膠管柱層析,得到以下列的式[化71](XXXI)表示的2-溴-4-甲氧基甲基-3,5,6-三氟苄基2,2,3,3-四甲基環丙烷羧酸酯(本發明化合物69)18mg:

Figure 106111751-A0305-02-0104-81
Add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (30mg, 0.16mmol) and 4-dimethylaminopyridine (3mg) to 2-bromo-4- A solution of methoxymethyl-3,5,6-trifluorobenzyl alcohol (30mg, 0.11mmol) and 2,2,3,3-tetramethylcyclopropanecarboxylic acid (23mg, 0.16mmol) in chloroform (2mL) ). After stirring at room temperature for 24 hours, water was added to the reaction liquid, and the reaction liquid was extracted with ethyl acetate. After drying the organic layer with magnesium sulfate, it was concentrated under reduced pressure, and the residue was added to a silica gel column chromatography to obtain 2-bromo-4-methoxy represented by the following formula [Chem71] (XXXI) Methyl-3,5,6-trifluorobenzyl 2,2,3,3-tetramethylcyclopropane carboxylate (Compound 69 of the present invention) 18 mg:
Figure 106111751-A0305-02-0104-81

無色液體:1H-NMR(CDCl3,TMS)δ(ppm):1.17(s,7H)、1.25(s,6H)、3.40(s,3H)、4.59(m,2H)、5.30(m,2H) Colorless liquid: 1 H-NMR (CDCl 3 , TMS) δ (ppm): 1.17 (s, 7H), 1.25 (s, 6H), 3.40 (s, 3H), 4.59 (m, 2H), 5.30 (m, 2H)

其次,顯示製劑例。此外,份是表示質量份。 Next, the preparation examples are shown. In addition, part means mass part.

製劑例1 Preparation Example 1

將本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的各0.1份溶解於二甲苯10份,將其混合於脫臭煤油89.9份,得到油劑。 0.1 parts of each of the compounds 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 of the present invention were dissolved in 10 parts of xylene and mixed with 89.9 parts of deodorized kerosene to obtain oil Agent.

製劑例2 Preparation Example 2

將混合溶解了本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的各0.1份及脫臭煤油39.9份之物填充於噴霧罐容器,安裝了閥部分後,經由該閥部分加壓填充噴射劑(液化石油氣)60份,得到油性噴霧罐。 The spray can container was filled with 0.1 parts of each of the compounds of the present invention mixed with 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 and 39.9 parts of deodorized kerosene. After the valve portion, 60 parts of a propellant (liquefied petroleum gas) was pressurized and filled through the valve portion to obtain an oily spray can.

製劑例3 Preparation Example 3

將混合溶解了本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的各0.6份、二甲苯5份、脫臭煤油3.4份及RHEODOL MO-60(乳化劑,花王股份有限公司註冊商標)1份之物,與水50份填充於噴霧罐容器,經由閥部分加壓填充噴射劑(液化石油氣)40份,得到水性噴霧罐。 0.6 parts of each of the compounds 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 of the present invention were mixed and dissolved, 5 parts of xylene, 3.4 parts of deodorized kerosene and RHEODOL MO-60 (Emulsifier, registered trademark of Kao Co., Ltd.) 1 part is filled with 50 parts of water in a spray can container, and 40 parts of a propellant (liquefied petroleum gas) is pressurized and filled through a valve part to obtain an aqueous spray can.

製劑例4 Preparation Example 4

將本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的各0.3g及BHT0.5g均勻攪拌混合於蚊香用基材(混合了除蟲菊萃取糟粉、木粉、紅楠粉及澱粉之物)99.2g後,將加入包含作為著色劑的孔雀綠的水100mL,充分混練後之物成型乾燥,得到蚊香。 0.3 g of each of the compounds 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 and 0.5 g of BHT were evenly mixed and mixed on the base material for mosquito coils (with pyrethrum extract mixed) After 99.2g of gluten powder, wood powder, red powder and starch), 100mL of water containing malachite green as a coloring agent was added, and the material after thorough kneading was molded and dried to obtain a mosquito coil.

製劑例5 Preparation Example 5

將脫臭煤油加到本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的各0.8g、胡椒基丁醚0.4g及 染料並溶解,全部以10mL。將該溶液0.5mL均勻含浸於22mm×35mm、厚度2.8mm的蚊香片用基材(將棉籽絨與紙漿的混合物的原纖維凝固成板狀者),得到蚊香片劑。 Add deodorized kerosene to each of the compounds of the present invention 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 0.8g, piperonyl butoxide 0.4g and Dye and dissolve, all in 10mL. 0.5 mL of this solution was uniformly impregnated with a base material for mosquito coils of 22 mm×35 mm and a thickness of 2.8 mm (those in which fibrils of a mixture of cotton seed wool and pulp were coagulated into a plate shape) to obtain mosquito coil tablets.

製劑例6 Preparation Example 6

將本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的各0.7份及BHT0.3份溶解於界面活性劑(二乙二醇單丁醚)50份與淨化水49份而得的液劑放入聚酯製容器,藉由插入能以加熱器將上部加熱的吸液芯(將無機粉體燒成者),得到加熱蒸散裝置所使用的水性蚊香液劑。 0.7 parts of each of the compounds of the present invention 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 and 0.3 part of BHT were dissolved in a surfactant (diethylene glycol monobutyl ether) 50 parts of the liquid agent obtained from 49 parts of purified water is put into a polyester container, and by inserting a liquid-absorbing core that can heat the upper part with a heater (the inorganic powder is sintered), the liquid used in the heating evapotranspiration device is obtained. Water-based mosquito repellent.

製劑例7 Preparation Example 7

將本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的各3.0份、惡蟲酮3.0份及偶氮二甲醯胺94.0份充分混合後,將其20g填充到塑膠膜袋,將其收納於耐熱容器並裝填點火器得到燻煙劑。 After fully mixing 3.0 parts of each of the compounds of the present invention 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69, 3.0 parts of oxadiazon and 94.0 parts of azodimethanamide, Fill 20g of it into a plastic film bag, store it in a heat-resistant container and fill it with an igniter to obtain a smoker.

製劑例8 Preparation Example 8

將本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的各10mg溶解於適量的丙酮,均勻塗佈於5cm×5cm、厚度0.3mm的不織布後,將丙酮風乾,得到常溫揮散劑。 Dissolve 10 mg of each of the compounds of the present invention 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 in an appropriate amount of acetone, and uniformly apply to a non-woven fabric of 5 cm x 5 cm and a thickness of 0.3 mm , Air-dried acetone to get room temperature dispersant.

製劑例9 Preparation Example 9

將本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的各10份、包含聚氧乙烯烷基醚硫酸銨鹽50份的白碳35份及水55份混合,藉由以濕式粉碎法進行微粉碎,得到10%流動劑。 10 parts of each of the compounds 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 of the present invention, 35 parts of white carbon containing 50 parts of polyoxyethylene alkyl ether ammonium sulfate, and 55 parts of water was mixed and finely pulverized by a wet pulverization method to obtain a 10% flowable agent.

其次,顯示以本發明化合物作為有害生物防除劑的有效成分有效當作試驗例。 Next, it was shown that the compound of the present invention was effectively used as an active ingredient of a pest control agent as a test example.

效果試驗例1(使用淡色庫蚊的接觸試驗) Effect test example 1 (contact test using Culex pipiens pallens)

將包含0.1mg的本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的0.2%丙酮溶液0.05mL滴下到直徑28mm、內高13mm、底面積6.15cm2之培養皿,均勻地擴展於底面後,以二連球去除丙酮。將淡色庫蚊的雌6隻放入各試樣被保持於底面的培養皿,以開孔的膜覆蓋上側後,每1分記錄擊倒數,測定且記錄了KT50(50%擊倒的時間)與24小時後的致死率。關於就擊倒率顯示規定以上的數值的試樣係更將丙酮加到前述0.2%丙酮溶液稀釋成10倍,當作0.02%丙酮溶液,依次重複了前述的各器具(培養皿)、試驗方法。 0.05 mL of 0.2% acetone solution containing 0.1 mg of compounds of the present invention 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 was dropped to a diameter of 28 mm, an internal height of 13 mm, and a bottom area of 6.15 After the cm 2 petri dish spreads evenly on the bottom surface, the acetone is removed with a double ball. Six females of Culex pipiens pallens were placed in petri dishes where each sample was held on the bottom surface, and the upper side was covered with a perforated membrane. The number of knockdowns was recorded every 1 minute, and KT 50 (50% knocked down) was measured and recorded. Time) and lethality after 24 hours. For the sample system showing the above-mentioned value for the knockdown rate, acetone was added to the aforementioned 0.2% acetone solution to dilute it 10 times as a 0.02% acetone solution, and the aforementioned various instruments (petri dishes) and test methods were repeated in sequence. .

而且,作為比較對照使用胺菊酯:1,3,4,5,6,7-六氫-1,3-二氧代-2H-異吲哚-2-基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(以下記為比較化合物A),同樣地進行了試驗。 Furthermore, as a comparative control, pyrethrin was used: 1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl(1R)-trans, cis The formula-3-(2-methyl-1-propenyl)-2,2-dimethylcyclopropane carboxylate (hereinafter referred to as Comparative Compound A) was tested in the same manner.

將結果顯示於表4 Show the results in Table 4

【表4】

Figure 106111751-A0305-02-0108-82
【Table 4】
Figure 106111751-A0305-02-0108-82

試驗的結果得知本發明化合物3,9,16,23,26,32,39,46,49,55,62及69都顯示超過比較化合物A(胺菊酯)之高的擊倒率。 As a result of the test, it was found that the compounds 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62, and 69 of the present invention all exhibited a higher knockdown rate than that of Comparative Compound A (Pyrethrin).

效果試驗例2(使用淡色庫蚊的常溫揮散性試驗) Effect Test Example 2 (Normal volatility test using Culex pipiens pallens)

將淡色庫蚊的雌10隻放入直徑9cm、內高1.9cm、底面積63.6cm2之培養血,以16網目的金屬絲網覆蓋。將包含0.09mg的所調製的藥劑的本發明化合物23,46及69的2%丙酮溶液0.5mL滴下到相同尺寸的培養皿(直徑9cm、內 高1.9cm、底面積63.6cm2),將丙酮風乾。接著,將塗佈了該藥劑的培養皿倒置於上述金屬絲網之上。然後每1分調查擊倒的淡色庫蚊的雌成蟲的數,求擊倒率。 Ten females of Culex pipiens pallens were placed in culture blood with a diameter of 9 cm, an internal height of 1.9 cm, and a bottom area of 63.6 cm 2 , which was covered with a 16-mesh wire mesh. 0.5 mL of 2% acetone solutions of the compounds 23, 46 and 69 of the present invention containing 0.09 mg of the prepared agent was dropped into a petri dish of the same size (diameter 9 cm, internal height 1.9 cm, bottom area 63.6 cm 2 ) Air dry. Next, the petri dish coated with the medicine was placed upside down on the wire mesh. Then, every 1 minute, the number of female adults of Culex pipiens pallens knocked down was investigated to find the knockdown rate.

而且,作為比較對照使用益避寧:(RS)-(EZ)-1-乙炔基-2-甲基-2-戊烯基(1R)-反式,順式-3-(2-甲基-1-丙烯基)-2,2-二甲基環丙烷羧酸酯(以下記為比較化合物B),同樣地進行了試驗。 Also, as a comparative control, Essolin: (RS)-(EZ)-1-ethynyl-2-methyl-2-pentenyl (1R)-trans, cis-3-(2-methyl (-1-propenyl)-2,2-dimethylcyclopropane carboxylate (hereinafter referred to as Comparative Compound B), and the same test was conducted.

將結果顯示於表5 Show the results in Table 5

Figure 106111751-A0305-02-0109-83
Figure 106111751-A0305-02-0109-83

試驗的結果得知本發明化合物23,46及69都顯示超過比較化合物B(益避寧)之高的擊倒率。 As a result of the test, it was found that the compounds 23, 46 and 69 of the present invention all showed a higher knockdown rate than that of the comparative compound B (Yininging).

效果試驗例3(利用蚊香進行的殺蟲試驗) Effect test example 3 (insecticide test using mosquito coils)

將淡色庫蚊成蟲約50隻釋放到70cm立方的玻璃箱內,將電池式小型風扇(葉片的直徑13cm)設置於箱內使其旋轉。一將藉由製劑例4得到的本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的蚊香0.1g的兩端點火後放入玻璃箱,在15分以內就能使80%以上的淡色 庫蚊擊倒,在翌日就能使其80%以上致死。 Approximately 50 adults of Culex pipiens pallens were released into a 70 cm cubic glass box, and a small battery-type fan (with a blade diameter of 13 cm) was installed in the box to rotate it. First, 0.1g of the mosquito coils of the compounds 3, 9, 16, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 of the present invention obtained in Preparation Example 4 were ignited at both ends and placed in a glass box. Within 15 minutes can make more than 80% of the light color Culex mosquitoes are knocked down and can kill more than 80% the next day.

效果試驗例4(利用燻煙劑進行的殺蟲試驗) Example 4 of effect test (insecticide test using smoke agent)

在6榻榻米的房間使用加熱器將比照製劑例7調製的本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的燻煙劑1袋加熱到約250℃的結果,成分由以塑膠膜形成的噴煙孔擴散到房間全體,對以蟑螂、蚤、臭蟲為首,以及室塵蟎或腐食酪蟎等的家塵蟎類的防除也有效。 In a 6-tatami room, use a heater to heat 1 bag of the fumigant of Compounds 3, 9, 16, 23, 26, 32, 39, 46, 49, 55, 62 and 69 prepared according to Preparation Example 7 to about As a result of the temperature of 250°C, the components spread from the smoke holes formed by the plastic film to the entire room, and it is also effective for the prevention of house dust mites such as cockroaches, fleas, bed bugs, and house dust mites or carrion mites.

效果試驗例5(利用噴霧罐進行的殺蟲試驗) Example 5 of effect test (insecticide test using spray can)

將家蠅雌成蟲約30隻釋放到60cm立方的玻璃箱內,由箱子的側壁的孔每一秒鐘將藉由製劑例2得到的本發明化合物3,9,16,23,26,32,39,46,49,55,62及69的噴霧罐噴霧。其結果,在2分以內能使100%的家蠅擊倒,認定了本發明化合物具有高的擊倒效果。 Approximately 30 female housefly adults were released into a 60 cm cubic glass box, and the compound 3, 9, 16, 16, 23, 26, 32 of the present invention obtained by Formulation Example 2 was taken from the hole in the side wall of the box every second. Spray in spray cans of 39, 46, 49, 55, 62 and 69. As a result, it was possible to knock down 100% of house flies within 2 minutes, and it was confirmed that the compound of the present invention had a high knockdown effect.

本發明化合物因具有優良的有害生物防除效力,故可當作有害生物防除劑的有效成分利用。而且,本發明化合物具有也能當作對獲得了抵抗性的有害生物的防除劑的有效成分利用的可能性,極為有效。 Because the compound of the present invention has an excellent pest control effect, it can be used as an effective component of a pest control agent. In addition, the compound of the present invention has the possibility of being used as an active ingredient of a control agent against a pest that has acquired resistance, and is extremely effective.

Claims (6)

一種酯化合物,以下列的通式[化1](1)表示:
Figure 106111751-A0305-02-0111-84
[式中R1是表示氫原子,R2為以下列通式[化2](2)
Figure 106111751-A0305-02-0111-85
(此處X及Y為同一或不同,表示氫原子、鹵素原子、氰基、或碳數1~4的烷基,X表示氫原子時Y表示碳數1~4的烷基,X表示鹵素原子、氰基、或碳數1~4的烷基時,Y表示鹵素原子、或碳數1~4的烷基)表示的基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基]。
An ester compound, represented by the following general formula [Chem 1] (1):
Figure 106111751-A0305-02-0111-84
[In the formula, R 1 represents a hydrogen atom, and R 2 is represented by the following general formula [Chem 2] (2)
Figure 106111751-A0305-02-0111-85
(Here X and Y are the same or different and represent a hydrogen atom, a halogen atom, a cyano group, or a C 1-4 alkyl group, X represents a hydrogen atom, Y represents a C 1-4 alkyl group, X represents a halogen When an atom, a cyano group, or an alkyl group having 1 to 4 carbon atoms, Y represents a halogen atom or an alkyl group having 1 to 4 carbon atoms), and R 3 represents a hydrogen atom, a trifluoromethyl group, a methyl group, Methoxy, methoxymethyl, allyl, ethynyl or propynyl].
一種酯化合物,以下列的通式[化3](I)表示:[化3]
Figure 106111751-A0305-02-0112-86
[式中R1是表示氫原子,R2為以下列通式[化4](II)
Figure 106111751-A0305-02-0112-87
(此處X及Y為同一或不同,表示氫原子、鹵素原子、氰基、或碳數1~4的烷基,X表示氫原子時Y表示碳數1~4的烷基,X表示鹵素原子、氰基、或碳數1~4的烷基時,Y表示鹵素原子、或碳數1~4的烷基)表示的基,R3是表示氫原子、三氟甲基、甲基、甲氧基、甲氧基甲基、烯丙基、乙炔基或丙炔基]。
An ester compound represented by the following general formula [Chem 3] (I): [Chem 3]
Figure 106111751-A0305-02-0112-86
[Where R 1 represents a hydrogen atom, and R 2 is represented by the following general formula [Chem 4] (II)
Figure 106111751-A0305-02-0112-87
(Here X and Y are the same or different and represent a hydrogen atom, a halogen atom, a cyano group, or a C 1-4 alkyl group, X represents a hydrogen atom, Y represents a C 1-4 alkyl group, X represents a halogen When an atom, a cyano group, or an alkyl group having 1 to 4 carbon atoms, Y represents a halogen atom or an alkyl group having 1 to 4 carbon atoms), and R 3 represents a hydrogen atom, trifluoromethyl, methyl, Methoxy, methoxymethyl, allyl, ethynyl or propynyl].
如申請專利範圍第1項或第2項之酯化合物,其中R3是以氫原子、甲基、或甲氧基甲基表示。 For example, the ester compound of the first or second patent application, wherein R 3 is represented by a hydrogen atom, a methyl group, or a methoxymethyl group. 一種酯化合物,以下列的化學式[化48](38)表示:
Figure 106111751-A0305-02-0112-88
An ester compound, represented by the following chemical formula [Chem 48] (38):
Figure 106111751-A0305-02-0112-88
.
一種有害生物防除劑,含有以申請專利範圍第1項、第2項或第4項中任一項的酯化合物作為有效成分。 A pest control agent containing an ester compound taking any one of the first, second, or fourth patent application scope as an active ingredient. 一種有害生物的防除方法,將申請專利範圍第1項、第2項或第4項中任一項的酯化合物施用於有害生物或有害生物的棲息地,該有害生物的防除方法排除使用於人體或動物。 A pest control method, applying the ester compound of any one of the first, second, or fourth items of the patent application to a pest or a pest habitat, the pest control method is excluded from use in humans Or animals.
TW106111751A 2016-04-15 2017-04-07 Ester compounds and use thereof TWI687161B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2016082141 2016-04-15
JP2016-082141 2016-04-15
JP2016113552 2016-06-07
JP2016-113552 2016-06-07

Publications (2)

Publication Number Publication Date
TW201739353A TW201739353A (en) 2017-11-16
TWI687161B true TWI687161B (en) 2020-03-11

Family

ID=60041581

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106111751A TWI687161B (en) 2016-04-15 2017-04-07 Ester compounds and use thereof

Country Status (4)

Country Link
JP (1) JP6716686B2 (en)
CN (1) CN109071410B (en)
TW (1) TWI687161B (en)
WO (1) WO2017179568A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6628000B1 (en) * 2018-10-23 2020-01-08 住友化学株式会社 Ester compounds and their uses
CN111122688B (en) * 2019-11-25 2022-06-28 应急管理部沈阳消防研究所 Fire material evidence identification method for cigarette combustion ash

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183950A (en) * 1976-12-22 1980-01-15 Bayer Aktiengesellschaft Combating arthropods with 2,2-dimethyl-3-vinyl-cyclopropane carboxylic acid esters of halogenated benzyl alcohols
DE2840992A1 (en) * 1978-09-21 1980-05-29 Bayer Ag AGENT AGAINST SOIL INSECTS
US4259349A (en) * 1978-10-13 1981-03-31 Shell Oil Company Halobenzyl ester pesticides
ZA795532B (en) * 1978-10-27 1980-09-24 Ici Ltd Halogenated esters of cyclopropane acids,their preparation compositions and use as pesticides
EP0060617A1 (en) * 1981-03-18 1982-09-22 Imperial Chemical Industries Plc Fluorobenzyl cyclopropane carboxylates, their preparation, compositions and use as insecticides
GB2120655A (en) * 1982-05-21 1983-12-07 Ici Plc Insecticidal halogenated ester of cyclopropane carboxylic acid
JPS63267706A (en) * 1987-04-22 1988-11-04 Dainippon Jiyochiyuugiku Kk Insecticide containing benzyl alcohol ester for smoking combustion and thermal evaporation and production thereof
JP3728967B2 (en) * 1998-02-26 2005-12-21 住友化学株式会社 Ester compound
MY118214A (en) * 1998-02-26 2004-09-30 Sumitomo Chemical Co Ester of 2,2-dimethyl-cyclopropanecarboxylic acid and their use as pesticides
JP2007145781A (en) * 2005-11-30 2007-06-14 Sumitomo Chemical Co Ltd Ester compound and its use

Also Published As

Publication number Publication date
TW201739353A (en) 2017-11-16
CN109071410B (en) 2022-11-01
WO2017179568A1 (en) 2017-10-19
JPWO2017179568A1 (en) 2019-02-21
CN109071410A (en) 2018-12-21
JP6716686B2 (en) 2020-07-01

Similar Documents

Publication Publication Date Title
TWI663151B (en) Ester compounds and use thereof
TWI687161B (en) Ester compounds and use thereof
JP6879449B2 (en) Ester compounds and their uses
JP2010173951A (en) Cyclopropanecarboxylic acid ester and use thereof
JP2010047561A (en) Ester compound, and use thereof
JP5906723B2 (en) Pest control composition and pest control method
JP5251116B2 (en) Cyclopropanecarboxylic acid ester and use thereof
JP7220954B2 (en) Ester compound and its use
JP6910728B2 (en) Ester compounds and their uses
JP2014159380A (en) Pest control composition and controlling method of pest
JP2017214310A (en) Ester compound and usage thereof
JP6618364B2 (en) Ester compounds and uses thereof
JP2020105128A (en) Ester compound and use thereof
JP6382083B2 (en) Ester compounds and uses thereof
JP6061758B2 (en) Transester compounds and uses thereof
JP6061759B2 (en) Transester compounds and uses thereof
JP2019089717A (en) Insecticidal composition
JP2019043890A (en) Ester compound and use therefor
JP2018043961A (en) Ester compound and use therefor
JP6685600B2 (en) Heating transpiration agent for mosquito control
JP2018048081A (en) Ester compound and use thereof
JP2009143810A (en) Cyclopropane carboxylate and use of the same
JP2009120534A (en) Cyclopropanecarboxylic acid ester and its use
JP2010024212A (en) 2-cyano-2,3,3-trimethylcyclopropanecarboxylic acid ester and use thereof
JP2010173953A (en) Cyclopropanecarboxylic acid ester and application thereof